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Abstract 
Several disorders including pulmonary hypertension (PH) and heart failure (HF) 
could lead to right ventricle (RV) hypertrophy and failure. RV failure is one of the 
most important prognostic factors for morbidity and mortality in these disorders. 
However, there is still no therapy to prevent the RV hypertrophy in PH. Treatments 
developed for the left ventricle (LV) failure do not improve the survival in patients 
with RV failure probably due to the significant differences in the chambers 
physiology and hemodynamic function. A better understanding of the cellular and 
molecular mechanisms of RV hypertrophy is needed. Our focus lies into the 
alterations of cellular microarchitecture that promotes functional changes in Ca2+ 
handling. Recently our group showed that reorganisation of the transverse-axial 
tubular system (TATS) in HF are of particular importance for Ca2+ mishandling and 
contractile impairment of failing cells.  
Rationale: This study aims to establish the differences in membrane organisation of 
Ca2+ handling between healthy RV and LV myocytes, and to investigate the 
remodelling of RV during disease. 
Specifically, the objectives are: (1) To study the membrane organisation of RV and 
LV myocytes by revealing the surface topography using Scanning Ion Conductance 
Microscopy and by studying the TATS using confocal microscopy. (2) To assess 
the contraction and Ca2+ transients in RV and LV myocytes. (3) To determine the 
spatial distribution and properties of single L-type Ca2+ channels (LTCC) in RV 
myocytes using “smart patch clamp” technique. (4) To describe the changes 
occurring in the RV and LV in the two disease rat models: PH induced by 
monocrotaline injection and HF induced by chronic myocardial infarction (MI).  
This thesis showed that in healthy samples the TATS of RV myocytes has a 
different organization as compared to LV. Two main Ca2+ channels for the 
excitation-contraction coupling: LTCC and ryanodine receptors (RyR) were studied 
by immunofluorescence staining. The density of LTCC was lower in RV than in 
LV myocytes. However, the density of RyR was similar between the chambers. 
Contraction duration was longer in RV than in LV myocytes. The distribution of 
4 
 
functional LTCCs in RV myocytes was uniform along the cell surface, in contrast 
to LV myocytes, where LTCCs were primarily located in the T-tubules. 
Secondly, PH rats showed a reduction of the conduction velocity anisotropy 
throughout the RV as well as prolongation of the refractoriness of the tissue. The 
hypertrophy of RV myocytes in PH was accompanied by the reduction of the TATS 
organisation. The amplitude of contraction of RV PH myocytes was higher, the 
activation of Ca2+ transients was more desynchronised than in controls, and the rate 
of spontaneous Ca2+ activity was significantly elevated. Functionally, in PH the 
open probability (Po) of LTCC located in the T-tubules was significantly higher. 
On the other hand, PH LV myocytes had preserved TATS but still showed 
prolonged Ca2+ transients that could influence increased refractoriness of LV tissue.  
Thirdly, by studying RV myocytes from the MI model, a significant hypertrophy 
was found, accompanied by a reduction of TATS organisation. The study reports a 
prolongation of Ca2+ transients with more frequent local Ca2+ waves in MI versus 
control RV myocytes. Higher Po of LTCCs was shown in MI RV myocytes could 
be associated with the PKA-mediated phosphorylation.  
In summary, RV myocytes have a lower TATS organisation than LV myocytes 
probably related to the lower workload of the RV chamber. Consequently, RV 
myocytes present several differences with LV myocytes, including changes in the 
Ca2+ handling or a more uniform distribution of LTCC on the membrane. Diseases 
induce reduction of TATS and Ca2+ mishandling in both chambers. Due to the 
intrinsic differences of RV versus LV myocytes, the RV could be more prone to 
pathological events in early stages of the diseases, which should be investigated 
further.  
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1.  General introduction 
For the many years, more attention was given to study the left ventricle (LV) 
disorders, overshadowing the investigation of the right ventricle (RV) physiology 
and pathologies (Greyson, 2010). Recently, RV pathological changes was not 
considered as primary ones and not as critical for heart functioning and ejection 
fraction maintenance as the LV, and that’s why less attention was paid to the RV. 
Now growing body of clinical and experimental data indicates the participation and 
importance of RV in many severe disorders. RV is suffering in the settings of 
respiratory disorders, which leads to pulmonary vasoconstriction and pulmonary 
hypertension (Greyson, 2010; Thenappan et al., 2010; Zapol and Snider, 1977). In 
case of primary pulmonary hypertension, in average 1 in 2000 of the 10–15 million 
pulmonary hypertensive people will develop RV failure (Naeije, 2005). Pulmonary 
embolism induced causes more than 50,000 deaths annually, mostly due to acute 
RV failure (Hirsh and Hoak, 1996). Several disorders like sepsis and coronary 
ischemia, can directly induce RV dysfunction (Goldstein, 2002; Lambermont et al., 
2003). Idiopathic dilated cardiomyopathy can lead to pulmonary hypertension and 
RV failure. (La Vecchia et al., 2001). Moreover, in patients with left heart failure, 
RV failure was shown to be an independent risk factor for morbidity and mortality 
(Ghio and Tavazzi, 2005). RV failure is still a leading cause of death early after 
cardiac transplant (Stobierska-Dzierzek et al., 2001) and following several other 
cardiothoracic procedures (Kaul, 2000). Altogether this indicates a high clinical 
importance of RV function in heart pathophysiology.  
Interventricular differences could be important for understanding the RV 
physiology and pathophysiology. RV differs stridently from LV in terms of 
working conditions and responses to high pressure and load (Greyson, 2008). Inter-
ventricular differences in organisation of excitation- contraction coupling were 
observed on cellular level (Molina et al., 2014; Sathish et al., 2006). These findings 
indicate that the mechanisms of RV progression in disease can differ from those 
observed in LV. 
This chapter will review the recent findings of RV and LV behaviour, especially 
cell organisation and excitation- contraction coupling. 
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1.1 Mechanics of the right and left ventricle contraction 
1.1.1 General heart function 
The heart is a muscular organ located in the chest immediately posterior to the 
sternum. The heart is connected to the vascular system which delivers blood 
through the body. The main function of cardiovascular system is to transport 
oxygen and nutrients to the cells of the body and remove carbon dioxide and other 
metabolic waste products. The heart consists of two thin walled atria and two more 
thicker muscular ventricles (Figure 1.1; (Bettex et al., 2014)). The right and left 
sides of the heart have different functions. The right heart pump the blood in the 
lungs for oxygenation and the left heart pumps the oxygenated blood to the body. 
 
Figure 1.1 General heart organisation. From thoughtco.com 
Atria main function is to receive the blood from the veins and to pump it to the 
ventricles. Their thin-walled organisation allows atria to cope with sudden changes 
in venous return. The right atrium gets the deoxygenated blood from systemic 
circulation and delivers it to the RV which pumps it out to the pulmonary vein. The 
left atrium takes the oxygenated blood from pulmonary circulation and brings it to 
the LV which pumps it in the systemic circulation. The ventricles have a more 
muscular body than the atria to pump the blood out of the heart. Each cardiac cycle 
consists of two phases, namely diastole and systole. In diastole, atria are contracting 
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and ventricles are filling with blood. In systole, the ventricles are contracting and 
atria are relaxing (Sonnenblick et al., 1967).  
1.1.2 Pulmonary and systemic circulation cycles 
The structure and the function of ventricles cannot be described without taking in 
consideration a circulation cycle. RV pumps blood into pulmonary circulation and 
LV pumps blood into systemic circulation. Pulmonary circulation has several 
remarkable differences from the systemic circulation. Anatomically, the systemic 
circulation presents a big circuit that consists of one large main artery with small 
brunches. On the contrary, the pulmonary circulation has a wide network of short 
vessels which repeatedly branches in three daughter vessels (Horsfield, 1978). 
Besides structural differences between pulmonary and systemic circulations they 
markedly differ in function. Systemic circulation has a much higher pressure and 
resistance than pulmonary system (Table 1). Also, these circuits act differently 
under external stimuli. For example, hypoxia causes the dilation of systemic 
circulation but constricts pulmonary circulation constricts.  
Table 1. Average values of systemic and pulmonary circulation resistance and 
pressure. Adapted from (Greyson, 2008). 
 Pulmonary/ RV/RA Systemic/ LV/LA 
Vascular resistance 
(dyne*s*sm-5M2) 
123±54 2130±450 
Pressure (mmHg)   
Atrial mean 2-7 2-12 
Ventricular systolic 15-28 90-140 
Ventricular diastolic 0-8 4-12 
Vascular mean 10-16 65-105 
 
1.1.3 Left ventricle  
Properties of the circulation system are among main factors that determine the 
ventricular properties. The LV presents an ellipsoidal thick walled chamber (Figure 
1.1. Two thick papillary muscles anchor the chordae tendinae to the two flaps of 
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the mitral valve which prevents backflow of blood into the atrium during systole 
(Sengupta et al., 2008).  
When the heart contracts during systole, the apex of the heart is pulled towards the 
base while simultaneously sheets of fibres slide past each other in a “wringing” 
motion due to muscle fibre orientation. It then thickens the ventricle wall reducing 
the chamber lumen further and efficiently ejecting blood (Figure1.2, Hales et al., 
2012). 
 
Figure 1.2. Schematic of the RV and LV contractions. From (Greyson, 2008). 
 
1.1.4 Right ventricle 
The RV pumps blood out into a highly compliant and low resistance pulmonary 
circulation, which requires around one sixth of the work of the LV (Greyson, 2008). 
The amount of blood injected in one contraction cycle is similar between the RV 
and LV. In LV a relatively large portion of stroke goes to pressure generation 
whereas in RV most part of the stroke generates the blood steam momentum. 
Moreover, there is a small blood ejection from the RV even during diastole (Pouleur 
et al., 1980).  
In cross-section, the RV has a crescent shape (Figure 1.2). The normal RV seldom 
exceeds 2–3 mm wall thickness at end-diastole, compared with 8–11 mm for the 
LV (Portman et al., 1987). The contraction pattern of the RV is drastically different 
from the LV. The RV has a peristaltic like contraction through longitudinal 
shortening that begins at the apex and moves to the outflow tract (Dell’Italia et al., 
1995; Greyson, 2008). Ejection is further assisted by the LV pulling on the RV at 
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the points of attachment to the interventricular septum. The differences between the 
RV and LV result in a higher ratio between the RV volume change to RV free wall 
surface area change and let the RV eject a large volume of blood with a less amount 
of RV stretch (Greyson, 2008). This type of contraction allows the RV to move 
large and varying volumes of blood but it is not well adapted to generate a high 
pressure. In addition, at end-systole, LV free wall radius of curvature decreases, 
which facilitates further development of pressure by decreasing the wall stress. 
Whereas the free wall of the RV increases the radius of curvature at the end of 
systole that produces a higher stress at peak pressure and prevents high pressure 
development (Greyson, 2008). 
The dynamics of contracting hearts is usually analysed by using pressure-volume 
(PV) loops. The typical examples of PV loops for the LV and RV are shown in 
Figure 1.3. LV contraction produces a square shape of PV loop with clear points of 
end-systole and aortic valve closure. The function of the LV is usually described in 
terms of time varying elastance. This parameter can be determined from the slope 
of the PV relation at specific (“isochronal”) times in the cardiac cycle (Suga, 2003). 
In contrast, RV ejects blood even during the ventricular relaxation, that produces a 
triangular shape of the PV loop (Shaver et al., 1974). This leads to a problematic 
determination of the “end-systole” and difficulties in interpretation of RV 
dynamics.  
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Figure 1.3. Pressure-volume relationships for the LV (left) and RV (right). From 
(Greyson, 2010). 
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1.2 Electrical properties of cardiac tissue 
Synchronous contraction of all the parts of the heart is led by electrical waves. 
Cardiac tissue represents a striated muscle that is structurally similar to the skeletal 
one. However, the physiology of the cardiac tissue is distinct from that of the 
skeletal one (Hopkins, 2006). The skeletal muscle generates a very short action 
potential which is controlled by the nervous system. The heart can autonomously 
generate the action potentials at the specialized areas called nodes. Neurons can 
only modulate the rate of spontaneous electrical activity of the heart. The duration 
of the cardiac action potential is quite long (200-400 ms), which results in the 
generation of a full force during one action potential, but not a from a sequence of 
stimulations. Moreover, the force of contraction can be modified according to a load 
or modulated by the cardiac nerves. 
The heart walls can be divided into three different cell layers: the pericardium, the 
myocardium and the endocardium (Sanchez-Quintana et al., 1990). The 
myocardium is a main layer that is responsible for contraction. It represents a 
special tissue, consisting of individual cells joined by electrical gap junctions. This 
communication allows the spread of electrical wave from one cardiac cell to another 
throughout the whole heart (Carmeliet and Vereecke, 2002). The depolarization 
wave causes a contraction, which also spreads like a wave throughout the heat from 
atria to ventricles. 
There are two main types of muscle cells in the heart: contractile cells and 
conductive cells. The main difference between them is the generation of 
spontaneous action potential (Woodcock and Matkovich, 2005). Conductive 
(pacemaker) cells are able to spontaneously generate the depolarization waves 
(action potentials (APs)), whereas contractile cells contracts following these APs. 
Furthermore, an AP in one cardiac muscle cell will stimulate its neighbouring cells 
to undergo the depolarization (Hill, 2016). The waveform of AP depends on the 
tissue type, the typical waveforms of APs in different parts of the heart are shown 
in Figure 1.4. 
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Figure 1.4. Representative action potential waveforms from different regions of the 
heart. AV = atrioventricular node; Endo = myocytes from endocardium; Epi = myocytes 
from epicardium; LV = left ventricle; M Cells = myocytes from midmyocardium; RV = 
right ventricle; SA = sinoatrial node. From (Molina et al., 2016).  
The propagation of depolarization waves starts in the sinoatrial (SA) node. This is 
a specialized tissue located in the right atrium, which can trigger a normal 
pacemaker activity of the heart (Hill, 2016). The impulse then travels from the SA 
node into the atrial syncytium, and the atria begin to contract. After that the impulse 
reaches the atrioventricular (AV) node. AV node has two main functions: to transfer 
depolarization from the atria to the ventricles and to induce a delay in the 
propagation of excitation from the atria to the ventricles (Kléber and Rudy, 2004). 
This time delay is important to allow the atria to eject blood into ventricles in prior 
of ventricular contraction. Then the depolarization wave reaches the specialized 
33 
 
conducting cells, called Purkinje fibres (Hill, 2016). This special cells can rapidly 
transmit electrical signals down to the apex of the heart so that all the contractile 
cells in the apex can contract nearly simultaneously (Silverthorn, 2009). 
1.2.1 Action potential in myocytes 
The excitation and repolarization of cardiomyocytes during each cycle of 
contraction are produced by the work of multiple ion channels and pumps which 
regulate disequilibrium of the electrical potential between inner and outer sides of 
the cellular plasma membrane. Ion channels and pumps modulate membrane 
potential through the entry or extrusion of selected ions.  
The shape of cardiac AP shows large variations depending on the cell type (Figure 
1.4), but generally it can be subdivided into five phases presented in Figure 1.7 
(Carmeliet and Vereecke, 2002). Phase 0 starts when a negative resting membrane 
potential (-90 mV) reaches the threshold value (-70 mV) that necessary to open the 
fast voltage gated Na+ channels. Influx of Na+ ions depolarises the membrane, and 
the transmembrane potential reaches +20 mV. Phase 1 starts when Na+ current 
inactivates. The openings of voltage gated outward K+ (Ito,f) channels produce 
increased K+ efflux out of the cytosol. This step leads to a slight repolarization of 
the cardiomyocytes (back to +5 mV). Phase 2 characterized by the opening of 
voltage gated Ca2+ ion channels. For a short time the rapid and slow delayed-
rectifier K+ efflux (IKr and IKs, respectively) and the Ca
2+ influx counterbalance each 
other and keep the membrane potential at a relative plateau. Later, the Ca2+ current 
declines due to voltage and Ca2+ dependent inactivation of the voltage-gated Ca2+ 
channels which finishes the phase 2. However, the K+ efflux continues during the 
phase 3. The inward-rectifier K+ current (IK1) activates late during the AP and 
controls final repolarization and resting membrane potential stability. At the end of 
phase 3, the membrane potential is turned back to its resting state (at -90mV) 
(Nerbonne and Kass, 2005). In working myocardium, phase 4 is determined by a 
stable membrane potential at -80 mV (Bers and Perez-Reyes, 1999; Fabiato and 
Fabiato, 1978). 
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Figure 1.5. Shape of ventricular AP. Phases: resting (4), upstroke (0), early repolarization 
(1), plateau (2), and final repolarization (3). INa = Na+ current; Ito = transient outward K+ 
current; ICaL = L-type Ca2+ current; INCX = Na+-Ca2+ exchange current; IK,ATP = ATP-
sensitive K+ current; IKr = rapid component of delayed-rectifier K+ current (IK); IKs = slow 
component of IK; IK1 = inward-rectifier K+ current. Schematic from (Molina et al., 2016). 
It is important to mention the differences between the heart rate and AP properties 
from different species (Figure 1.6 and Table 2). There is a big difference of the heart 
rate between rodents and large animals such as rabbit, dog and human (Table 2). 
These differences are responsible for a much shorter AP duration measured in rat 
and mouse compared to a human. Moreover, APs in rodents lack the plateau phase 
(2 phase of AP) (Figure 1.6). All these differences account for the limitations of the 
usage of small rodents as a models of human disease.  
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Figure 1.6. Representative shapes of ventricular APs, recorded from mouse, 
rat, rabbit and human ventricular myocytes. All action potentials were 
stimulated in 0.5 Hz and recorded in room temperature, from isolated ventricular 
myocyte. Figures were adapted from (Varro’ et al., 1993). 
Table 2. Species related properties of APs 
Properties Specie  
Mouse  Rat  Rabbit  Dog  Human 
Heart rate, bpm 500-724 330-480 120-150 60-140 56-101 
Resting 
membrane 
potential, mV 
-73±1 −75±4 -76±3 −82±2 −82 ± 2 
Maximum 
upstroke velocity, 
V/s 
114±12 148±12 158±18 275 ±58  
AP amplitude, 
mV 
125.6±2.7 98.5±2.3 125.8±3.9 120-145 120-130 
AP duration at  
50%, ms 
4.5±0.3 13±1 193±25 189+34 314 ± 23 
AP duration at 
90%, ms 
64.0±2.7 62±3 225±6 295±34 434 ± 39  
 (Knollmann 
et al., 2007) 
(Pandit et 
al., 2001; 
Sanchez-
Alonso et 
al., 2016) 
(Giles and 
Imaizumi, 
1988; 
Mcintosh 
et al., 2000; 
Tsuji et al., 
2000) 
(Kääb et 
al., 
1996; 
Lue and 
Boyden, 
1992) 
(Bayer 
et al., 
2010; 
Feng, 
1998) 
The data presented from AP recorded from isolated cardiomyocytes at stimulation 
frequency 1Hz.  
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1.2.2 Interventricular differences in action potential 
Workload and electrophysiological specialisation of different regions of the heart 
have resulted in characteristic patterns of AP (Nerbonne and Kass, 2005). These 
patterns are determined by the specific properties of the ion channels, which have 
been shown at mRNA, protein, and functional levels (Molina et al., 2016). This 
specificity is species- dependent, but there are some similarities which are presented 
in Figure 1.9 and Table 3.  
 
Figure 1.7. Representative shape of action potential waveforms from the RV and LV. 
Ionic currents involved in the initiation and maintenance of an action potential (AP) and 
their chamber-specific differences. Green means up-regulation and red down-regulation in 
the RV versus the LV and black indicates no change between chambers. Schematic is taken 
from (Molina et al., 2016). 
Table 3. Differences in mRNA, protein expression and current density between RV and LV 
myocytes for the major ion currents participating in the AP formation.  
Current Species Differences in RV versus LV 
myocytes 
References  
 
mRNA Protein 
levels 
Current 
density  
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INa, Mouse  ND  ND ND (Martin et al., 2012) 
Ito Mouse 
Dog 
↑ (50%) 
ND 
↑ (50%) 
 
↑ (40%) 
↑ (60-
70%) 
(Martin et al., 2012) 
(Volders et al., 1999) 
ICaL Mouse 
Cat  
Dog  
ND ND ND 
ND 
ND 
(Kondo et al., 2006) 
(Kleiman and 
Houser, 1988)  
(Ramakers et al., 
2003) 
IK1 Mouse 
Dog 
Guinea 
pig 
ND 
 
↓ (30 %) 
 
ND 
 
↓ (10 %) 
ND 
ND 
↓ (40 %) 
(Kondo et al., 2006; 
Martin et al., 2012)  
(Volders et al., 1999) 
(Warren et al., 2003) 
IKr Dog  ↑ (75%)  ND (Volders et al., 1999) 
IKs  Dog ↑ (20-
80%) 
↑ (20%) ↑ (37- 
50%) 
(Molina et al., 2014; 
Volders et al., 1999) 
↑, ↓ or ND – is upregulated, downregulated or not different levels of the mRNA, protein 
expression or whole cell current density, respectively; INa = Na+ current; Ito = transient 
outward K+ current; ICa,L = LTCC; IKr = rapid component of delayed-rectifier K+ current 
(IK); IKs = slow component of IK; IK1 = inward-rectifier K+ current. 
In most of the species, the RV myocardium shows a slight overexpression of Kv4.2 
and Kv4.3 as compared to the LV (Martin et al., 2012; Ramakers et al., 2005). These 
channels are the molecular components of Ito. KCNQ1 which shows a greater 
expression in the RV versus the LV (Ramakers et al., 2003; Sathish et al., 2006). 
Functional studies showed that the RV has a larger IKs and Ito as compared with the 
LV. Finally, some studies have suggested that INa is similarly expressed in the RV 
than the LV (Martin et al 2012). 
The regional differences of the ion channel expression lead to a deeper notches and 
shorter AP durations (APD) at 50 % and 95 % of repolarization in the RV vs. the 
LV in canine myocardium (Di Diego et al., 1996; Ramakers et al., 2005). Also in 
rats the APD at 90% of repolarisation was significantly shorter in RV than in LV 
myocytes (Benoist et al., 2011). Similarly, the duration of monophasic APs in vivo 
in dogs was shown to be shorter in the RV than in the LV (Ramakers et al., 2003). 
Despite such variation of the AP duration between ventricles, the resting membrane 
potential and AP upstroke velocity was found to be similar in LV and RV (Di Diego 
et al., 1996; Volders et al., 1999).  
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1.2.3 Electrocardiography 
Electrocardiography is the one of the gold-standard methodologies, which allow 
investigation of the electrical activity in the heart. Electrocardiogram (ECG) 
represents a temporal recording of the changes in electrical charge of all four 
chambers of the heart during each beat (Figure 1.8; Farraj et al., 2011). ECG 
consists of two major components: waves and segments. All the deflections of the 
signal above or below baseline are called waves, whereas sections between two 
waves are named segments. The first wave is P wave which represents the 
depolarization of atria. The depolarization of the right atrium produces first half of 
P wave and the left atrium produces the second half of it (Carmeliet and Vereecke, 
2002). PQ segment represents the contraction of the atria. The next complex of 
waves (QRS complex) appears due to the ventricular activation. This activation is 
followed by a period of contraction, ST interval. The last component is T wave 
which indicates ventricular repolarization. The peak of T wave correlates in time 
with the full repolarization of myocardium. The average duration of the QT interval 
reflects the ventricular APD. Since QT interval depends on the heart rate, for a 
proper APD evaluation QT should be corrected for the duration of RR interval. In 
order to evaluate the duration, it needs to be corrected for frequency. Interval 
between T wave and next P wave represents the time of ventricular relaxation and 
filling it by blood. Described sequence of all waves and complexes repeats with 
each heartbeat at 60 bpm (in human heart). ECG is a common tool for the 
characterization of the electrical activity in the heart. 
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Figure 1.8. Electrocardiogram and related action potentials. ECG signal is present in 
red, the atrial action potential in green and ventricular action potential in blue. The right 
top panel shows the direction of wave propagation (Zubieta and Paulev, 2004). 
The traces described above presents a typical example of a human ECG. Rats have 
some specific differences. Examples of a human and rat ECG are shown in Figure 
1.9. Rat heats have a much higher contraction rate than a human, ~400 bpm vs. 60 
bpm in human that produces some alterations in the shape of ECG. The traces of 
rat heart ECG sometimes lacks a pronounced Q wave and have very short QT 
segment (Figure 1.9; Konopelski and Ufnal, 2016). Nevertheless, essential 
similarities between rat and human ECG allow wide usage of rat studies for heart 
physiology (Sambi and White, 1960).  
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Figure 1.9. Relative time lapse of the human (a) and rat (b) ECG. In rat ECG Q waves 
and ST segments in rats are difficult to detect. Schematic from (Konopelski and Ufnal, 
2016) 
1.3 Excitation-contraction coupling  
When the impulse reaches the myocyte it causes a contraction through the cascade 
of processes known as excitation-contraction coupling (ECC) (Bers and Perez-
Reyes, 1999). Schematic representation of ECC is shown in Figure 1.10. Briefly, 
the AP -induced depolarization of the cell membrane causes activation of the 
voltage-gated Ca2+ channels also named as L-type calcium channels (LTCCs) 
located at the surface membrane and invaginations called transverse tubules (T-
tubules). Ca2+ influx via LTCCs triggers Ca2+ release from the sarcoplasmic 
reticulum (SR) stores through ryanodine receptors (RyRs) (Saucerman and Bers, 
2008). This amplifying process is called Ca2+-induced Ca2+ release (CICR) (Fabiato 
and Fabiato, 1978). The result of CICR is a rapid increase of the intracellular Ca2+ 
concentration up to ∼1 μM that binds troponin C. Activation of troponin C by Ca2+ 
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causes a release of the myosin heads from the tropomyosin complex and a 
subsequent hydrolysis ATP to ADP to generate energy. The myosin filaments use 
this energy to change their conformation and move along the actin filaments that 
leads to cell contraction (Carafoli et al., 2001).  
After contraction, cardiac myocytes need to remove Ca2+ from cytosol to relax 
again. There are several ion pumps and transporters that are responsible for Ca2+ 
removal from the cytosol. First, Ca2+ ions are sequestrated back to SR stores by 
sarcoendoplasmic reticulum Ca2+-ATPase (SERCA2). Second, Ca2+ is extruded out 
of the cell via the NCX and plasma membrane Ca2+ ATPase (PMSA) (Bers, 2008). 
A small amount of Ca2+ can be uptake into the mitochondria via the Ca2+ uniporter 
(Nerbonne and Kass, 2005). 
 
 
Figure 1.10. Cardiac E-C coupling. The action potential (AP) induces membrane 
depolarization, which activates L-type Ca2+ channels openings. Ca2+ influx through LTCC 
triggers RyR2 openings and release a large amount of Ca2+ from the sarcoplasmic 
reticulum, a mechanism called “calcium induced calcium release” (CICR). This high 
intracellular [Ca2+] binds to the myofilaments through troponin C and activates contraction 
through release of myosin heads. During diastole phase Ca2+ is removed from the cytosol 
mainly by the SR Ca2+ ATPase (SERCA) and the NCX in its “forward” mode. (Schematic 
taken from (Scoote et al., 2003)). 
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1.3.1 Interventricular features of Ca2+ handling and contractility  
Analysis of interventricular differences regarding ECC in the RV and the LV is 
very limited and depends on species. Literature summary of interventricular 
differences in ECC are shown in Table 4, focusing in the cardiac contraction and 
expression of related proteins. Kondo et al. showed much lower cell shortening and 
Ca2+ transients in RV myocytes as compared to LV myocytes in murine myocytes 
(Kondo et al., 2006). Whereas in rats, Sathish and colleagues found as well longer 
Ca2+ transients but the same amplitude of contraction (Sathish et al., 2006). On the 
other hand, a study performed in rats by Sabourin et al. showed a lower amplitude 
and a longer decay time of Ca2+ transients in RV myocytes compared to LV 
myocytes (Sabourin et al., 2018). In larger species such as dogs and cats, similar 
contraction properties of RV and LV myocytes were reported at baseline, but the 
contraction became significantly different under β-adrenergic stimulation (Kleiman 
and Houser, 1988; Molina et al., 2014). Diversity of the data indicates the 
complexity of the differences between contraction of RV and LV myocytes. 
Table 4. Interventricular differences in contraction, Ca2+ transients and Ca2+ handling 
proteins. 
Property  Species RV versus 
LV myocytes 
References  
 
Cell shortening Mouse 
Rat   
Rat 
Dog  
↓ (30%) 
↓ (35%) 
ND 
ND  
(Kondo et al., 2006) 
(Sathish et al., 2006) 
(Sabourin et al., 2018) 
(Molina et al., 2014) 
Contraction 
duration 
Mouse  
Dog  
↑ (20%) 
ND 
(Kondo et al., 2006) 
(Molina et al., 2014) 
Diastolic Ca 
concentration 
Mouse  
Rat 
Dog 
ND 
ND 
ND 
(Kondo et al., 2006) 
(Sathish et al., 2006) 
(Molina et al., 2014) 
Ca transient 
amplitude 
Mouse  
Rat  
Rat  
↓ (40%) 
ND 
↓ (35%) 
(Kondo et al., 2006) 
(Sathish et al., 2006) 
(Sabourin et al., 2018) 
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Dog ND (Molina et al., 2014) 
Ca transient 
duration 
Rat  
Rat  
Dog 
↑ (40%) 
↑ (30%) 
ND 
(Sathish et al., 2006) 
(Sabourin et al., 2018) 
(Molina et al., 2014) 
RyR (mRNA) Mouse  
Rat  
Dog 
ND  
ND 
↓ (32%) 
(Kondo et al., 2006) 
(Sabourin et al., 2018) 
(Molina et al., 2014) 
RyR (protein) Rat 
Dog  
ND 
↓ (55%) 
(Sabourin et al., 2018) 
(Molina et al., 2014) 
NCX (mRNA 
SLC8A1) 
Mouse 
Rat  
Dog  
ND 
↓ (50%) 
↑ (50%) 
(Kondo et al., 2006) 
33 
(Ramakers et al., 2005) 
SERCA2 
(mRNA) 
mouse ND (Kondo et al., 2006) 
SERCA2 
(protein) 
Rat  ↓ (14%) (Sathish et al., 2006) 
SERCA2 
(current) 
Mouse  
Rat 
Dog  
ND 
↓ (80%) 
↓ (27%) 
(Kondo et al., 2006) 
(Sathish et al., 2006) 
(Gupta et al., 1997) 
Phospholamban 
(mRNA) 
 
Mouse  ND (Kondo et al., 2006) 
 
Phospholamban 
(protein) 
 
Rat  ↓ (17%) (Sathish et al., 2006) 
↑, ↓ or ND – increase, reduction or not different cell property, mRNA, protein 
expression or whole cell current density in RV myocytes versus LV myocytes, 
respectively. 
Why RV myocytes have different ECC is not so clear. Different embryonic origins 
of the RV and LV or differences in loading conditions were proposed as the main 
reasons for such alterations. Another possible reason for such alterations could be 
a different force of contraction produced by the RV and LV. It was shown that 
contractile strength of myocytes depends on a balance between Ca2+ influx and Ca2+ 
removal from cytosol (Watanabe et al., 1983). Duration of AP significantly 
determines the duration of LTCC openings (Watanabe et al., 1983). In adult mice 
and rats, the APD at a fixed heart rate is shorter in the RV vs. the LV (Clark et al., 
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1993; Knollmann et al., 2001). In larger mammals RV and LV have similar duration 
of AP but the notch during phase 1 of the AP is deeper in the RV than in the LV 
(Di Diego et al., 1996). Voltage-clamp study of (Bouchard et al., 1995) showed that 
prolongation of APD increased a total amount of Ca2+ entry per AP waveform and 
also increased maximal myocyte shortening. Similar total density of LTCCs in RV 
and LV myocytes (Kleiman and Houser, 1988) suggests that a larger SR Ca2+ load 
or faster SR Ca2+ uptake in LV vs. RV myocytes could be responsible for larger 
Ca2+ transients. Proteomics study of SERCA2a and RyR2 showed similar 
expression levels in the RV and the LV myocytes of pigs and rabbits (Phillips et al., 
2011). Alteration could occur on the regulation of the proteins, for example, Sathish 
et al. found a smaller fraction of SR SERCA2 units available in the RV compared 
to LV in rats that leads to reduced effectivity of Ca2+ sequestration in the RV 
myocytes and prolonged Ca2+ transients (Sathish et al., 2006).  
It is important to mention that in rodent myocytes more than 90% of total Ca2+ flux 
during each beat originates from the SR Ca2+ release and subsequent SR Ca2+ 
reuptake (Luss et al., 1999). In contrast, in larger mammals there is a much larger 
role for Ca2+ entry via ICa,L and NCX-mediated Ca
2+ extrusion, which accounts for 
~30 % of the total Ca2+ flux (O’Rourke, 2008). Thus, a direct extrapolation of the 
data on LV/RV differences in Ca2+ handling from rodents to humans is difficult. 
1.4 Arrhythmogenic activity in the heart 
In pathological conditions, disruptions of the normal propagation of AP can lead to 
arrhythmias. These alterations of the normal impulse generation and propagation 
induce atrial (AF) or ventricular fibrillation (VF) that are the most common causes 
of sudden cardiac death (Rubart and Zipes, 2005). The arrhythmogenic activity 
could be classified in several groups, such as non-re-entrant and re-entrant activity 
or activity occurred at cellular and tissue levels (Anumonwo and Pandit, 2015; Tse, 
2016). At the cellular level, arrhythmias could originate from abnormal oscillations 
(automaticity) of pacemaker cells or early and delayed depolarizations, i.e., EADs 
and DADs, respectively (Anumonwo and Pandit, 2015). At the tissue level, 
different types of re-entry in the form of spiral waves or rotors is now thought to 
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play an important role in sustaining arrhythmias, including AF and VF (Pandit and 
Jalife, 2013). 
1.4.1 Arrhythmogenesis at cellular level 
Cellular arrhythmogenesis could originate from the enhanced automaticity of 
pacemaker cells located in sinoatrial node (SAN) and atrioventricular node (AVN). 
This can be physiological, due to increased sympathetic tone during exercise, or 
pathophysiological, due to hypovolemia, ischemia, or electrolyte disturbances (Tse, 
2016). Enhanced automaticity can also occur in the AVN, under conditions of acute 
myocardial infarction, digitalis toxicity, isoprenaline administration, and recent 
cardiac surgery (De Azevedo et al., 1973). When the discharge rate of the AVN is 
higher than the sinus rate, it can lead to abnormal rhythms called accelerated 
junctional rhythms (De Azevedo et al., 1973). Extra beats could happen when a 
latent pacemaker is protected from the dominant pacemaker by entrance block and 
becomes ectopic, discharging APs independently. A region of entrance block can 
occur when the dominant pacemaker is surrounded by ischemic, infarcted, or 
otherwise compromised tissues that prevent conduction of APs to the latent 
pacemaker (Gussak and Antzelevitch, 2003). 
Abnormal impulses that originate outside of the SA could occur during or after APs. 
EADs and DADs are able to trigger, if of sufficient magnitude, self-sustaining APs, 
resulting in cardiac arrhythmias (Rosen and Schwartz, 1991). Generally, EADs are 
promoted by APD prolongation when the loss of repolarizing K+ currents occurs. 
Prolonged APs could reactivate the LTCC that further depolarizes the membrane 
(Cranefield and Aronson, 1989; Michael et al., 2009). This sets up a positive 
feedback loop, triggering an AP. EADs have also been associated with shortening 
in APDs, occurring late in phase 3 of the AP (Patterson et al., 2006)]. This could 
happen if the intracellular Ca2+ concentration remains elevated when the membrane 
potential is lower than the equilibrium potential for NCX. So INCX can be activated, 
causing membrane depolarization. These late EADs are clinically relevant, as they 
can occur immediately after termination of other types of tachycardia, such as atrial 
flutter, AF and VF (Burashnikov and Antzelevitch, 2006).  
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In contrary, DADs happen after APs under conditions of intracellular Ca2+ 
overload, which can result from exposure to digitalis, catecholamines, 
hypokalaemia, hypercalcemia, and in hypertrophy and HF (Tse, 2016). SR Ca2+ 
overload leads to increased Ca2+ leak that in turn activates NCX and the calcium-
activated chloride current, ICl. Together, these currents could depolarise the 
membrane and trigger additional APs (Cranefield and Aronson, 1989; Llach et al., 
2011). 
DADs and late EADs are somewhat similar, as they occur under conditions of 
intracellular Ca2+ overload and involve spontaneous SR Ca2+ release. The 
difference appears to be the timing of this release which occurs during the 
repolarizing phase of the AP in the case of late EADs, and at the resting membrane 
potential for DADs (Fink and Noble, 2010).  
1.4.2 Re-entry 
Re-entry occurs when an AP fails to extinguish itself and reactivates a region that 
has recovered from refractoriness (Janse and Wit, 1989). It can be divided into two 
types: (i) circus type re-entry occurred with an obstacle; and (ii) re-entry that occurs 
without an obstacle (reflection or phase 2).  
Circus type of wave occurs when an AP moves around an anatomical or functional 
obstacle and reexcites the site of origin (Mines, 1913). This type of re-entry was 
proposed by Mayer and it happens when a slower conduction and a shorter duration 
of excitation wave would permit the tissue ahead of the excitation wave to recover 
from refractoriness. In contrary, when the excitation wave has a high propagation 
rate and a long duration, the whole circuit would be excited at the same time, 
causing the excitation to die out (Mines, 1913). Three criteria for this type of re-
entry were proposed: (a) occurrence of the area with unidirectional block; (b) the 
excitation wave propagates along a distinct pathway, returns to its point of origin, 
and starts again; and (c) interruption of the circuit at any point would terminate this 
circus movement (Mines, 1913). Thus, for these events, both the conduction 
velocity (CV) and the refractory period determine whether re-entrant 
arrhythmogenesis occurs. Propagating waves in the myocardium have a wave front 
that represents AP depolarization, and a tail that represents repolarization (Weiss et 
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al., 2000). The length of this excitation wave is given by the product of its CV and 
refractory period (Wiener and Rosenblueth, 1946), and must be smaller than the 
length of the circuit in order for re-entry to be successful (APD).  
Circular re-entry could happen with a functional obstacle, which could be a part of 
the tissue held above the threshold by the electrotonic influences of the 
depolarization wavefront that is going around it (Allessie et al., 1976). Here, the 
circuit is defined entirely by the electrophysiological properties of the tissue. The 
smallest circuit permitting successful re-entry, which was called the leading circle, 
is the one in which the circulating wave front can just excite again the tissue ahead 
that is still in the relative refractory period (Allessie et al., 1977). 
The occurrence of this re-entry depends on the AP wave curvature (Cabo et al., 
1994). For a planar wave, each cell activates one cell downstream. If a wave has 
front curving inwards (concave), each cell will be activating less than one cell 
downstream. This will induce a source–sink mismatch that will increase the 
depolarizing current available for each downstream cell. All this results in a greater 
rate of voltage rise, and therefore, a higher CV compared to that of a planar wave. 
The opposite is true for a wave front curving outwards (convex). This is situation 
when each cell will be activating more than one cell downstream, and thus the CV 
will be smaller than that of a planar wave. If the curvature is sufficiently convex, 
conduction block can result (Cabo et al., 1994). The point where the activation and 
repolarization wave fronts meet is called the phase singularity (Winfree, 1989). The 
latter corresponds to the functional obstacle because all phases of the wave meet 
here. 
This model was later modified for a moving obstacle called spiral wave re-entry 
(Ikeda et al., 1996). A spiral wave is a two-dimensional wave of excitation emitted 
by a self-organizing source of functional re-entrant activity, termed a rotor (Ikeda 
et al., 1996). Spiral waves have been subsequently observed in the chemical 
reaction of Belousov–Zhabotinsky and in the thin slices of epicardial muscle using 
a potentiometric dye (Tse, 2016). The phase singularity is excitable part of 
myocardium but remains nonexcited, and therefore acts as a functional obstacle 
around which the spiral wave can circulate (Ikeda et al., 1996). The sites in front of 
48 
 
the wave are excited faster than those behind the wave. This may be the underlying 
mechanism of torsade de pointes (Dessertenne, 1966), in which the periodic torsion 
of the QRS axis has been attributed to two widely separated foci discharging at 
different frequencies.  
1.4.3 Reflection 
The arrhythmogenic events occur also without an obstacle and reflection is one of 
them. It was originally observed in canine Purkinje fibers (Wit et al., 1972). It these 
preparations AP traveling in the forward direction was sometimes followed by a 
return potential that travelled in the backward direction. These events happen when 
the initiating impulse reached an area of depressed excitability. To illustrate this 
type of re-entrant arrhythmias a sucrose gap model was developed (Figure 1.11; 
(Antzelevitch et al., 1980)). It included canine Purkinje fibres where a central 
unexcitable gap was produced by an ion-free isotonic sucrose solution. Electrical 
stimulation at the proximal segment elicits an AP. This excitation is transmitted 
across the gap to the distal segment after a delay. However, AP cannot be activated 
in the middle part of the tissue because the extracellular space is ion-free. The 
excitation induces a passive spread of the local current (electrotonic current) across 
the low-resistance intracellular pathway. When depolarization reaches threshold, an 
AP is initiated in the distal segment. This, in turn, generates electrotonic currents in 
the retrograde direction. With a further delay, the proximal region can be excited 
again when it has recovered from refractoriness. This results in a return 
extrasystole, completing reflection (Antzelevitch et al., 1980). Successful segment-
type reflection requires a balance between the conduction delay and the cellular 
membrane excitability (Tung, 2011). Segment-type reflection has been 
demonstrated in isolated atrial (Lukas and Antzelevitch, 1989) and ventricular 
(Rozanski et al., 1984) tissues. 
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Figure 1.11. Illustration of reflection process. AP is elicits by stimulation of the proximal 
segment. The middle region is ion free and AP conduction there is slow. But it involves 
electrotonic current that through the cells. It reaches the distal area after delay and 
originates another AP. From (Tse, 2016). 
Another re-entrant arrhythmia mechanism that does not depend on the obstacle is 
the Phase 2 arrhythmia (Di Diego and Antzelevitch, 1993). This type of events 
occurs in the settings of high heterogeneity in AP repolarization when the 
electrotonic currents can flow from sites with longer APDs to sites with shorter 
APDs. These currents could reactivate the AP when the latter sites have recovered 
from refractoriness (Dias et al., 2002). Phase 2 arrhythmias were shown in Brugada 
syndrome, where the resulting premature beat initiates spontaneous polymorphic 
VT (Moe, 1975). Heterogeneity in AP repolarization between cardiac regions 
leading to phase 2 re-entry occurs following exposure to the sodium channel 
inhibitor flecainide and under conditions of raised Ca2+ concentration and ischemia 
(Lukas and Antzelevitch, 1996).  
Thus arrhythmogenic activity happens when a delicate balance between cell and 
tissue excitability and refractoriness is lost; understanding the mechanisms of 
arrhythmogenesis is very important for the interpretation of the experimental data. 
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1.5 Structural organisation of ventricular cardiomyocytes  
Ventricular myocytes represent a rod shape cells with a regular striations and 
one/two nuclei (Figure 1.12). Cardiomyocytes connect with each other by the 
intercalated disks, where the gap junctions are located. These junctions are small 
channels that allow cells to exchange ions and small cytosolic molecules, like Na+ 
and Ca2+ and transmit the signals (Goodenough and Paul, 2009). Single human and 
rat ventricular myocytes have highly organized surface and internal structures 
(Lyon et al., 2009). The structure of myocytes is maintained by cytoskeleton which 
is composed of rigid filaments of actin and desmin and microtubules build up by α 
and β tubulin (Hein et al., 2000). Cardiomyocyte contractile proteins are organized 
in repeating functional units called sarcomeres. The length of each sarcomere is 
around 2 microns. Sarcomeres are delimited by Z-lines (Solaro and Stull, 2011).  
The surface of cardiomyocytes has a complex pattern of Z-grooves, crests and T-
tubule openings (Figure 1.12). Z-grooves presents a drains in surface membrane of 
cardiomyocytes separated by a dome-like structures, called crests (Gorelik et al., 
2006).  
 
Figure 1.12. Structural organisation of ventricular myocyte. It shows a well- organized 
surface topography and repetitive sarcomeres Modified from (Sanchez-Alonso et al., 
2019).  
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1.5.1 Transverse-axial tubular network  
Plasma membrane of ventricular myocytes is folded into continuous invaginations 
through the cell interior, named transverse-axial tubular network (TAT) (Soeller 
and Cannell, 1999). The complex three-dimensional morphology of the TAT 
system in living rat ventricular cardiomyocytes was first revealed by Soeller and 
Cannell by using an extracellular dye solution together with two-photon 
microscopy (Soeller and Cannell, 1999). TAT network of ventricular myocytes 
predominantly consists of T-tubules, which are located close to the Z-lines between 
sarcomeres (Brette and Orchard, 2003). Axial or longitudinal tubules (A-tubules) 
are presented at between Z-lines and usually less frequent compared to T-tubules in 
ventricular myocytes (Asghari et al., 2009; Swift et al., 2012). Organisation and 
density of TAT network in cardomyocytes is highly dependent on the host heart 
rate. In rodents and other small animals, who has a high heart rate, myocytes possess 
a higher density of TAT network as compared to larger species who shows a 
relatively slower heart rate and less dense TAT network (Brette and Orchard, 2003; 
Louch et al., 2010; Song et al., 2005).  
A high density of TAT network is important to maintain a rapid and synchronous 
Ca2+ release across the cell (Brette et al., 2005; Bu et al., 2009). This is achieved 
via a close proximity of TAT membrane to specialized terminals of SR, called 
junctional SR. The fine adjustment of the cardiomyocyte membrane forms a tight 
coupling between LTCC and RyR2 clusters, called dyadic couplons (Scriven et al., 
2002). Among different parts of surface membrane, the coupling between LTCC 
and RyR2 was found predominantly within the TAT network in ventricular 
myocytes (Chen-Izu et al., 2006; Mackenzie et al., 2004).  
Moreover, TAT network provides a regulatory function of ECC. TAT network 
accumulates a number of molecules that are important for Ca2+ signalling such as 
LTCC, NCX, β-2 adrenergic receptors (β2AR), protein kinase A (PKA), and other 
regulatory proteins (Brette and Orchard, 2003). Thus, TAT network provides a 
rapid regulation of a cell contraction and relaxation (Richards et al., 2011). The 
TAT network furthermore limits the diffusion of ions which can enter into them 
and thereby establishes a microenvironment with relatively constant ion content 
(Brette et al., 2005).  
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1.5.2 Plasticity of TAT network 
TAT network organisation varies in different type of myocytes, and depends on age 
and species (Jones et al., 2018). In contrast to adult ventricular cardiomyocytes with 
high TAT network organisation, neonatal cells lack a TAT network (Richards et al., 
2011). The mechanisms responsible for the development of the TAT network and 
its maintenance during adulthood are not yet fully understood. An array of various 
proteins has been shown to participate in TAT formation and organisation. 
Caveolae, that are flask shape invaginations in sarcolemma membrane, are believed 
to be progenitors for T-tubule formation (Harvey and Calaghan, 2012; Wong et al., 
2013; Woodman et al., 2002). T-tubular maturation was shown to coincide with the 
expression of junctophilin 2 (JPH2) (Munro and Soeller, 2016; Ziman et al., 2010). 
This protein anchors T-tubular membrane to junctional SR membrane producing 
stabilization of dyadic complexes. There is an evidence showing a role of JPH2 in 
the orientation of tubules (Pinali et al., 2013). Knock in of JPH2 in mouse showed 
an immature TAT network organisation (Chen et al., 2013; Reynolds et al., 2016). 
Another key protein for TAT network formation is amphyphisin-2 (BIN1) which 
can participate in tubule growth and intricate membrane folding (Hong et al., 2014). 
Telethonin (T-Cap) that is involved in sarcomere assembly, was proposed to play a 
role of mechanical stress transducer and load dependence in TAT network (Ibrahim 
et al., 2013).  
Flexibility of TAT network is highly studied on diseased myocytes. TAT 
remodelling was studied in a big array of aetiologies, such as spanning myocardial 
infarction (Frisk et al., 2014; Louch et al., 2006; Lyon et al., 2009; Sanchez-Alonso 
et al., 2016; Swift et al., 2012; Wagner et al., 2012), aortic stenosis (Ibrahim et al., 
2013; Pinali et al., 2013; Wei et al., 2010), heart failure (HF) induced by fast pacing 
(Balijepalli et al., 2003; He et al., 2001), hypertension (Singh et al., 2017; Song et 
al., 2006), chronic ischemia (Heinzel et al., 2008), and diabetes (Stølen et al., 2009; 
Ward and Crossman, 2014). Most of these studies reported a reduced TAT density 
and regularity in diseased myocytes, which sometimes is accompanied by an 
increased density of axial tubules. Resent works with more precise view on TAT 
structure revealed T-tubular swelling and fusion in failing LV myocytes (Pinali et 
al., 2013; Seidel et al., 2017; Wagner, 2012). Moreover, similar reduction of TAT 
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network organisation has been shown during right ventricular failure (Caldwell et 
al., 2014; Prins et al., 2017; Xie et al., 2012) and in the atria during heart failure 
(Dibb et al., 2009) and atrial fibrillation (Lenaerts et al., 2009). All these studies 
indicate a possible existence of the similar mechanism of TAT network remodelling 
in a variety of cardiac pathologies across the chambers of the heart. 
1.5.3 Caveolae  
Another important structure of cardiomyocyte sarcolemma membrane is caveolae. 
These lipid structures are flask shaped invaginations of the sarcolemma, enriched 
in cholesterol and glycosphingolipids. These nanostructures have a width around 
50 to 100 nm, an can be clearly visualised in the electron microscopy images 
(Wright et al., 2014). In cardiomyocytes without a TAT network, like neonatal and 
some atrial myocytes, caveolae structures likely serve as a primary place of 
excitation-contraction coupling (Wong et al., 2013). They organise signalling 
microdomains in the sarcolemma membrane by attracting the palmitoylated 
transmembrane proteins, such as LTCC, β2AR, adenyl cyclases (AC) and the α-
subunit of G-proteins (Balijepalli et al., 2006; Brown and Borutaite, 2007). Through 
the accumulation of the signalling proteins, caveolae can modulate Ca2+ handling 
and β2AR signalling (Bossuyt et al., 2006; Calaghan and White, 2006). Moreover, 
caveolae are involved in the stretch-induced regulation of different 
mechanosensitive ion channels such as volume regulated chloride channels (Egorov 
et al., 2019; Petroff et al., 2001).  
The flask-like structure of caveolae serves as an ion reservoir, maintained by 
structural proteins called caveolins. Three isoforms of caveolins were found in 
different tissues. Caveolin 3 (Cav3) is predominantly expressed in cardiac, skeletal 
and smooth muscle cells (Song et al., 1996). Cav3 is important for maintaining 
cardiac function, as murine model of the Cav3 knockout develop a pronounced HF 
(Woodman et al., 2002). 
1.6 L-type Ca2+ channels 
Among other ion channels participating in the generation of AP in the heart, the 
voltage-gated L-type Ca2+ channels constitutes a major pathway for Ca2+ entry into 
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cardiac cells. The Ca2+ entry through the LTCC shapes the plateau phase of the 
ventricular AP and is required for the contraction as it induces CICR. 
1.6.1 Classification of voltage-gated Ca2+ channels 
Voltage-gated calcium channels (VGCCs) react to changes in the transmembrane 
potential. According to the activation voltage threshold, all VGCCs can be divided 
into high voltage-activated (HVA) Ca2+ channels, which include L-type, N-type, R 
type and P/Q type, and low voltage-activated (LVA) Ca2+ channels, such as T-type 
Ca2+ channels.  
In the cardiac myocytes, there are two main types of VGCCs: L- type and T-type. 
L-type Ca2+ channels (LTCC, ICaL) are characterized by a large conductance (25 pS 
in 110 mM Ba), long lasting openings, sensitivity to dihydropyridines (DHPs) and 
activation at more positive membrane potentials than T-type. In contrast, T type 
Ca2+ channels (ICaT) have different characteristics: tiny conductance (8 pS in 110 
mM Ba), insensitivity to DHPs and more negative potentials of activation. The 
relative amount of ICaL and ICaT varies among different types of cardiac myocytes. 
In normal ventricular myocytes ICaT is almost absent, but it can become more 
prominent in hypertrophy. For example, Nuss and Houser  reported a substantial 
ICaT expression in hypertrophied cat ventricular myocytes (Nuss and Houser, 1993).  
1.6.2 Subunit composition of VGCCs 
Physiological and pharmacological properties of VGCCs are determined by the 
pore-forming α1 subunits. Three clusters of α1 subunits were named as Cav1 
(Cav1.1, Cav1.2, Cav1.3 and Cav1.4), Cav2 and Cav3, which correspond to L-type, 
non-L-type (HVA) and LVA or T-type channels, respectively (Catterall et al., 
2005). The pore-forming subunit is associated with the accessory subunits Cavβ (4 
different isoforms), Cavα2/δ (4 different isoforms Cavα2/δ 1-4) and γ (8 isoforms) 
(Catterall, 2000). All these axillary subunits play important roles in the regulation 
of VGCCs activity and trafficking. 
Schematic of LTCC channel subunit organisation is presented in Figure 1.13. The 
pore is formed by α subunit. β subunit interacts with a cytosolic conserved motif 
located at I-II loop of α subunit (Pragnell et al., 1994). α2 subunit is located 
extracellularly and is linked to δ subunit via a disulfide bridge which is connected 
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to the pore-forming subunit (De Jongh et al., 1990). The γ subunit consists of 4 
transmembrane domains with intracellular N- and C- tails. Although the function 
of γ subunit in the heart is not determined; the expression of γ 4, 6,and 8 was 
detected at mRNA level (Yang et al., 2011).  
  
Figure 1.13. L-type calcium channel structure. The main pore-forming α1 and auxiliary 
β, α2δ and γ subunits integrated in membrane phospholipid bilayers. From (Rougier and 
Abriel, 2016). 
1.6.3 Different roles of LTCC subunits 
The Cavα1C subunit constitutes the pore of the calcium channel and mediates the 
influx of calcium ions into the cell upon membrane depolarization. Structural 
analysis of Cavα1 subunits revealed that the pore contains four repeated domains (I 
– IV), each of them includes six transmembrane regions (S1-S6) and a pore loop 
(Durell et al., 1998). The voltage sensor is located at S6 region which contains 
several positively charged residues. S3 contain a few charged residues and may play 
a role in the charge-charge interaction with S4. Ion selectivity is produced by the 
loop between S5 and S6 regions that dangles into the outer mouth of a channel.  
The distal C-terminal part of the α1C subunit has been shown to have an auto-
inhibitory effect on the calcium current (Crump et al., 2013; De Jongh et al., 1996). 
This subunit also included a phosphorylation site for PKA (Fuller et al., 2010; 
Mitterdorfer et al., 1998). However, this site, Ser1928, is located in the C-terminal 
portion of α1C that is cleaved off the full-length protein in vivo (Hell et al., 1996). 
But a minor expression of the full-length α1C was also observed in vivo, and 
biochemical and functional evidence indicates that the cleaved C-terminal fragment 
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remains tethered to the channel (Gao et al., 1997; Gerhardstein et al., 1999). 
Nevertheless to what extent PKA phosphorylation occurs in vivo of α1C remains 
unclear. 
Although the α1 subunit largely determines the current gating, the auxiliary 
subunits affect the voltage-dependence, the rate of activation and the kinetics of 
current inactivation of the channel (Birnbaumer et al., 1998; Lacerda et al., 1991).  
There are 4 β subunit genes (β1-β4) described, and the predominant cardiac isoform 
is β2. All 4 types of beta subunits of LTCC enhance the L-type Ca2+ current when 
they are co-expressed with Cavα in heterologous expression systems. They 
modulate the kinetics of channels activation and inactivation, without affecting the 
channel conductance (Kamp et al., 1996; Singer et al., 1991). Moreover, Cavβ is 
involved in the regulation of LTCC by protein kinases, G proteins and ubiquitin 
ligases (Buraei and Yang, 2010; Gerhardstein et al., 1999). Three PKA 
phosphorylation sites (Ser459, Ser478, and Ser479) were also determined in this β2  
subunit (Gerhardstein et al., 1999) and two of them (Ser478, Ser479) were shown 
to contributes to channel regulation by PKA (Bünemann et al., 1999). Sites for PKC 
phosphorylation were found in both α1C and β2 subunit and the expression of both 
α1C and β2 was required for PKC induced reduction of ICaL (Puri et al., 1997). 
Another important role of Cavβ is the channel drugs sensitivity. For example, the 
effective concentration of verapamil for cells Cav1.2 co-expressed with Cavβ was 
14 times lower concentration than for the cells with Cav1.2 expressed alone 
(Lacinová et al., 1995). Cavβ also plays an important role in Cav1.2 trafficking to 
the plasma-membrane (Jiang et al., 2005; Josephson and Varadi, 1996) as well as 
channel internalization (Gonzalez-Gutierrez et al., 2007). Moreover, it was shown 
that different Cavβ subunits target LTCC to the specific subcellular domains (Foell 
et al., 2004). For example, Cavβ1, Cavβ2 and Cavβ3 isoforms localize predominantly 
in T-tubule membrane, while the expression of Cavβ1a and Cavβ4 was found at 
surface membrane (Foell et al., 2004). 
Several studies have shown that Cavα2/δ has an effect on Cavα1C and Cavβ channel 
trafficking. Co-expression of Cavα1C with α2/δ1 in oocytes substantially increased 
the amount of α1 subunit protein associated with the plasma membrane (Shistik et 
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al., 1995). Moreover, co-expression of Cavα1C and Cavβ with α2δ1 was found to 
increase the ICaL and accelerate the activation and deactivation kinetics (Felix et al., 
1997; Klugbauer et al., 2003). Interestingly, animals studies with Cavα2/δ1 subunit 
knockout demonstrated a reduced basal myocardial contractility and relaxation 
along with decreased ICaL peak current amplitude (Fuller-Bicer et al., 2009). 
The Cavγ subunit effects on Cav1.2 are incompletely elucidated. All 4 Cavγ subunits 
that found in the human heart can differentially modulate the LTCC function when 
they are co-expressed with the Cavβ1b and Cavα2/δ1 subunits in HEK-293 cells, 
altering both the activation and inactivation properties (Yang et al., 2011). The 
functional effects of Cavγ on LTCC are dependent on the Cavβ subunit and the 
presence of Cavα2/δ1 subunit (Yang et al., 2011).  
1.6.4 Properties and regulation of LTCC  
The physiological conditions such as ion composition and membrane potential can 
significantly alter the amplitude and kinetics of ICaL. In this chapter, a brief 
summary of the important LTCC properties is presented.  
 One of the important features of LTCC is Ca2+-dependent inactivation (CDI), 
which provides a feedback control to limit the Ca2+ entry inside the cell. When the 
myocyte possesses a relatively high Ca2+ load and a large Ca2+ transient, CDI limits 
further Ca2+ influx. Conversely, when the myocyte’s [Ca2+] is low and SR Ca2+ 
release is small, there is less CDI and enhanced Ca2+ entry which increases SR Ca2+ 
content. It was shown that CDI occurs through Ca2+ binding to calmodulin (CaM). 
CaM tethers to the Cav1.2 C- terminus. CaM activates by Ca
2+ changes its position 
in C-terminus of Cav1.2, thereby accelerating ICaL inactivation (Pitt et al., 2001).  
On another side, LTCCs undergo a frequency-dependent facilitation (CDF). It was 
observed that with increased frequency of voltage-clamp pulses ICaL showed a 
higher amplitude and prolongation of inactivation (Hryshko and Bers, 1990; Lee, 
1987; Mitra and Morad, 1986). This increase of ICaL was shown to be Ca
2+-
dependent and the effect is modulated through the Ca2+/calmodulin-dependent 
protein kinase II (CaMKII)- dependent phosphorylation (Yuan and Bers, 1994; 
Zygmuntt and Maylie, 1990). For the effective CDF, CaMKII should be closely 
localized to LTCC, so CDF does not happen equally throughout the sarcolemma 
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(Hryshko and Bers, 1990). The physiological impact of CDF becomes more 
important at high frequencies of contraction where it competes for the influence on 
ICaL with CDI. These two effects have different speeds of activation. CDI responds 
rapidly (during the same beat), while Ca2+-dependent activation occurs more slowly 
(from beat to beat). Phosphorylation sites of CaMKII was found in both α1C C-
terminus and β2 subunit (Pitt et al., 2001). Overexpression of CaMKIIδC in 
transgenic mouse myocytes and in rabbit myocytes produces higher ICaL with a 
slower inactivation time (Kohlhaas et al., 2006; Maier et al., 2003). 
β-adrenoreceptor stimulation produces a substantial increase in ICaL (Reuter, 1967). 
The effect is mainly modulated through PKA stimulation (Mcdonald et al., 1994). 
PKA phosphorylation of Cav1.2 produces a two- to four time increase in basal ICaL 
and shifts the voltage-dependence of channel activation and inactivation to more 
negative potentials (Hartzell, 1988; Tsien et al., 1986). Single channel studies 
showed that PKA phosphorylation significantly prolongs the open time of the 
channel without altering unitary conductance of the channel (Cachelin et al., 1983; 
Yue et al., 1990). PKA is anchored in close vicinity of the LTCC via “A-kinase 
anchoring protein” AKAP79 (Gao et al., 1997). The importance of this localization 
could be demonstrated by loss of the PKA-dependent activation of ICaL in 
heterologous expressing systems (Zong et al., 1995).  
One of the characteristic features of LTCC is their sensitivity to DHPs, such as 
nifedipine, amlodipine, nitrendipine, BayK8644, azidopine, iodopine. Most of these 
DHPs inhibit ICaL and are used as LTCC antagonists. At the same time, some of 
them, such as BayK8644, CGP28392, benzoyl pyrrole are known LTCC agonists 
as they increase the whole cell LTCC current. The effect of LTCC agonists is 
produced by prolongation of the single-channel opening duration with a slight 
modification of single-channel conductance (Brown et al., 1984; Hess et al., 1984; 
Kokubun and Reuter, 1984). Thus, the application of agonistic DHPs results in long 
and large Ca2+ tail currents attributable to the abrupt increase in electrochemical 
driving force upon repolarization (Tsien et al., 1986). These could contribute to 
EADs during rapid depolarizations (January and Riddle, 1989). 
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To understand the LTCC behaviour Hess et al. proposed a model of three states or 
modes (Figure 1.14; (Hess et al., 1984)). In this model the bust of LTCC activity in 
one mode is faster than switching between modes. Under physiological conditions 
LTCC can be quiescent for many seconds (mode 0), switch to the mode 1 for a few 
seconds and return back to mode 0. Mode 1 has a short opening time. The mode 2 
activity with very long LTCC openings is very rare in normal conditions (Hess et 
al., 1984). Binding of BayK8644 to the channel stabilizes the channel in mode 2, 
but the channel can still occur at mode 1. On the other hand, binding of antagonistic 
DHPs promotes channel to occur in mode 0. This state is characterized by channels 
being unavailable to open (Yue et al., 1990). 
 
Figure 1.14 Model of the LTCC gating modes. The channels could exist in one of the 
three modes. The transition between modes is very slow compared to the gating within the 
mode. From (Hess et al., 1984).  
 
1.6.5 Spatial localisation of LTCC in cardiac myocytes 
Immunochemical studies revealed that LTCCs are not equally distributed in 
sarcolemma membrane in ventricular cells (Brette and Orchard, 2003; Scriven et 
al., 2000). Approximately 80% of all LTCCs are located in T-tubules in close 
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proximity to the calcium sensing and release units of SR (Smyrnias et al., 2010). 
Until recently, spatial distribution of LTCCs on the cellular membrane could be 
assessed only by immunolabelling or electron microscopy immunogold-labelling 
techniques. These methods lack functional information of the channel behaviour. 
Interesting approach was applied to understand the relative impact of T-tubular and 
surface membrane anchored LTCCs. Bryant et al. measured LTCC activity were 
performed in the normal cardiomyocytes before and after detubulation, induced by 
formamide treatment (Bryant et al., 2015). Such treatment induces a disconnection 
of TAT membrane from the surface sarcolemma. They showed that the density of 
ICaL in T-tubules was around 3.2 times higher than the density of ICaL originated 
from the detubulated part of surface membrane (Bryant et al., 2015). 
Recently, the development of super-resolution patch clamp technique allowed a 
direct investigation of spatial clustering of ion channels, such as LTCCs, and 
functional analysis of the channels in relation to their localization (Bhargava et al., 
2013; Novak et al., 2013). This methodology presents a combination of scanning 
ion conductance microscopy with the cell-attached configuration of the patch clamp 
technique (Figure 1.15; (Bhargava et al., 2013; Gu et al., 2002)). Recently, “smart 
patch-clamp technique” allowed to analyse a single channel density via 
measurement the chance to get the channel in the patch (occurrence). Bhargava et 
al showed a 30% occurrence of LTCC occurrence in T-tubule and less than 10% - 
on the surface sarcolemma membrane (crest) in rat LV myocytes (Figure 1.15C; 
(Bhargava et al., 2013)). This 3.5 higher prevalence of LTCC in T-tubule versus 
surface membrane was similar to the results observed by Bryant et al. in whole cell 
ICaL experiments (Bryant et al., 2015). 
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Figure 1.15 Schematic of the smart patch clamp technique. A sharp high resistance 
pipette used to resolve the topographical structure of the cardiomyocytes. The pipette is 
moved to a cell-free area on the dish and the fall rate is increased to clip the pipette tip. The 
pipette is then returned to the surface of choice, and patch clamp can be performed with a 
wider pipette tip. (B) Illustration of recordings of LTCC obtained at T-tubule (left panel) 
and sarcolemma membrane (crest, right panel). (C) Chance of recording of LTCC in patch 
represents as LTCC occurrence at T-tubules and crest in rat adult ventricular 
cardiomyocytes. From (Bhargava et al., 2013). 
As most of the LTCC are located in the TAT membrane, the development and 
organisation of TAT network plays a crucial role in the distribution of LTCC across 
the membrane. In neonatal rat ventricular myocytes, that lack T-tubular structures, 
the chance of finding the LTCC current on sarcolemma membrane is 30% 
(Bhargava et al., 2013), almost the same as in T-tubule of adult ventricle. 
Interestingly, in rat atrial myocytes which have a disperse or almost absent TAT 
network, almost equal chance exists of obtaining the LTCC current at the T-tubule 
and at the crest (Glukhov et al., 2015). Moreover, loss of TATS in failing myocytes 
during HF was found to be associated with the re-distribution of LTCC from a 
predominant T-tubular localization to crests areas of surface sarcolemma (Sanchez-
Alonso et al., 2016). The occurrence of single LTCC in T-tubules and crest areas 
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became similar after HF (Sanchez-Alonso et al., 2016) and the density of ICaL was 
similar in these two membrane regions (Bryant et al., 2015). 
Smart patch clamp technique allows not only investigating the spatial distribution 
of LTCC but also revealing functional properties of LTCC as well as local control 
of LTCC activity. For example, an unchanged whole cell ICa,L was observed in HF 
conditions by many groups (Ibrahim et al., 2012; Louch et al., 2004). It has been 
found that crest subpopulation of LTCC in failing rat and human myocytes undergo 
phosphorylation by CaMKII and this subpopulation of LTCC could trigger 
abnormal electrical activity in failing hearts (Sanchez-Alonso et al., 2016). In 
failing atrial cells T-tubule-specific reduction of LTCCs conductance occurred, 
whereas crest channels remain unchanged (Glukhov et al., 2015). All these data 
showed the importance of investigation of microdomain-specific localization and 
functioning of LTCC. There is a lack of knowledge of LTCC localization in RV 
myocytes.  
1.6.6 Functional roles of LTCC subpopulations. 
It was shown that groups of LTCCs localized in different microdomains play a 
specific function in myocyte homeostasis (Best and Kamp, 2012). Subpopulations 
of LTCC and their roles are schematically presented in Figure 1.16. The channels 
that form dyads or couplons and participate in ECC represent the subpopulation of 
the LTCC which is the most crucial for cell contraction. Interestingly, only 75% of 
the dyadic LTCC were found in the TAT network, the other 25 % of the dyads are 
located at the surface membrane (Brette and Orchard, 2003; Scriven et al., 2010). 
Those LTCCs located at the surface membrane are believed to play a role in SR 
Ca2+ loading (Kawai et al., 1999).  
Among all the LTCC located both in T-tubules and surface sarcolemma, there is a 
big group of channels that is anchored to caveolae. A strong colocalization was 
shown between Cav1.2 and Cav3 (Balijepalli et al., 2006; Cavalli et al., 2007; 
Shibata et al., 2006). Caveolae membrane accumulates several important signalling 
proteins such as G-protein coupled receptors, AC and PKA (Kamp and Hell, 2000), 
so it becomes a site of signal transduction and its regulation. Disruption of caveolae 
63 
 
leads to reduction of basal ICaL and the loss of β2AR-dependent Ca2+ current 
augmentation (Bryant et al., 2014). 
Recently, a cleaved Cav1.2 C-terminus was found in the nucleus of cardiac 
myocytes, where it autoregulates CACNA1C transcription (Schroder 2009). It was 
hypothesized that different β subunits of LTCC could promote changes in the LTCC 
localization. For example, in ventricular myocytes, β4 fused to GFP showed a 
significant localization of in the nucleus; however, the significance of this pathway 
is currently unclear (Colecraft et al., 2002).  
Moreover, it was proposed that a specific pool of LTCC is responsible for Ca2+-
dependent signal transduction to nucleus in the hypertrophic cardiomyocytes. The 
mechanism involves β1AR, CaM and CaMKII which activates a number of 
hypertrophic transcriptional pathways (Maier and Bers, 2002). 
 
Figure 1.16 Subpopulations of LTCCs. Within T-tubules, LTCCs form dyadic junctions 
with ryanodine receptors (RyR2) that stay in the sarcoplasmic reticulum (SR). Caveolae is 
housed LTCC, β2ARs, adenylyl cyclase (AC), protein kinase A (PKA), and A-kinase 
anchoring proteins (AKAPs) (2). These specialized domains contribute to cAMP 
production and signal transduction in cellular processes. Cleaved C-terminus of LTCCs can 
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translocate to nucleus and can act as a transcription factor (3). Non-caveolae LTCC mainly 
couple with ß1ARs which can induce CaMKII mediated apoptosis (4). From (Best and 
Kamp, 2012).  
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1.7 Sarcoplasmic reticulum Ca2+ release and sequestration. Role of 
Ryanodine receptors. 
The main Ca2+ release channels involved in Ca2+ release from sarcoplasmic 
reticulum (SR) are represented by the ryanodine receptors (RyR) (Otsu et al., 1990) 
and inositol 1,4,5-triphosphate receptors (IP3Rs) (Nixon et al., 1994). IP3 receptors 
are involved in Ca2+ cycling, but their role in ECC is less clear (Borgatta et al., 
1991). This section will focus on the structure and function of RyR.  
1.7.1 RyR structure  
RyR are called so due to their specific binding to ryanodine. This plant alkaloid was 
used to purify the RyRs from skeletal (Inui et al., 1987) and cardiac muscle (Lai et 
al., 1988; Inui et al., 1987). Three isoforms of the RyR have been identified. RyR1 
was predominantly found in skeletal muscle cells with a lower expression present 
in smooth muscle cells, cerebellum, testis, adrenal gland, spleen, and ovary. RyR2 
is the most abundant in the heart, lung, and brain (Nakai et al., 1990; Otsu et al., 
1990). RyR3 is found in the brain, spleen, heart, and testis (Hakamata et al., 1992). 
The RyRs have a molecular weights ∼2260-kDa. They are present in 
homotetrameric complexes consisted of four ∼565-kDa subunits. RyRs have large 
N-terminal cytoplasmic domains that modulates the gating of the channel pore 
located in the C-terminus. Electron microscopy studies showed the overall structure 
of the receptor (Figure 1.17). Shape of the complex resamples a mushroom with a 
large cytoplasmic cap, representing ∼80% of the volume and the leg crossing the 
SR membrane. The dimensions of the head are ∼280 x 280 x 120 Å and are much 
larger than the size of the transmembrane part of the channel (∼120 x 120 x 60 Å) 
(Wagenknecht et al., 1989). These two major parts are connected via four thick 
columns. The head part represents not a rigid block but cavities filled with solvent. 
These structures allow the modulation of RyRs gating by interaction with solvent, 
small molecules and protein modulators. The corners of the cytoplasmic area are 
called “clamps”. They undergo conformational changes during openings and closes 
of RyR2 and participate in intermolecular interactions with close RyRs or 
modulators (Samsó et al., 2009; Serysheva et al., 2008; Wagenknecht et al., 1996). 
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Figure 1.17 Schematic of RyR channel organisation. From (Lanner et al., 2010). 
1.7.2 Regulation of RyR2 
RyRs are approximately 10 times larger than the voltage gated Ca2+ and Na+ 
channels. In asymmetric solutions, RyR incorporated in a bilayer showed a high 
conductance of ~100 pS that is 5 times higher than the conductance of LTCC (Gao 
et al., 2000). N-terminal cytoplasmic domain serves as a scaffold for proteins and 
small molecules that regulates the function of RyR. Here is a summary of different 
regulators of RyR2. 
First of all, Ca2+ has multiple direct effects on RyR2 and it can regulate receptor 
function through CaM and CaMKII. Ca2+ ions that reached the cytosolic part of 
RyR2, act as a ligand inducing opening of the receptor (Näbauer et al., 1989). Single 
channel experiments have shown that Ca2+ concentrations of ~1 µM are required to 
activate RyR2 openings (Meissner, 1986). In contrast to skeletal RyR, Ca2+- 
induced inhibition of cardiac RyR2 requires a relatively high concentration of 
cytosolic [Ca2+]. Luminal Ca2+, which is stored in the SR, can stimulate Ca2+ release 
from the RyR2. Experiments on single RyRs have shown an increased Ca2+ release 
in the presence of cytosolic agonists such as ATP and caffeine (Sitsapesan and 
Williams, 1995; Smith et al., 1989; Xu et al., 1998). When SR [Ca2+] is decreased, 
it inactivates RyR2 and contributes to the termination of CICR (Terentyev et al., 
2002). The exact mechanism of SR [Ca2+] RyR2 regulation is still unclear. 
67 
 
Another potent RyR2 regulator are Mg2+ ions. There are two proposed mechanism 
of Mg2+ regulation of RyR2. Mg2+ reduces the RyR2 open probability by competing 
with Ca2+ in high-affinity activation sites or it can bind to less selective low affinity 
Ca2+ sites to mediate Ca2+ inhibition (Laver et al., 1997; Meissner, 1986). The 
cytosol of most cells contains approximately 1 mM free Mg2+ and approximately 5 
mM ATP, most of which is bound to Mg2+. During pathology, such as ischemia, 
the concentration of ATP drops, so higher [Mg2+] contributes to altered RyR2 Ca2+ 
sensitivity. RyR2 can be activated by ATP itself and some other adenosine 
nucleotides (ADP, AMP, cAMP, adenosine and adenine) (Meissner, 1984). Cardiac 
RyR2 are less effectively activated by ATP, than skeletal RyR1 (Xu et al., 1996).  
Well known binding partners of RyRs are FK506-binding proteins (FKBPs) or 
castabins. Castabin2 (FRBP12.6) was co-purified with RyR2. It has a peptidyl-
prolyl-cis-trans isomerase activity. Each monomer of RyR2 binds to one molecule 
of castabin2 (Jayaraman et al., 1992). Removal of castabin2 from RyR2 induces an 
increase in RyR2 open probability and appearance of subconductance states of the 
receptor. Thus, the role of Castabin2 in stabilizing the closed state of the RyR2 was 
proposed (Brillantes et al., 1994). It binds to a cytoplasmic portion of RyR close to 
the clamp regions and this binding induces significant conformational changes in 
the transmembrane domain (Marx et al., 1998). Moreover, castabin2 can be 
important for the oligomerisation of RyR2 monomers and interaction between 
tetramers (Brillantes et al., 1994; Kaftan et al., 1996). Castabin2 deficiency results 
in cardiomyopathy which mimics a human congenital heart disorder (Shou et al., 
1998). 
CaM is a 17 kDa Ca2+ binding protein that is ubiquitously expressed and binds to 
RyR2 at a 1:1 stoichiometry. Binding of CaM to RyR2 shifts the Ca2+ dependence 
of RyR2 activation to a higher [Ca2+] and hence inhibits the receptor activity at all 
[Ca2+] (Balshaw et al., 2001; Meissner and Henderson, 1987). Reduced affinity of 
CaM binding to RyR2 with PKA phosphorylation was shown in catecholaminergic 
polymorphic ventricular tachycardia (CPVT) mouse model increasing spontaneous 
local Ca2+ releases and arrhythmogenicity (Xu et al., 2010). In addition to CaM 
some other Ca2+ binding proteins were found in association with RyR2, including 
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calumenin, S100A1 and sorcin (Bers, 2004; Jung et al., 2006). However, their role 
in RyR2 functioning is still not fully clear. 
Calcequestrin (CSQ) is a major Ca2+ buffering protein that is located in the SR. Due 
to a high binding capacity (40-50 molCa
2+
/molCSQ2) and low affinity, CSQ can not 
only buffer a large amount of Ca2+, but can also release bound Ca2+ into the SR 
(Slupsky et al., 1987). At the same time, the free Ca2+ level inside the SR is 
maintained below the inhibitory level of the SERCA (Murphy et al., 2011). There 
are two genes encoding CSQ1 and CSQ2, with a predominant CSQ2 expression in 
the cardiac tissue. CSQ forms oligomers in the SR lumen and interacts with 
membrane associated proteins junctin and triadin. Together they modulate the 
activity of RyR2 (Beard et al., 2009; Györke et al., 2009). Mutation in CSQ2 gene 
were linked to exercise-induced cardiac death in CPVT, but not to alterations in 
cardiac contractility under basal conditions (Postma et al., 2002). 
RyR activity can be strongly modulated by phosphorylation. The channel complex 
is associated with protein kinase A (PKA) and phosphatases PPI and PP2A. 
Interaction with kinases includes muscle mAKAP which is the target of PKA and 
phosphodiesterase 4D3 (PDE4D3) (Kapiloff et al., 2001). β-adrenergic stimulation 
induces PKA activation and RyR2 phosphorylation at Ser2808, that leads to a 
decrease in binding affinity of RyR to castabin2 and increases the open probability 
of the receptor (Doi et al., 2002; Wehrens et al., 2003). This is a part of “fight or 
flight” response to elevated stress. Chronic PKA activation in HF conditions can 
produce an incomplete channel closure and an enhanced Ca2+ leak during diastole. 
High diastolic Ca2+ leak depletes of SR Ca2+ stores and produces smaller Ca2+ 
transients (Wehrens et al., 2004). Association of RyR2 with PDE4D3 produces a 
local cAMP and PKA control loop to ensure a tight regulation of RyR2 activity 
(Lehnart et al., 2005). 
Moreover, RyR2 association and regulation by CaMKII was shown (Witcher et al., 
1991). Phosphorylation of RyR2 by CaMKII leads to an increased open probability 
of the receptor and an increased Ca2+ sensitivity (Wehrens et al., 2004). CaMKII 
activity is regulated by changes of intracellular [Ca2+] through the CaM (Huke and 
Bers, 2007). It can phosphorylate Ser2808 and Ser2814 residues of RyR2 (Huke 
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and Bers, 2007; Witcher et al., 1991). In failing hearts, CaMKII -dependent 
phosphorylation of RyR2 was found to produce an enhanced Ca2+ leak with a 
reduction of SR Ca2+ load leading to arrhythmias and contractile dysfunction (Chelu 
et al., 2009; Curran et al., 2010).  
RyR is an established redox sensitive channel. RyR redox state can induce both an 
activation (Stoyanovsky et al., 1997) or inactivation of the receptor gating(Boraso 
and Williams, 1994; Marengo et al., 1998). RyR has 80-100 cysteines per monomer 
and ~8 of them are ready for redox modifications by oxidation, nitrosylation, or 
alkylation by the redox active molecule glutathione (Xu et al., 1998; Zable et al., 
1997). Production of reactive oxygen species promotes Ca2+ efflux from SR store 
with CaM – mediating effects on RyR2 (Kawakami and Okabe, 1998). High levels 
of reactive oxygen species and reactive nitrogen species are able to irreversibly 
modify and even damage proteins in cardiac ischemia-reperfusion injury 
(Ferdinandy and Schulz, 2003). 
Caffeine increases both the RyR mean open time and open probability (Rousseau 
et al., 1987). This drug acts extremely rapidly and reversibly, which makes it a 
useful tool to study the SR Ca2+ loading. Application of 10 mM of caffeine induces 
a release of the full SR content, so it is widely used for SR content estimation (Bers 
and Perez-Reyes, 1999). Another important drug for RyR function is ryanodine, 
which has 2 binding sites on the receptor. At low concentrations (1nM- 10µM), it 
binds to a high affinity site and promotes RyR2 conduction at subconductance states 
(Rousseau et al., 1987) . At higher concentrations, (0.3-2 mM), it binds to a lower 
affinity site and induces a complete block of RyR2 (Rousseau et al., 1987). The 
binding of ryanodine is very slow and almost irreversible. The application of 
ryanodine to cells results in activation of a small fraction of RyR, and SR Ca2+ pump 
usually exceeds it to accumulate a higher SR Ca2+ content (Bers et al., 1987; Bers 
and Perez-Reyes, 1999). 
1.7.3 Distribution of RyR2 in ventricle cardiomyocytes 
Immunofluorescence studies of RyR2 from both fixed and live myocytes revealed 
a predominant localization of RyR2 along Z-lines (Figure 1.18, (Hiess et al., 2015; 
Jayasinghe et al., 2009; Soeller et al., 2007)). Only a small portion of RyR2 was 
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found between Z-lines, mostly on cell periphery. It was suggested to play a role in 
Ca2+ spread along the myofilaments (Subramanian et al., 2001). 
Transversal tubules of TAT network in myocytes are highly colocalized with RyR2 
(Hiess et al., 2015; Jayasinghe et al., 2010). Interestingly different types of 
myocytes can have a variable degree of TAT structure, but most of them have a 
highly regular organisation of RyR2 (Dries et al., 2013; Frisk et al., 2014; Hebisch 
et al., 2016). Differences in organisation of TAT structure and RyR2 indicate the 
presence of so called ‘orphaned’ RyRs along Z-line which do not colocalize with 
T-tubule (Figure 1.18; (Heinzel et al., 2008; Louch et al., 2006; Song et al., 2005)). 
Ca2+ release from these ‘orphaned’ RyRs is delayed, because they can’t be activated 
by the Ca2+ release through the LTCC. Instead, their activation occurs via Ca2+ 
spread from the nearby RyRs (Frisk et al., 2014; Louch et al., 2006; Song et al., 
2005). Thus, loss and reorganisation of TAT network occurred during the disease 
progression would promote the desynchronization and slowness of Ca2+ transients. 
 
Figure 1.18. Example of a relative RyR2 alignment with TAT network in pig 
myocytes. A TAT system visualized by NCX antibody labelling, B) RyR2 signal, C. 
Merged signals. Obtained from (Dries et al., 2013). 
1.7.4 Ca2+ sparks and Ca2+ transients 
RyR2s are anchored to the SR membrane which makes patch-clamp investigations 
of their behaviour in live myocyte a very challenging approach. In contrary, optical 
methods with the Ca2+ sensitive dyes provides an easy and comprehensive way to 
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study the RyR2 functional behaviour (Cheng et al., 1993). Ca2+ sparks were firstly 
documented by Cheng et al., as a local, short lived Ca2+- release events in cardiac 
tissue. These events can either occur spontaneously or be triggered by Ca2+ influx 
through the LTCCs (Cannell et al., 1995; Tsugorka et al., 1995). Ca2+ sparks are 
usually detected by the line-scan confocal imaging. The 3D illustration of Ca2+ 
spark activity is presented in (Figure 1.19, left panel). Ca2+ sparks are complex 
events with multiple factors affected their properties. One of the main determinants 
of Ca2+ spark behaviour is the frequency of sparks occurrence, which reflects the 
open probability of RyRs. The shape of the Ca2+ sparks is usually characterized by 
the amplitude, the width at half-maximum of amplitude (FWHM, Figure 1.19, top 
right panel), and the duration at half-maximum of amplitude (FDHM, Figure 1.19, 
bottom right panel). A typical cardiac Ca2+ spark may last for about 50 ms and have 
a width around 2 µm (Cheng et al., 1993). All the sparks parameters are tightly 
regulated. Moreover, Kolstad and co-authors suggested two additional parameters: 
spark mass can be calculated via multiplication of amplitude by FWHM and 
FDHM, and spark-mediated Ca2+ leak, can be calculated via multiplication of spark 
mass by frequency (Kolstad et al., 2018). These two parameters of Ca2+ sparks 
allow estimation of the amount of Ca2+ released thorough one spark.  
The mechanisms underlying the spark formation are still not completely clear 
(Hoang-Trong et al., 2015). Most of the factors that can affect RyR2 behaviour, 
alter can influence the properties of the Ca2+ sparks (Bers, 2000).  
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Figure 1.19. Representation of a typical Ca2+ spark recording illustrations Left: Line 
scan of fluorescence showing 3D Ca2+ sparks. Top right: spatial projection, Down right: 
time projection. 
Ca2+ spark was proposed as an elementary event of so called “visible” Ca2+ leak 
(Cheng et al., 1996). Synchronous activation of Ca2+ sparks during AP causes the 
formation of Ca2+ transient and cell contraction (Cheng et al., 1996; Wier et al., 
1997). Membrane TAT network largely determines the synchronization of Ca2+ 
transient via dyadic organisations. Dyads in ventricular myocytes contain a large 
cluster of RyRs (30-100 channels) in the SR membrane and a smaller cluster of 
LTCCs anchored to T-tubule. The high organisation of TAT network produces the 
synchronous activation of the most RyRs throughout the cell, but in atrial cells with 
a sparse TAT network, Ca2+ transient has a characteristic “U” shape (Figure 1.20, 
(Frisk et al., 2014)). Moreover, desynchronization of Ca2+ transients was frequently 
observed in failing ventricular myocytes due to membrane disorganisation and loss 
of LTCC- RyR2 communication (Song et al., 2006).  
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Figure 1.20. Differences in activation of Ca2+ transient in ventricular and atrial 
myocytes. From (Frisk et al., 2014).  
The occurrence of orphaned RyR2 in myocytes, which have different properties and 
regulation that the normal receptors, drives the interest to separate the sparks 
occurred from RyR2 coupled with T-tubule from uncoupled ones (Heinzel et al., 
2002). This relation is largely dependent on the type of myocytes. For example, 
Ca2+ sparks mainly occur close to T-tubules in rat ventricular myocytes 
(Lukyanenko et al., 2007), while in atrial cells Ca2+ sparks occur near the 
sarcolemma membrane and at the central area (Sheehan et al., 2006). Several groups 
have shown a correlation between the time of activation of Ca2+ release unit and its 
location to the sarcolemma membrane (Dries et al., 2013; Heinzel et al., 2002). 
They assigned the Ca2+ sparks as an early or delayed according to the time of 
activation (Figure 1.21, (Biesmans et al., 2011; Dries et al., 2013; Heinzel et al., 
2002)).  
 
Figure 1.21. Example of a line scan of Ca2+ transient and following Ca2+ sparks in pig 
ventricular myocyte. Left graph represents a comparison of fluorescence of this pixel with 
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a mean fluorescence at 50 % of Ca2+ transient amplitude, lower values are colored in red, 
higher are in blue. From (Biesmans et al., 2011). 
Investigation of the subcellular Ca2+ sparks heterogeneity is of particular 
importance, because it can provide the information on a local Ca2+ release control 
in health and disease. The work by Biesmans et al. has shown that in pig myocytes 
the coupled RyRs have a higher frequency of Ca2+ sparks as compared to the 
uncoupled ones (Biesmans et al., 2011). The duration of the coupled sparks was 
shorter than the uncoupled ones. HF does not affect the frequency of the sparks, but 
it changes the duration of coupled events. The authors proposed that in the number 
of active NCX produced longer Ca2+ sparks in these experiments. 
Another interesting work was made by Dries et al. on pig myocytes: they have 
shown a direct correlation between the Ca2+ transient activation sites and their 
distance to the nearest membrane (Dries et al., 2013). They observed a similar 
frequency of Ca2+ sparks between coupled and uncoupled RyRs. The authors found 
the potentiation of coupled Ca2+ sparks by high speed stimulation via CaMKII 
phosphorylation that was not observed in uncoupled sparks. HF leads to loss of 
CaMKII – mediated potentiation of coupled Ca2+ sparks with the appearance of the 
effect on uncoupled Ca2+ sparks (Dries et al., 2013). 
Determination of coupled and uncoupled Ca2+ sparks are usually performed on 
myocytes from big mammalians, such as dog and pig, which have a rather low T-
tubular density (Biesmans et al., 2011; Dries et al., 2013; Heinzel et al., 2008). The 
work on rat and mice ventricle myocytes is challenging because of high degree of 
T-tubular organisation, which diminishes the fraction of uncoupled RyRs (Heinzel 
et al., 2002). Recent advantages of development of high speed oblique plane 
microscope allows to overcome these problems (Sikkel et al., 2016). Sikkel and 
colleagues observed a high frequency of the Ca2+ sparks in tubulated regions of rat 
ventricular myocytes as compared to non-tubulated regions (Sikkel et al., 2016). 
1.7.5 Ca2+ efflux from the cytosol 
Ca2+ removal from the cytosol plays an important role in the maintaining of low 
basal [Ca2+] concentration. Cytosolic Ca2+ removal occurs through several routs: 
Ca2+ sequestration to SR by SERCA2, Ca2+ extrusion out of cell by NCX, and 
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mitochondrial Ca2+ loading via mitochondrial Ca2+ uniporter. The contributions of 
these proteins vary in different species. For example, in rat ventricular myocyte the 
main role is played by SERCA2 pump (~ 90% uptake) with a small contribution of 
others: NCX extrusion (~7%), by mitochondria (1%–2%) and by PMCA (Bers et 
al., 1996).  
As most of Ca2+ release units are organized by TAT, Ca2+ removal also largely 
relies on TAT structure (Chase and Orchard, 2011). SERCA2 pumps are located 
close to junctional SR. NCX are predominantly located in T-tubules (~ 60 %), so 
the extrusion of Ca2+ occurs mostly from places close to TATS (Chase and Orchard, 
2011; Scriven et al., 2010; Sjaastad et al., 2003). Interestingly, both LTCC and NCX 
were found to colocalize with Cav3, but they show no direct colocalization between 
each other (Scriven, et al 2005). Thus, Cav3 seems to organize different signalling 
microdomains through the T-tubule membrane. NCX can regulate the Ca2+ sparks 
activity via reduction of [Ca2+] near RyRs (Bovo et al., 2014). During its work, 
NCX exchanges one Ca2+ ion by three Na+ ions, and the depolarizing NCX current 
could serve as a trigger for arrhythmogenic activity (Pitts, 1979). 
Another exchanger which is located in TAT is PMCA. This protein uses the ATP 
hydrolysis for Ca2+ extrusion (Chase and Orchard, 2011). The work of PMCA is 
very slow so its impact on the total Ca2+ removal is relatively small. The negligible 
amount of Ca2+ (~1%) could be uptaken to mitochondria via Ca2+ uniporter MIM 
(Lu et al., 2013).  
 
1.8 Pulmonary hypertension and RV failure 
1.8.1 Etiology of pulmonary hypertension 
Pulmonary hypertension (PH) is a broad spectrum of disorders that affect both the 
pulmonary vasculature and the heart (Chesler et al., 2009). PH is characterized by 
an increased resistance of pulmonary circulation. This usually occurs through an 
excessive vascular proliferation and vasoconstriction. Clinical manifestation of PH 
is a substantial increase of the mean pulmonary pressure from 11-17 mmHg to the 
values above 25 mmHg (Subias et al., 2016). PH cases were classified into 5 groups 
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depending on the etiology of disease: 1) idiopathic pulmonary arterial hypertension 
(PAH), 2) pulmonary hypertension secondary to left heart failure, 3) pulmonary 
hypertension secondary to lung disease, 4) pulmonary hypertension caused by 
chronic embolism, and 5) pulmonary hypertension with unclear or multifactorial 
causes (Simonneau et al., 2009).  
The most common cause of PH is the second type, due to the LV failure. Most of 
the patients with HF develop an increased pulmonary artery pressure > 25 mmHg 
with a pulmonary capillary wedge pressure >15 mmHg (Guazzi and Borlaug, 2012; 
Hoeper et al., 2013). The idiopathic PAH is relatively rare, with the incidence varies 
from 2.0 to 7.6 cases per million of adults per year (Mckee et al., 1971). The 
incidence of PAH is two to fourfold higher in women than in men (Hatton and 
Ryan, 2014). At the same time, women with PAH can survive much longer than 
men (Jacobs et al., 2014). 
During the last two decades, the progress in PAH treatment significantly improved 
the survival of PAH patients. One year survival increased from 65% to 86-90% 
(D’Alonzo et al., 1991; Sitbon et al., 2010) and the median survival time in 2010 
became around six years (Thenappan et al., 2018). Despite this, most of the 
treatments are still not able to stop the obstruction of pulmonary microvasculature 
that imposes an RV with a significantly higher pressure. The survival of the PAH 
patients is predominantly determined by the response of the RV to the increased 
afterload (D’Alonzo et al., 1991; Sandoval et al., 1994). Moreover, RV failure is 
the leading cause of death in PAH patients (Delcroix and Naeije, 2010). 
Interestingly, the RV status was shown to be a key determinant of survival in LV 
failure (Szwejkowski et al., 2012). Importantly, there is no current treatment in PH 
directed to fix RV (Thenappan et al., 2018).  
1.8.2 RV hypertrophy and failure in pulmonary hypertension. 
For the long time the research of heart disorders was concentrated in the LV, while 
little attention was given to study the RV progression in disease.Now, there is a 
growing amount of data regarding the RV behaviour in disease. The progression of 
RV to failure under high pressure is illustrated in Figure 1.22. In contrast to LV that 
works in generating pressure, RV is not prepared to work under a high pressure. In 
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circumstances of elevated ejection pressure, the stroke volume of the RV drops 
faster compared to the LV (Greyson, 2008). Several reasons could explain this. 
First, the thinner RV free wall faces with a greater wall tension under increments 
of pressure. Second, at end of LV contractions, the stress of the walls is significantly 
reduced because of the diminishing the curvature radius (Yin, 1981). On contrary, 
the contraction of RV leads to a higher radius of wall curvature, which increases 
the stress on the walls.  
Several mechanisms of ventricular adaptation to the increased pressure was 
proposed, such as the Anrep effect (homometric autoregulation), the Frank-Starling 
mechanism (sometimes referred to as heterometric autoregulation), and 
catecholamine induced inotropy. The Anrep effect is mediated through the rapid 
changes in Ca2+ dynamics happened in the absence of external regulatory 
stimulation (Pawlush et al., 1989). It was believed to be a first adaptation response 
of RV to a high pressure (De Vroomen et al., 2000; Hon et al., 2001). According to 
Frank-Starling mechanism, a higher stretch of the walls will produce a larger stroke 
work (Karunanithi et al., 1992). However, at the baseline, a large increase in RV 
volume results in the increment of stretch, therefore, the Frank-Starling mechanism 
has a small impact on RV function at baseline (De Vroomen et al., 2000). Only 
when RV dilates and becomes more circular, the Frank-Starling mechanism can 
effectively determine the RV function (Szabo et al., 2006). Sympathetic stimulation 
permits the RV to further implement the pressure via an increase in inotropy 
(Handoko et al., 2010; Maughan et al., 1979; Naeije and Manes, 2014). When the 
most of the contractile reserve mechanisms are exhausted, systemic pressure begins 
to fall, with a dramatic, sudden, and irreversible reduction of RV contractile 
function (Guyton et al., 1954). 
With increasing the pressure, RV is not able to maintain a high working load and 
becomes uncoupled from the load, making energy transfer inefficient, and 
ultimately RV failure develops (Vonk Noordegraaf et al., 2017). The wall stress 
determines the ventricular oxygen consumption (Sarnoff et al., 1958; Wong et al., 
2011). Moreover, an increased wall thickness diminishes the oxygen delivery to the 
cells from blood, that affects the energy metabolism and changes the muscle 
contraction (Van Wolferen et al., 2008).  
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Figure 1.22. Schematic of the RV progression in pulmonary hypertension. Adapted 
from (Westerhof et al., 2017). 
1.8.3 Models of pulmonary hypertension in rat 
Investigations of the mechanisms of PH- related RV hypertrophy and failure are 
mostly performed in animal models (Nogueira-Ferreira et al., 2017). An ideal PH 
model should mimic the key clinical, hemodynamic and histopathological features 
of human disease (Ryan et al., 2011). PH is a complex disease of diverse etiology 
and so there is no single animal model that accurately reproduces the human 
disease, even focusing on just one of the PH groups (Das et al., 2012). Despite not 
fully replication of the aspects of human cardiovascular disease, animal models can 
provide invaluable insight into the processes and pathways underpinning 
pathological remodelling. A vast variety of PH animal models is currently available 
(Table 5). The models are grouped in the table according to the stimuli that result 
in PH development. Each model has its own characteristics and usage is highly 
dependent on the specific hypothesis of the study. Some of the models are 
commonly used as they recapitulate a broad spectrum of PH-related features and 
some could be used for investigation of the specific pathway and its role in disease 
progression. 
Table 5. List of the commonly used animal models of PH 
Experimental 
models 
Animal 
species 
Pathological findings Advantages  Limitations References  
Chronic hypoxia mouse,  
rat,  
Chronic hypoxia results in 
vasoconstriction, muscularization 
of non- muscular arterioles, 
increased matrix deposition 
 Widely used 
 Simple 
implementation 
 Results in lung 
damages 
 Not included 
heart damage. 
(Janssens, 
Thompson, 
Spence, & Hales, 
1991; Meyrick & 
Reid, 1980; 
Steudel et al., 
1998) 
Pulmonary 
arterial binding 
Mouse, 
rat  
Pulmonary arterial binding leads to 
pulmonary arterial stenosis that 
causes RV hypertrophy  
Model could mimic 
congenital heart 
diseases and 
investigation of the 
RV response to 
increased pressure  
 
 
 Required highly 
technical skills 
 Generally 
associated with a 
high percentage 
of animal death  
(Dias et al., 2002; 
Maarman, 
Lecour, Butrous, 
Thienemann, & 
Sliwa, 2013) 
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Vascular 
obstruction 
Rat   Embolization of pulmonary arteries 
via intravenous administration of 
synthetic microspheres 
 Allow to study 
chronic pulmonary 
thromboembolism 
 Possibility to target 
different size of 
microspheres  
 Possible cellular 
reaction to 
microspheres 
 Effects are mostly 
on the lungs 
(Marsboom & 
Janssens, 2004; 
Shelub, van 
Grondelle, 
McCullough, 
Hofmeister, & 
Reeves, 1984; 
Weimann et al., 
1999) 
Monocrotaline Rat  PH induced via single MCT and 
characterized by vascular 
remodeling, increased 
muscularization, vascular 
inflammation and RV hypertrophy 
and failure 
 Simple 
implementation 
 Commonly used  
 Relatively 
inexpensive 
 Recapitulate PH 
related problems of 
the heart and lungs 
 MCT response 
vary among 
species, strain and 
animals 
 Could produce 
damage of liver 
(Gomez-Arroyo 
et al., 2012; 
Hilliker, Bell, & 
Roth, 1982; Zeng 
et al., 2013) 
Other chemical- 
induced PH 
Mouse, 
rat 
 Α-naphthylthiourea- induced 
pulmonary vascular remodeling 
associated with RV hypertrophy.  
 Bleomycin–induced pulmonary 
fibrosis with increased lungs 
inflammation 
 Simple 
implementation 
 Relatively 
inexpensive 
 
 Mimic only a few 
features of a 
human PH, not 
commonly used 
(Hill, O’Brien, & 
Rounds, 1984; 
Ortiz et al., 2002) 
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Genetic induced 
PH 
Mouse, 
rat 
 Mice overexpressing IL-6 
develop PH with increased 
pulmonary arterial 
muscularization and RV 
hypertrophy. IL-6 effects are 
augmented by hypoxia 
 Transgenic rats overexpressing 
Ang-1 develop increased 
pulmonary arterial 
muscularization and vascular 
occlusion 
 5-HTT overexpression leads to 
PH development and RV 
hypertrophy 
 Useful for 
investigation of the 
specific pathways in 
PH development and 
progression  
 Not reflex all the 
complex features 
of PH 
 Relatively 
expensive  
(Chu et al., 2004; 
MacLean et al., 
2004; Steiner et 
al., 2009) 
Multiple stimuli 
SU5416 + 
chronic hypoxia 
Mouse, 
rat  
VEGFR-2 blockade with chronic 
hypoxia leads to PH development 
with a complex plexiform like 
lesions formation 
Mimic more accurately 
human PH that single 
stimuli models: 
development more 
severe PH with 
vascular lesions  
 Relatively 
expensive 
 Require technical 
skills  
 Associated with a 
high mortality 
(Abe et al., 2010; 
Taraseviciele‐
Stewart et al., 
2001) 
Athymic + MCT Rat Athymic rats treated with MCT 
develop severe PH with a great 
number of mast cell and severer 
histopathologial changes 
(Miyata et al., 
2000) 
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MCT + 
pneumonectomy 
Rat  Addititonal preunonectomy in 
MCT treated rats leads to RH with 
additional neointimal lesions 
formation 
 
(Okada et al., 
1997) 
Endothelin 
receptor B 
deficiency + 
MCT 
Rat Monocrotaline administration in 
endothelin receptor-B deficiency 
rats leads to acceleration of PH 
progression, enhances the 
appearance  of cellular and 
molecular markers related to PH 
progression and develops 
neointimal lesions  
(Ivy et al., 2005) 
5-HTT serotonin transporter, Ang-1: angiotensin 1, IL-6: Interleukin -6, VEGFR-2: vascular endothelial Growth Factor Reseptor-2,  
  
1.8.4 The chronic hypoxia model of pulmonary hypertension  
The chronic hypoxia model is one of the most used to study PH pathogenesis and 
treatment. Its pathological features of pulmonary vasoconstriction and vascular 
medial hypertrophy mimic the ones observed in human PH (Zhao, 2010). This 
model could be produced by exposing animals to oxygen-low air at normal pressure 
or to normal air at hypobaric pressure (Voelkel and Tuder, 2000). The decrease in 
oxygen pressure causes a strong pulmonary vasoconstrictor response that is 
characteristic of this model (Barman et al., 2009). However, there is little evidence 
of RV failure in this model (Zhao, 2010).  
1.8.5 The surgical models of pulmonary hypertension  
The surgical models are designed to mimic the increased blood flow and pressures 
imposed on the RV in Group 1 PH. There are two main surgical methods used: 
pulmonary artery banding (PAB) and aorto-caval shunt. The PAB produced a 
constriction imposed in the pulmonary artery, which leads to an increased afterload 
in the RV that drives the hypertrophic response. This produces only a cardiac 
disease, but not pulmonary. Thus PAB does not replicate the human pathology 
entirely, only the mechanisms of RV dysfunction (Ryan et al., 2013; Vonk 
Noordegraaf and Galiè, 2011).  
The aorto-caval shunt is a volume overload method which displays a similar RV 
hypertrophy when compared with PAB. This model can be combined with the 
monocrotaline (MCT) model, leading to more severe disease development (Ryan 
et al., 2013; West and Hemnes, 2011). The main disadvantages of these surgical 
methods are related with the fact that they require highly technical skills and are 
usually associated with a high percentage of animal death (Ryan et al., 2011).  
1.8.6 Monocrotaline induced pulmonary hypertension in rat 
MCT is a pyrrolizidine alkaloid isolated from the seeds of the Crotalaria spectabilis 
plant. The model is produced by intraperitoneal MCT injection. MCT injection 
affects both lungs and heart, mimicking the two key pathological featured of human 
PH: vascular remodelling and inflammation (Umar et al., 2012).  
Low doses around 30-40 mg/kg produced a compensated hypertrophy without the 
heart failure, and these doses are used for the investigation of the long term effects 
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of PH on the RV and LV (Benoist et al., 2012; Ruiter et al., 2013). A middle dose 
of 60-80 mg/kg the MCT produced a PH that leads to RV hypertension after 2 
weeks and RV failure after 3-4 weeks (Abdul-Salam et al., 2019; De Man et al., 
2012; Lamberts et al., 2007). The doses higher than 80 can cause an acute lung 
injury, interstitial pulmonary fibrosis and hepatic veno-oclusive disease (Copple et 
al., 2003).  
The mechanism of MTC action is complex and not well understood. The MCT is 
not active by itself, but in the liver, it is oxidized by cytochromes P450 CYP3A4 to 
the short-lived, reactive MCT-pyrrole compound (Kasahara et al., 1997; Mattocks 
et al., 1990). The active compound is pumped by the RV to the lungs where it 
damages the endothelial cells of pulmonary arterioles. MCT-pyrrole causes the 
death of pulmonary vascular cells. When the barrier function of pulmonary 
vasculature is comprehended, it starts the inflammation leading to lung fibrosis (Pan 
et al., 1993; Sahara et al., 2007). Also, MCT-pyrrole promotes the proliferation, 
constriction and hypertrophy of smooth muscle cells (Huang et al., 2010; Ramos et 
al., 2007). Importantly, MCT-pyrrole has no direct action on the systemic 
circulation and peripheral resistance because of a small lifetime in the systemic 
circulation (Correia-Pinto et al., 2009). There is an evidence of significant liver and 
kidney damage by MTC-pyrrole (Huang et al., 2010), but it appears at the late 
stages of the disease. Moreover, there is a report indicating that MCT can cause 
myocarditis affecting both RV and LV, which complicates the evaluation of the 
direct effect of PH to the RV hypertrophy and failure at severe stages of PH 
(Miyauchi et al., 1993). Generally, MCT-pyrrole is proposed to produce the PH via 
acute/subacute damage of peripheral vasculature of the lungs and other organs.  
1.8.7 Genetic animal models  
In the past few years, there is a growing amount of animal PH models produced by 
genetic manipulation (Barman et al., 2009; Piao et al., 2010; Ryan et al., 2011). The 
transgenic and knockout models allow the evaluation of the role of a specific gene 
or protein modifications in the susceptibility to the development of PH. These 
models allow developing the molecular pathways underlying PH development 
rather than the PH-induced RV failure (Das et al., 2012; West and Hemnes, 2011).  
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1.9 Heart failure and the effect on the RV.  
HF is a progressive clinical syndrome in which the heart is not pumping enough 
blood to the body. HF is associated with a high risk of morbidity and mortality; it 
causes more than 7.4 million of deaths annually (World health organisation, 2017). 
Moreover, many other cardiovascular diseases, including pulmonary arterial 
hypertension, atrial fibrillation, valve disease, and cardiomyopathy, can contribute 
to HF. As stated above, PH due to left heart disease is the most common cause of 
the pulmonary disease. It includes around 65-80 % of all the cases of PH 
(Rosenkranz et al., 2016). The prevalence of PH in HF varies from 36 to 83 %, 
because different estimations gave variable values. For example, echocardiography 
tends to overestimate the pulmonary arterial pressure so the detection of PH should 
be performed by right heart catheterization (Kalogeropoulos et al., 2011).  
The presence of PH in the settings of left sided HF, predicts an increased morbidity 
and mortality (Guazzi and Borlaug, 2012; Salamon et al., 2014). Most of the efforts 
in the treatment of PH were concentrated on group one , i.e., PAH, leaving the 
second group of PH without a proper attention (Kalogeropoulos et al., 2011). 
However the treatments of PAH can be partially beneficial or ineffective for the 
treatment PH due to the HF. Deeper understanding of the mechanisms of RV 
pathophysiology in PH can help to find a better treatments. 
The pathophysiology of PH in this case is related to the backward transmission of 
LV filling pressures into the pulmonary circulation that is followed by pulmonary 
vasoconstriction, decreased nitric oxide availability and desensitization to 
natriuretic peptide-induced vasodilatation (Rosenkranz et al., 2016). Pulmonary 
vascular remodelling leads to RV strain and dysfunction. Uncoupling of RV from 
pulmonary artery leads to RV dilatation, increased wall stress, tension and elevated 
myocardial oxygen consumption that result in ischemia and failure 
(Kalogeropoulos et al., 2011).  
If PH occurs during LV failure, the disease progresses from a predominantly LV 
cardiomyopathy phenotype to biventricular or RV dysfunction predominant 
phenotype. At certain stage of disease, it is hard to establish what is the reason or 
the cause of dysfunction. At the beginning, LV dysfunction can produce PH, but 
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later the worsening of PH can worsen the disease progression. For example, 
dilatation of RV at the late stages of PH shifts the septum leftwards and impairs the 
global ventricular function (Haddad et al., 2008).  
1.9.1 Animal models of heart failure 
Small animal models are commonly used for deeper the understanding of various 
aspects of HF (Goh et al., 2016). Mice and rats are the most commonly used as they 
have a relatively short breeding cycle, low housing costs, and share a high degree 
of homology to the human genome (Riehle and Bauersachs, 2019). However, the 
pathogenesis of HF is multifactorial and is not a model that can recapitulate the 
whole range of HF induced remodelling. Thus, there are numerous small rodent HF 
models have been developed that allowed investigating HF induced remodelling 
and specific molecular pathways (Riehle and Bauersachs, 2019). These models 
could be grouped according to the stimulus into surgical, toxic and genetic models. 
The main characteristics of the commonly used rodent models are summarized in 
the Table 6. 
In this work, we used a model of the myocardial infarction (MI) induced via left 
anterior descending (LAD) artery ligation. This model was established by Pfeffer 
et al. (Pfeffer et al., 1979). LAD showed good reproducibility, as rats with 
infarctions greater than 46% developed congestive HF after 21 days with elevated 
filling pressures, reduced cardiac output, and minimal capacity to respond to pre- 
and after-load stress (Pfeffer et al., 1979). The degree of impairment of LV function 
is directly related to the extent of myocardial loss (Pfeffer et al., 1979). This model 
was thoroughly characterized in our group showing that after sixteen weeks of 
infarction animals had developed significantly increased heart weight/body weight 
ratios, ventricular dilatation, with reduced ejection fraction and elevated end-
diastolic pressure (Lyon et al., 2009).  
Importantly, RV hypertrophy was shown in 30-60% cases in this model (Pfeffer et 
al., 1979).In MI, the degree of RV hypertrophy correlated to increases in the LV 
end-diastolic pressure and RV systolic pressure . In addition, the change of the 
pulmonary circulation resistance due to MI can  influence RV function (Sicard et 
al., 2019). Another evidence of declined RV contractile function was observed in 
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coronary ligated MI mouse and pig (Danton et al., 2001; Toldo et al., 2011). Thus, 
there is a remodelling occurring in the RV due to the LV MI and this model is 
suitable to investigate the cellular and molecular mechanisms of the adaptation RV 
myocytes in the settings of LV failure. 
 
Table 6. Characteristics of animal models of HF. 
Experimental models Animal 
species 
Pathological findings Advantages Limitations References  
LV pressure overload via 
transverse aortic 
constriction (TAC) 
Mouse, 
rat 
TAC increases LV 
after-load, which 
results in concentric 
cardiac hypertrophy 
and, ultimately, HF. 
Reliable model to 
induce cardiac 
hypertrophy and HF 
The acute increase in 
afterload does not reflect 
the gradual progression 
observed in human 
patients 
(Grund et al., 
2019; Riehle 
et al., 2011; 
Schwarzer et 
al., 2014) 
LV pressure overload via 
ascending aortic 
constriction 
Rat In this model, LV 
hypertrophy is 
observed by 6 weeks 
and overt HF by 18 
weeks post-surgery. 
Gradual onset of 
pressure overload 
that mimics the 
gradual onset of 
arterial hypertension 
in patients 
Induced in young animals, 
whereas arterial 
hypertension is primary 
observed in elderly 
patients 
The technical challenge of 
such a delicate procedure 
(Schunkert et 
al., 1990) 
Myocardial infarction (MI) 
via left anterior descending 
(LAD) artery ligation 
Mouse, 
rat 
Myocardial scar and 
dilated 
cardiomyopathy 
develop several 
weeks post-surgery.  
This model mimics 
the effects of a 
completed human 
myocardial 
infarction in patients 
Model does not reflect the 
clinical settings with 
reperfusion of the 
occluded vessel during 
coronary angiography 
High perioperative 
mortality 
Variations in the size of 
infarct 
(Fraccarollo et 
al., 2011; 
Pfeffer et al., 
1979) 
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Ischemia/reperfusion (I/R) 
injury via temporary LAD 
ligation 
Mouse, 
rat 
I/R model typically 
exhibits less tissue 
damage compared to 
permanent LAD 
occlusion. 
Close to scenario 
with reperfusion of 
the occluded vessel 
during coronary 
angiography 
performed after 
acute MI 
More complex and 
challenging surgery 
(Lindsey et al., 
2018; Yeang 
et al., 2019) 
Volume overload via 
aorto-caval fistula (shunt) 
Mouse, 
rat 
Volume overload in 
rats initially decreases 
LV function. The 
subsequent 
compensatory 
hypertrophy 
normalizes contractile 
function at one month 
post-surgery.  
Model mimic the 
volume overload 
observed in patients 
with mitral valve 
regurgitation 
The acute increase in 
volume overload does not 
reflect the gradual 
progression of mitral 
valve regurgitation in 
patients 
The time course of HF 
development strongly 
dependent on the shunt 
volume 
Shunt create an artificial 
mix of arterial with venous 
blood 
(Liu et al., 
1991; Toischer 
et al., 2010) 
Toxic cardiomyopathy via 
doxorubicin injection 
Mouse, 
rat 
Doxorubicin causes 
dilated 
cardiomyopathy in a 
dose-dependent 
manner that is 
typically irreversible 
and progressive. 
Potent stimulus to 
induce dilated 
cardiomyopathy 
Systemic toxic effects, 
especially on bone 
marrow cells and 
gastrointestinal system 
(Hayward and 
Hydock, 2007; 
van der Vijgh 
et al., 1988) 
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Chronic activation of 
adrenergic signalling by  
Isoproterenol injections  
Mouse  Chronic activation of 
adrenergic signalling 
with isoproterenol 
provokes 
cardiomyocyte 
hypertrophy and 
fibrosis  
Potent stimulus to 
induce cardiac 
hypertrophy  
Model mimic only one 
factor contributing to HF 
development in patients 
(Thum et al., 
2008) 
Chronic stimulation of 
angiotensin II Type 1 
receptor (AT1R) signalling 
Mouse, 
rat  
Chronic AT1R  
stimulation causes 
hypertension and 
cardiomyocyte 
hypertrophy  
Reliable model of 
cardiac hypertrophy; 
Technically easy 
surgery to implant 
osmotic mini-pumps 
Unspecific side effects on 
organ systems, especially 
kidney 
(Joseph et al., 
2002) 
Dahl rats that are 
susceptible to hypertension 
following a high salt diet 
Rat  When fed with a high-
salt diet containing 
8% NaCl, this model 
rapidly develops 
hypertension, 
diastolic dysfunction, 
and HF 
No surgery needed 
Slow progression of 
hypertension as 
observed in patients 
Slow progression of 
disease requires long 
housing for the animals 
(Dahl et al., 
1962) 
Spontaneous hypertensive 
rats 
Rat  Spontaneously 
progress to 
hypertension and HF 
Slow progression of 
hypertension as 
observed in patients 
High housing costs based 
on the slow progression of 
hypertension 
(Okamoto and 
Aoki, 1963) 
 
1.9.2 Structural changes in cardiomyocytes during heart failure 
Cardiac myocytes are terminally differentiated cells (de Tombe, 1998).  Thus the 
adaptation to a high working load is going through the changes of cell shape 
(increase cell mass, hypertrophy) rather than the cell proliferation (de Tombe, 
1998). Different loading conditions can modulate variable changes of myocytes 
geometry (Tamura et al., 1998). In circumstances of pressure overloaded, myocytes 
tend to become wider, as it helps to reduce the wall stress. When the ventricle 
experiences the volume overload, the myocytes tend to elongate to maintain the 
stroke volume (Grossman et al., 1975). At the same time, the capacity of cells to 
adapt to stress is very limited. If the initial stimuli remain and myocytes cannot 
sustain it, the pump failure will happen at certain point (Gerdes and Capasso, 1995).  
When the hypertrophy of the ventricle is established, it produces a mismatch of 
oxygen supply and demand, and development of hypoxic and unexcitable regions 
unable to contribute the contraction. Hypoxia promotes myocytes apoptosis 
fibrosis. Both of these factors have been observed in PH rats (Campian et al., 2009). 
Progressive fibrosis replaces the myocardium in order to maintain the structure 
organisation of the heart; however, it impairs heart pump function (Cingolani et al., 
2004).Adrenergic stimulation via βARs plays an important role in disease 
progression. There are three main subtypes of βARs expressed in the heart. The 
most abundant is β1ARs, with a β1/β2 ARs ratio of around ~80/20 found in ventricle. 
The β1ARs effectively regulate the contraction providing positive lusitropic and 
inotropic effects. From the other side, β2ARs are involved only in the inotropic 
response (Nikolaev et al., 2010). In pathology, the βAR system usually became 
overstimulated because of constitutive demand of increased contractility that leads 
to desensitization (Sato et al., 2015) and internalization of the βARs (Luttrell and 
Lefkowitz, 2002). Reduction in βAR inotrope results in hypophosphorylation of 
key Ca2+ handling proteins and reduction of the contractile reserve to adapt for acute 
stress, such as exercise (Holubarsch et al., 1996).  
Hypertrophic stimuli were shown to be associated with the reappearance of the fetal 
genes expression (Alpert and Gordon, 1962; Chien, 1999). An altered myosin heavy 
chain (MHC) expression is one of the most important changes (Alpert and Gordon, 
1962). β-MHC is expressed in the embryonic/fetal ventricles of all mammals. In 
92 
 
small mammals it is replaced (at approximately three weeks of age) by α-MHC 
(Schaub et al., 1998). In hypertrophy, a decreased myofibrillar ATPase activity 
makes a slow β-MHC more suitable for the contraction demands (Pope et al., 1980; 
Swynghedauw, 1986; VanBuren et al., 1995). Therefore in larger mammals, 
including humans, β-MHC remains the predominant ventricular isoform throughout 
adulthood, so the heart is already in low gear and there is little potential for a change 
as compared with the smaller mammals (Cooke, 1997; Schaub et al., 1998). The 
contractile dysfunction of the myocytes rises also from the changes in thin filaments 
and their associated proteins (LeWinter and VanBuren, 2002; Lowes et al., 1997). 
These include expression of alpha-skeletal actin (α-SKA) and alpha-smooth muscle 
actin (α-SMA) (Long et al., 1989; Swynghedauw, 1986). The enhancement of α-
SKA expression is associated with increased myocyte stretch, high wall stress, and 
pressure overload (Machackova et al., 2006). Another important protein that 
appears in hypertrophied myocardium is atrial myosin light chain 1 (ALC1). It is 
normally found in the developing heart and skeletal muscle (Price et al., 1980). The 
main consequence of ALC1 re-expression in the ventricle is the increase of Ca2+ 
sensitivity of the contractile apparatus (Morano et al., 1997). ALC1 modulates 
ventricular contractility by increasing the cross-bridge kinetics of the β-MHC 
isoform. Expression of β-MHC in combination with ALC1 produces a faster 
contraction with a higher ATPase efficiency (Morano et al., 1996). Failing 
myocardium has an altered expression of cardiac troponin T isoforms expression 
(Adamcová and Pelouch, 1999).  
Significant changes in the contractile apparatus of failing cardiomyocytes occur due 
to the endogenous phosphorylation status of thin and thick filament proteins 
(Suematsu et al., 2001; Van Der Velden et al., 2003). These alterations may be 
determined by the activity of different protein kinases, such as the PKA, protein 
kinase C (PKC), and myosin light chain kinase, as well as phosphatases, in the 
failing myocardium (Machackova et al., 2006). Most of these kinases are activated 
via βAR and can regulate the activity and Ca2+ sensitivity of the contractile proteins 
affecting the rate and force of contraction. 
During the progression of HF, many research groups have seen the disorganisation 
and loss of TAT system (Heinzel et al., 2002; Schobesberger et al., 2017; Wei et 
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al., 2010). JPH2 and BIN-1 that are the key proteins for T-tubular maintenance 
undergo significant down-regulation in HF (Hong et al., 2014; Schobesberger et al., 
2017). Disorganisation of TAT network was shown to uncouple the LTCC from 
RyRs which decreases a spatial synchrony of Ca2+ transients and reduce the 
contraction force (Louch et al., 2006). Cav1.2 expression and Ca2+ current density 
are usually not changed in HF, but single LTCC channels showed the redistribution 
from a predominant T-tubular localization to the surface sarcolemma (Bryant et al., 
2015; Sanchez-Alonso et al., 2016). Redistribution of LTCCs could be induced by 
the reduction of JPH2 and Cav3, that are essential for the maintenance of LTCC in 
T-tubular membrane (Bennett et al., 2015).  
1.9.3 Progression changes of RV myocytes Ca2+ handling in hypertrophy and 
failure 
The pathophysiology of RV in hypertrophy and failure is not clear. It can 
significantly vary depending on the model and the specie. Most of the studies were 
concentrated on the MCT model of PH (Nogueira-Ferreira et al., 2017) and we 
aiming to study this model, so results produced in MCT rats will be described here. 
The most consistent finding in failing RV myocytes is the prolonged action 
potentials and a steeper AP duration restitution that were described in PH rats 
(Benoist et al., 2011; Sabourin et al., 2018). The steep AP restitution can lead to the 
formation of altering long and short AP durations (namely, AP alternants) which 
can generate ventricular fibrillation (Rosenbaum et al., 1994).  
In the studies of Ca2+ handling in RV there are many contradicting results. At the 
early stages of PH, some have found the prolongation of contractions and Ca2+ 
sequestration (Brunner et al., 2002). In contrast, others have observed higher 
amplitudes and shorter durations of contraction and Ca2+ transients in RV 
(Kuramochi et al., 1994; Sabourin et al., 2018). In the late-stage PH in MCT rats, 
some groups observed smaller and slower Ca2+ transients (Kuramochi et al., 1994; 
Xie et al., 2012), but others reported an increase of SR Ca2+ loading, Ca2+ transients 
and cell shortening (Benoist et al., 2012).  
From molecular point of view, in PH the prolongation of Ca2+ transients in RV 
myocytes was supported by the reduction of SERCA2a expression and the reduced 
phosphorylation of its inhibitor, phospholamban (Benoist et al., 2014; Xie et al., 
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2012). Moreover, the reduction of SERCA2a activity provokes the decrease in SR 
Ca2+ loading and consequently Ca2+ transient amplitude. In contrary, Sabourin et 
al. found the unchanged levels of SERCA2a expression and increased 
phosphorylation of phospholamban by PKA in MCT model of PH, which produced 
higher levels of SR Ca2+ loading (Sabourin et al., 2018).  
Progressive loss of TAT structure was shown in hypertrophied RV myocytes (Wei 
et al., 2010; Xie et al., 2012). It was accompanied by down-regulation of two T-
tubule scaffolding proteins, BIN1 and JPH2 (Wei et al., 2010; Xie et al., 2012). 
TAT network loss resulted in the reduction of synchronous Ca2+ release, 
prolongation of Ca2+ transients and diminishing the force of contraction (Ferrantini 
et al., 2014; Xie et al., 2012). The mRNA and protein levels of LTCC were 
downregulated at severe PH (Benoist et al., 2011; Xie et al., 2012) whereas the 
whole-cell LTCC current was not altered (Benoist et al., 2012). It raises the question 
to what extend the mismatch of the expression and whole-cell current data could be 
attributable to single LTCC spatial localization or functioning.  
Higher rate of spontaneous Ca2+ waves and sparks release were shown in 
hypertrophied and failed RV myocytes (Benoist et al., 2012; Sabourin et al., 2018). 
Such enhanced Ca2+ activity promoted the loss of SR Ca2+ contents, participated in 
the formation of ectopic AP (Fujiwara et al., 2008) and provoked ventricular 
fibrillation (Benoist et al., 2011). 
1.10 Hypothesis and aims of the study. 
As indicated before RV is involved in several severe disorders, such as pulmonary 
hypertension and left ventricular failure. The adaptation RV was shown to be an 
important predictor of patient survival in PH (Thenappan et al., 2018). The 
behaviour and mechanism of LV progression in failing heart are well studyed, but 
the differences between the chamber and their working conditions did not allowed 
a direct translation of the results obtained from LV studies to the RV.  
Myocytes membrane is organized in microdomains that serve for synchronous 
contraction and regulation of ECC. TAT network plays an important role in 
organizing such signalling microdomains (Kamp and Hell, 2000). Cardiac disorders 
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usually promotes the disorganisation of TAT network and signalling complexes 
involving ion channels and associated signalling molecules that further contribute 
to the pathophysiology of disorder (Dibb et al., 2009; Schaper et al., 2002).  
Here we hypothesize that in rats RV myocytes have a distinct ECC organisation 
than LV myocytes which could be responsible for a different adaptation of RV 
myocytes to the disease conditions.  
The main aims of this thesis were: 
1. To compare myocyte membrane microdomain organisation and to reveal 
how the differences of microdomain organisation influence Ca2+ handling 
in normal RV and LV myocytes 
2. To analyse the influence of PH on RV and LV microdomain structure, in a 
rat model of the MCT-induced PH, to investigate the effect of PH on 
electrical conduction in-vivo, and on cellular ECC.  
3. To investigate RV microdomain changes after left-sided heart failure in a 
rat model of HF (in 16 weeks after myocardial infarction); to compare RV 
myocytes progress towards failure, relative to the LV myocytes. 
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2 General methods  
2.1 Animals  
2.1.1 Sprague Dawley rats  
All animals were treated and maintained under conditions fulfilling the criteria of 
Animals in Scientific Procedures Act 1986 (UK Home Office, ASPA 1986). The 
male outbred, Sprague Dawley rats (rattus norvegicus) were obtained from Harlan 
Laboratories (Wyton, UK). They were fed standard rat diet, which they had access 
to ad libitum. Rats were housed at a density of 4-6 per cage and maintained on a 
12-hour light/dark cycle at 21oC. The adult cardiomyocytes were isolated from 
males above 250g.  
2.1.2 Monocrotaline model of pulmonary artery hypertension 
Pulmonary hypertension was induced via monocrotaline injection accordingly to 
the protocol described (Abdul-Salam et al., 2019; Wojciak-Stothard et al., 2014). 
Rats were injected and carried out by Dr. Vahitha Abdul-Salam in Imperial College 
London and by Dr. Stefano Rossi in University of Parma. Monocrotaline (MCT; 
Sigma, UK) injections were prepared before the experiments by dissolving 80 mg 
of MCT in a 250 µL of 1 M HCl. After full dissolvent of MCT the volume was 
adjusted by a normal saline up to 3 ml. The pH was adjusted to 7.4 with 5 N NaOH. 
The final concentration of MCT was 20 mg.mL-1. Male Sprague-Dawley rats 
weighing 240 ± 10 g were injected intraperitoneally of 60 mg/kg MCT to induce 
the PH. Equivalent volume of 140 mM saline was injected in control rats (CON). 
Rats were weighed and checked for signs of HF daily after the MCT injection up to 
10-14 days after the injection (Abdul-Salam et al., 2019). Loss of more than 10% 
weight was used as sign of distress and the animal should be killed. Rats were 
checked for the other signs of distress, such as cachexia, lethargy, dyspnoea, cold 
extremities or piloerection. Experiments in control rats were performed on 
temporally equivalent days.  
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2.1.3 Myocardial infarction model of heart failure  
The study of the effect of the failure LV on the Ca2+ handling in RV myocytes was 
performed in the model of chronic myocardial infarction (MI) in rats as described 
previously (Lyon et al., 2009; Vescovo et al., 1989).  
Rats were anesthetized with isoflurane and placed in ventral recumbence. The 
thorax was shaved and sterilized. Then a left thoracotomy was performed, and the 
ligation was performed of the left anterior descending coronary artery. Sham 
ligation operation was performed for CON rats. The animals placed back to the 
cages and stayed 16 weeks to develop the MI. At that time, hearts were explanted, 
weighed, and prepared for cell isolation.  
MI has been established as model of congenital HF (Glukhov et al., 2015; Lyon et 
al., 2009; Sanchez-Alonso et al., 2016). The operation lead to extensive left 
ventricle dilatation reduced ejection fraction and increased LV myocytes length. 
The effect of chronic increase in afterload has been studied in LV myocytes, but 
not in RV.  
2.2 Myocytes isolation and plating 
2.2.1 Ventricular myocyte isolation 
The isolation of cardiomyocytes was performed by Mr. Peter O’Gara via enzymatic 
digestion as described previously (Gorelik et al., 2006). The rats were killed 
accordingly to UK Home Office Schedule 1 method. This method includes the 
animal being anesthetized with 5% isoflurane and then killed via cervical 
dislocation. The heart and lungs were removed from the body and rapidly placed in 
ice cold Krebs-Henseleit (KH) buffer (119mM NaCl, 4.7mM KCl, 0.94mM 
MgSO4, 1mM CaCl2, 1.2mM KH2PO4, 25mM NaHCO3, 11.5mM glucose; 95% 
O2, 5% CO2). Then the lungs were removed and the heart was cannulated through 
the aorta at the Langendorff perfusion system. Heart was perfused with KH at 37°C 
for 5 minutes, and then the solution was switched to low calcium (LowCa) buffer. 
This solution contained: 15μM CaCl2, 120mM NaCl, 5.4mM KCl, 5mM MgSO4, 
5mM pyruvate, 20mM glucose, 20mM taurine, 10mM HEPES, 5mM 
nitrilotriacetic acid; 100% O2). After the 5 min of LowCa buffer perfusion, the 
perfusion was switched to an enzyme (Enz) buffer with 1mg/ml Collagenase II and 
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0.6mg/ml Hyluronidase for 10 min. Enzyme buffer composited of 12- 15μM CaCl2, 
120mM NaCl, 5.4mM KCl, 5mM MgSO4, 5mM pyruvate, 20mM glucose, 20mM 
taurine, 10mM HEPES, 5mM nitrilotriacetic acid; 100% O2. After 10 min of 
perfusion with the Enz solution, the heart was removed from the perfusion system 
and placed in a petri dish with some enzyme free solution. The RV, LV and septum 
were carefully dissected, weighed and placed in separate tubed with 4 mL Enz 
solution containing Collagenase and Hyluronidase. The tubes were shaken 
mechanically for 5 min at 35 oC, and then the solutions were filtered through 200 
μm2 nylon mesh and replaced with new Enz buffer for isolation. After 30 min of 
mechanically shaking, the tissue has been almost completely digested. The tubes 
were centrifuged for 1 minute at 700 rpm. The supernatant was removed and the 
pellets were re-suspended in Enz buffer without the enzymes. Cardiomyocytes 
stayed in Enz buffer before the plating and the beginning of the experiments  
2.2.2 Cardiomyocytes plating and fixation 
In accordance to the type of experiment freshly isolated cardiomyocytes was plated 
on the 35 mm Petri dishes (for SICM and patch clamp investigation), 35 mm 
MatTek (MatTek Corp) dishes for TAT network visualization and 13 mm glass 
coverslips for the immunolabelling. All the dishes were coated with 20 µl of 
1mg/ml laminin (Sigma-Aldrich, UK) and left for 30 min. When the laminin was 
completely dried, a drop (200-300 µL) of cardiomyocyte solution was placed on 
the laminin area and left to stick for at least 30-45 minutes. Then the cells were 
washed with appropriate buffer to remove not attached dead cells. For the functional 
experiments and TAT network visualization cardiomyocytes were used on the same 
day of isolation. For the immunochemical staining myocytes were fixed in 4 % 
formaldehyde or methanol and kept at 4 оC.  
2.3 Methods of structural investigations 
2.3.1 TAT labelling and investigation 
Myocytes were stained according to the protocol described (Schobesberger et al., 
2017). To prepare the solvent for Di-8ANEPPS, 0.5 g of Pluronic acid was 
dissolved in 1.5 µL of DMSO under mild heating in water bath (70-80oC). Then 
630 µL of the warm mixture was added to the 5mg of the Di-8-ANEPPS powder. 
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When the dye completely dissolved, it was aliquoted by 10 microliter each and 
stored at -20°C until used. To stain the cells, one of the aliquots was dissolved in 1 
ml of Tyrode normal solution (contained in mM: 140 NaCl; 6 KCl; 10 Glucose; 10 
HEPES; 1 MgCl2; 1 CaCl2 and pH was adjusted to 7.4 by 1M NaOH) or any other 
suitable physiological buffer, i.e. Hank balanced salt solution (HBSS, Sigma-
Aldrich) and placed in water bath (Fisher Scientific, model FB15047) at 55oC for 5 
min and then cooled down to room temperature. Glass part of the Mat-Tek dishes 
with myocytes was covered with enough amount of dye suspension and left for 1 
min. Then the cells were washed 2 times with enough amount of Tyrode solution.  
Visualization of the membrane was performed with an inverted confocal 
microscope (Zeiss LSM-780). The excitation was performed with argon laser at 488 
nm and the fluorescence was collected through the filter centred at 615 nm and  
maxima at 635 nm. The Z-stack was taken of optical images at every 0.8 microns. 
2.3.1.1 Analysis of cell dimensions 
Cells were visualised using a phase contrast mode of confocal microscope in 
parallel with TAT network visualisation. The images were later analysed in FIJI 
according to the steps illustrated in Figure 2.1. 
 
Figure 2.1. Schematic illustration of the cell dimension analysis. Left. Original phase 
contrast image of LV myocyte. Middle. Image was rotated to place myocyte horizontally. 
Right. Image was thresholded to highlight the borders. Double arrows selected width and 
length. Bars -15 µm. 
2.3.1.2 The TAT network analysis 
Offline analysis of the TAT network parameters was performed simultaneously in 
Fiji (Schindelin et al. 2011) using a custom made macro. The macro combines the 
analysis of TAT density as described (Schobesberger et al., 2017), image 
processing for power of regularity analysis and image processing for analysis of 
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TATS skeleton and directional analysis accordingly to the protocol in (Wagner et 
al., 2014). The power of regularity of T-tubules was counted by Fast Fourier 
Transformation in a custom-made Matlab2016 (The MathWorks, Inc., Natick, MA, 
USA) accordingly to a protocol of (Lyon et al., 2009).  
The image processing and analysis steps of this macro are present in Figure 2.2.  
Steps 8 and 9 were performed in custom-made Matlab macro (Lyon et al., 2009). 
Briefly, macro converted the waveform obtained on the step 7 into power-frequency 
graphs by a Fast Fourier transformation as described before (Ibrahim et al., 2011). 
The output of the calculation is a power peak (Figure 2.2), which maximum serves 
as an indicator of how regular T-tubules appear at a physiological distance of ~2µm. 
 
Figure 2.2. Image processing steps for the analysis of TAT density and regularity. 
Then the macro turned back to the step 2 and performed a directionality analysis 
accordingly to (Wagner et al., 2014). The main steps are present in Figure 2.3.  
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The “Analyse Skeleton (2D/3D)” plugin was used to analyse the skeletonized TAT 
structure. The typical data table produced by this analysis contained the following 
skeleton parameters: #branches, #junctions, #end-point voxels, average branch 
length, #triple points, #quadruple points, and maximum branch length. Two main 
parameters were derived from this table: the total skeleton length per area and the 
number of junctions per area. Normalized skeleton length per area was calculated 
by the following formula:  
𝑇𝑜𝑡𝑎𝑙 𝑙𝑒𝑛𝑔𝑡ℎ 𝑝𝑒𝑟 𝑎𝑟𝑒𝑎 =
∑(#branches × average branch length)
𝑎𝑟𝑒𝑎
  (1) 
Total number of triple junctions per area was calculated using the following 
formula: 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑗𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑠 𝑝𝑒𝑟 𝑎𝑟𝑒𝑎 =
∑ #tripple points
𝑎𝑟𝑒𝑎
    (2) 
 
Figure 2.3. Image processing steps for the study of TAT skeleton and directional 
analysis of TATS. 
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The “Directionality” plugin (http://fiji.sc/Directionality) was used at step 19 to 
calculate the histogram of the TATS distribution in different directions. The cell 
image was rotated into horizontal position that made the A-tubules were 
represented around the 0° bin, whereas the transversal components were groupped 
around the 90° bin. The healthy ventricular myocytes have a double peak histogram 
(Figure 2.3 step 19) with a higher peak of transverse TATS than the axial TATS. 
The analysis of peaks was performed in Fiji, by summarizing all the values 
corresponding to the 0±10° bin for the axial and 90±10° bin for the transverse 
tubules. Then the obtained sums were multiplied by the normalized skeleton length 
from step 18 to get the normalized length of TATS aligned axially or transversally, 
respectively. 
2.3.2 Immunofluorescence labelling  
Immunocytochemical staining of fixed myocytes was performed accordingly to the 
protocol described in (Schobesberger et al., 2017). The primary antibodies were 
used against: the main pore forming subunit LTCC Cav1.2, ryanodine receptor type 
2, RyR2 and the caveolae protein Cav3. Error! Reference source not found.Table 
7 contains the list of antibodies used and corresponding concentrations and fixation 
type used. The myocytes suspension contained approximately 2000-3000 cells was 
plated at the laminin-coated 13 mm borosilicate glass coverslips. After 40-50 min 
of attachment, the cells were washed with PBS, and then fixed for 10 min with 4 % 
PFA in PBS at room temperature or for 10 min with pure methanol at -20 oC. Then 
the coverslips were washed 3 times with PBS containing 0.1 % tween (PBS-T). In 
case of PFA fixation 15 min of permeabilization step with the 0.1 % Triton X-100 
was performed. Then the cells were washed two times with PBS-T. The blocking 
step was performed by incubating the coverslips in PBS-T contained 3 % of goat 
serum and 0.3% of Triton X-100 for 1 h. After that, the blocking solution was 
aspirated and without washing the cells the primary antibody in blocking buffer was 
applied overnight at 4oC. On the next day the coverslips were washed three times 
with PBS-T for 5 min each. The secondary antibodies solution in blocking buffer 
was applied to the myocytes for 2 hours at room temperature and in the dark. As 
negative control myocytes were stained following the same protocol but without 
the application of the primary antibody. After two washes with PBS-T the 
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coverslips were mounted onto partly frosted coverslides (Thermo Scientific, 
Shandon TM # 6776108) using mounting medium (Vector Labs, Vectashield 
mounting medium). At the end the coverslips were sealed onto the coverslides with 
transparent nail polish and kept at 4°C prior to imaging.  
2.3.2.1 Confocal imaging of protein arrangement 
The imaging of the immunocytochemical staining molecules was performed in the 
Facility for Imaging by Light Microscopy of Imperial College London with a Zeiss 
LSM780 Laser Scanning Confocal Microscope (Carl Zeiss, Germany) equipped 
with a x63 magnification Zeiss DIC Plan-Apochromat oil-immersion objective 
(numerical aperture 1.4; Carl Zeiss, Germany). Also Cav1.2 and RyR2 
colocalization visualization was performed at Unit of Advanced Optical 
Microscopy in Humanitas Research Hospital equipped with Leica SP8 Laser 
Scanning Confocal Microscope, equipped with a diode white laser. To visualize the 
specific secondary dyes 488, 552 and 638 lines of the white laser were used. Z-
stack images were recorded at a distance of 0.5-1 µm. Image processing was 
performed with the freeware Fiji (Schindelin et al., 2012). The image analysis 
included two parts. First part included the signal density estimation according to 
the steps № 1-9 from TAT network analysis, the second was related to the 
colocalization between two proteins. The colocalization of two dyes was performed 
in Imaris (Ver. 7.4.2, Andor Technology Ltd) or Jacob plugin of Fiji (Bolte et al., 
2006).  
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Table 7. List of antibodies used for immunolabelling experiments 
Antibody Company and 
number 
Species Concentratio
n 
Fixation 
Cav1.2 Alomone labs, 
ACC-013 
Polyclonal rabbit 1:200 Methanol 
Cavb2 Abcam, 
ab93606 
Monoclonal 
mouse 
1:200 PFA 
RyR2 Sigma 
HPA020028 
Polyclonal rabbit 1:200 Methanol 
RyR2 Thermo-
scientific, C3-33 
Monoclonal 
mouse 
1:150 Methanol 
Cav3 BD biosciences, 
610421 
Monoclonal 
mouse 
1:1000 PFA 
Alexa Fluor 
488 
Invitrogen, Goat anti -rabbit 1:1000  
Alexa Fluor 
594 
Invitrogen, Donkey anti-
mouse 
1:1000  
Abberior 
Star 580 
Abberior Goat anti -rabbit 1:1000  
Abberior 
Star 635 
Abberior Goat anti-mouse 1:1000  
 
2.3.2.2 Super-resolution stimulation emission depletion microscopy (STED) of 
Cav1.2 and RyR2 colocalization in ventricular myocytes 
STED experiments were performed with assistance of Dr. Tilo Schorn at the Unit 
of Advanced Optical Microscopy of Humanitas Research Hospital, Milan, Italy. 
STED xyz images were acquired in bidirectional mode with a Leica SP8 STED3X 
confocal microscope system. Anti-rabbit Abberior STAR 580 antibody was excited 
with a 580 nm-tuned white light laser (WLL) and emission collected from 583 to 
634 nm, anti-mouse Abberior STAR 635 antibody was excited with a 635 nm-tuned 
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WLL and emission collected from 640 to 797 nm. Line sequential acquisition was 
applied to avoid fluorescence overlap. It was applied a gating between 0.3 to 6 ns 
to avoid collection of reflection and autofluorescence. 775 nm pulsed-depletion 
laser was used for Abberior STAR 580 excitations (60% of power) and Abberior 
STAR 635 excitations (10% of power). Images were acquired with Leica HC PL 
APO CS2 100x/1.40 oil STED White objective. Gated pulsed-STED was applied 
to Abberior STAR 580 and Abberior STAR 635 fluorophore. Signal density and 
regularity were analysed in the same manner as described above for the TAT 
system. Colocalization analysis was performed by Jacob plugin (Bolte et al., 2006) 
in Fiji. The Pearson and Manders colocalization coefficients were determined. 
2.3.3 Scanning Ion conductance microscopy 
Scanning ion conductance microscopy (SICM) is a non-contact scanning 
microscopy technique, which empowers three-dimensional imaging of surface 
structures on live cells with resolution of up to ≤ 20 nm (Figure 2.5; (Novak et al., 
2009)). This methodology is based on the evidence that the ion current through the 
glass pipette filled with electrolyte drops down when the pipette goes close to the 
surface of the sample (Ion-conductance et al., 1987; Korchev et al., 1997). Non-
contact scanning is provided by a hopping mode of scanning with a distance-
modulated feedback control system which keeps the ionic conductance and sample-
pipette distance constant. The hopping mode of SICM with the usage of nano-
pipette (internal diameter (I.D.) of 100 nm) allows visualizing even a very tiny 
nano-structures such as microvilli (Novak et al., 2009) 
The sharp pipette (with I.D. of 100 nm) was generated from the borosilicate glass 
capillaries BF100-50-7.5 (IntraCel) with the P-2000 laser puller (Sutter 
Instrument). The dish with isolated cells was placed on the piezoelectric stage 
which is able to move in X and Y directions. The nano-pipette was filled with 
electrolyte and fixed in the piezo-actuator that can move in Z- direction. When the 
tip of the pipette reached the solution the ion current was established between the 
nano-pipette and the electrode in the bath. The software IonView (IonScope, UK) 
was used to position the pipette on top of the cell and surface topography 
reconstruction. The map of surface is stored then on PC allows to precise position 
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of pipette to desired location for local drug application (Nikolaev et al., 2010) or 
switching to cell-attached patch-clamp recordings (Bhargava et al., 2013).  
 
Figure 2.4 Scanning Ion Conductance Microscope. The scanning pipette is mounted on 
a piezo- translation platform and connected to a patch-clamp amplifier (controller). The 
amplifier’s output drives a feedback control for the pipette’s piezo, which provides a Z-
only directional movement (top and bottom). Samples are placed on the stage which can 
make a scanning in 2 directions (X Y). Computer-controlled software provides a user 
interface to control the set-up. From (Bhargava et al., 2013). 
2.3.3.1 Surface structure analysis. Z-groove index 
Surface topography was analysed in SICM Image Viewer. To quantify surface 
structure development Z-groove index was used (Gorelik, Yang et al. 2006). Z-
groove index is a ratio of total length of the Z-grooves present on 10 x 10 µm scan 
(Figure 2.5) to the hypothetical value which represent the length of Z-grooves on 
the ideal ventricle myocyte (50 µm). Normally healthy ventricular cardiomyocyte 
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has 65-80% Z-groove index (Gorelik et al., 2006; Schobesberger et al., 2017). Also 
the amount of T-tubule openings per image was counted manually.  
 
Figure 2.5. SICM: a typical scan of 10x10 µm showing the Z - grooves. 
2.4  Functional investigations  
2.4.1 Super-resolution scanning patch-clamp technique 
Super-resolution scanning patch-clamp is a novel technical approach which allows 
direct investigation of ion channel clustering in the cell surface with a high 
resolution up to 20 nm (Bhargava et al., 2013). This technique presents a 
combination of Scanning Ion Conductance Microscopy with a cell-attached mode 
of a patch-clamp technique (Korchev et al., 1997). The major advantage of this 
methodology is that SICM could visualize surface membrane topography and 
piezo-actuator can bring the pipette to desired location of the surface membrane. 
The main steps of Super-resolution patch clamp technique are illustrated in Figure 
2.6. SICM requires a very sharp (~100 nm I.D.) pipette to detect a nanoscale 
changes in cell topography. On the other side, the probability of obtaining the ion 
current during patch clamp recordings is direct proportional to the size of pipette. 
Controlled clipping of the tip of pipette allows precise widening of the pipette I.D. 
to ~300-400 nm that significantly increases the probability of channel occurrence 
(Bhargava et al., 2013).  
The setup of Super-resolution Patch Clamp technique were based on the Axopatch 
200A patch-clamp amplifier (Molecular Devices, USA), the currents were digitized 
using Digidata 1200B and a pClamp 10 data acquisition system (Axon Instruments; 
Molecular devices).  
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Figure 2.6 Main steps of the Super-Resolution Patch Clamp technique 
2.4.1.1 Pipette clipping procedure 
Pipette clipping procedure is applied directly after the generation of cell 
topography. The pipette is positioned 10-20 um out of the cell surface, on the place 
free from cells. The piezo-control is switched to manual mode, in which it doesn’t 
control the distance to the surface. Then, the pipette is moved down with high 
velocity (10 times higher the normal rate). This high speed movement results in the 
crushing of the pipette tip by the bottom of the dish. The tip is become wider which 
is monitored by changes of the pipette resistance. To obtain desired resistance can 
require several clipping steps. The most important feature of this technique is a 
preserved shape of the pipette tip which allow than to perform gigaseal attachments. 
Depending of the size of desired patching area pipette size was adjusted. For 
example T-tubule openings have a restricted size, so the pipettes should have 
resistance around 30 MΩ (corresponding to ~350 nm ID) to patch only desired area. 
From the other side, crests are not so restricted in size, so wider pipettes can be used 
(16-30 MΩ) to increase the chance of channel occurrence. 
After clipping the pipette can be positioned back to the cellular microdomain of 
choice (in this case T-tubule or crest) by clicking the desired place on topography 
image. Then the feedback was turned off; pipette was lowered until it touches the 
cell surface and a gentle suction was applied to form a seal. Cell- attached single 
channel recordings are then performed by the conventional patch-clamp technique. 
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2.4.1.2  Patch Clamp technique 
The patch-clamp technique is used to record the single channel ion currents though 
the pipette electrode under voltage-clamp. In this condition voltage is constant and 
the current is directly proportional to the changes of the conductance. When the seal 
is established the measured current through the electrode is assumed to flow 
exclusively across the cell membrane proportionally to the membrane conductance 
(mediated by plasma-membrane ion channels). Patch clamp technique allows 
studying single ion channel and receptor properties under basic conditions or under 
drug interaction. 
The pipette for ion current recording were used the same as for SICM, pulled from 
borosilicate glass capillaries BF100-50- 7.5 (IntraCel) with the P-2000 laser puller 
(Sutter Instrument). Working and reference electrodes were Ag/AgCl electrodes, 
they were kept and checked to be fully chlorinated. The internal pipette solution 
contained in mM: 90 BaCl2, 10 sucrose, 10 HEPES, pH=7.4 adjusted with TEA-
OH. The external solution includes in mM: 120 K- gluconate, 25 KCl, 2 MgCl2, 1 
CaCl2, 2 EGTA, 10 Glucose, 10 HEPES, pH=7.4 was adjusted with NaOH.  
The surface of the cell were reached by manual or piezo-controlled approaching 
which used a small voltage pulses (1–5 mV, 2–10 ms) to check the current through 
the pipette. Near the surface the resistance substantially (by 10-15 %) increases and 
approaching stops. Then a small gentle suction through the syringe is applied and a 
high resistance of contact between surface and pipette is established. The contact is 
monitored in Clampex software as rise in pipette resistance, a formation of gigaseal 
(1-16 GΩ) is an evidence of a good contact with the membrane. We worked in cell-
attached patch-clamp configuration. This mode allows recording of single channel 
fluctuation with the range of several picoamperes. We applied this methodology to 
study single LTCC current behaviour in ventricle myocytes.  
2.4.1.3 Single L-type calcium channels analysis 
Single LTCCs were characterized and identified by their voltage dependent 
properties (Rosenberg et al., 1988). The current-voltage relationship is 
characterized by -30 mV to 30 mV voltage pulses applied from the held potential -
80 mV. Analysis was performed according to established protocol from (Bhargava 
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et al., 2013). Single channels were sampled at 10 kHz and filtered at 2 kHz (-3 dB, 
8-pole Bessel). The analysis of channels data was performed by Clampfit version 
10.6. A liquid junction potential, -16.7 mV, was calculated before, in (Sanchez-
Alonso et al., 2016). All the potentials presented in this work are shown after 
subtraction of the liquid junction potential. 
To determine the presence or absence of LTCC in the patch the sweeps from 
holding potential to a step with maximal availability (-6.7 mV) were checked for 
stepwise- like current fluctuations. To characterize the LTCC at least 100 sweeps 
from holding potential to -6.7 mV and three protocols of different voltages were 
performed. When no second level of spikes is observed in any of the sweeps the 
recording is classified as one channel. Then several parameters of LTCC behaviour 
were analysed. 
Occurrence of LTCC was calculated as a percentage of the recordings showing the 
LTCC activity to the total number of seals made in this position. Occurrence of 
single- channel L-type calcium current can characterize the distribution of channels 
across the different microdomains. It can be useful to show, for example 
redistribution of LTCC in failing myocytes versus normal ones. The occurrence of 
the channels doesn’t take into account the possible multichannel patches. To 
overcome this limitation we used a single channel density which calculated as the 
total number of channels found in that cellular microdomain to the sum of all the 
patched membrane area (Poulet et al., 2020). We estimated the pipette diameter (d) 
from the pipette resistance (Ω) by the following formula: 
𝑑 = 2/(0.18759125141643 ∗ Ω)      (3) 
The membrane area under the patch pipette was calculated according to the 
following formula: 
𝑎𝑟𝑒𝑎 = 𝜋 × (𝑑/2)2        (4) 
And the density of the channels was calculated via the ratio between the total 
numbers of recorded channels to the total patched area. This approach takes into 
account the multiple number of channels and variations of the pipette resistance.  
111 
 
Functional analysis of LTCC included the determination of the open probability 
(Po) and voltage- current characteristics. Open probability characterizes fast gating 
between channels “modes” (Cavalié et al., 1986) and how the available channel 
moves between the closed, open, and inactivated states during depolarization 
(typically in order of milliseconds, to 10 ms). We determined the Po by the Clampfit 
automatic analysis from 10-20 sweeps at -6.7 mV for each cell. Each cell was 
recorded only once, and only one value of Po per cell was used. In case of 
multichannel patches, Po calculated from multichannel fluctuation was divided by 
the n of the channels.  
Channel conductance was calculated from protocols with sweeps to different 
voltages in the range of -30 to +5 mV. Then the amplitudes of fully resolved 
openings plotted against the test potential and the channel conductance determined 
as a slope of I-V curve.  
2.4.2 Optical mapping of intracellular Ca2+ waves in single myocytes 
Optical mapping of Ca2+ waves was performed in single cell preparations according 
to the protocol described in (Glukhov et al., 2015). Freshly isolated myocytes were 
placed at 13 mm glass coverslips as described in paragraph 2.2.2. Firstly 100 mg of 
Pluronic Acid was dissolved in 4 ml of DMSO under heating in water bath. Fluo-
4AM stocks were prepared in advance by dissolving 5 mg of Fluo4-AM 
(Invitrogen) in 91 µL of DMSO with Pluronic acid. Then it was vortexed and 
aliquoted by 5 µL. The working dye solution contained 10 µmol/L Fluo4-AM was 
prepared via dilution of one aliquot in 500 µL of HBSS. The cover glasses were 
placed in petri dishes and covered with enough dye solution. After 30 min, the cells 
were washed with a dye-free HBSS and left for 20 min to allow dye de-
esterification. Then the cover glass was placed in the chamber of inverted 
microscope equipped with a MiCam Ultima-L CMOS camera (SciMedia, USA Ltd, 
Costa Mesa, CA). Fluo-4 was excited with 488 nm filtered light and fluorescence 
was collected through 520 nm filter at frequency 500 fps. Acquisition was 
performed with 20X objective that produced a resolution 1.5–2 μm/pixel. Two 
experimental protocols were used: 1) recordings of induced Ca2+ waves under the 
field stimulation with square 10 ms pulses at rising frequencies from 0.5 to 4 Hz 
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and 2) study of spontaneous Ca2+ activity during 16 s rest period after 1 min of 4Hz 
stimulation.  
Analysis of Ca2+ waves and transients parameters was produced in Brainvision Ana 
v. 1208. Spontaneous Ca2+ waves that occupy only a piece cell surface (local) were 
separated from ones propagated through the cell surface (propagated waves). Their 
frequencies were analysed separately. 
2.4.3 Confocal measurements of intracellular Ca2+ changes  
The experiments of confocal measurements of intracellular Ca2+ changes were 
performed according to established protocol (Bannister et al., 2016; Lyon et al., 
2009). Fluo4-AM dye stock solution was prepared as described above. Myocytes 
dye loading was performed in suspension by addition of 500 µL of cells in Enz 
buffer to 5 µL of Fluo4-AM stock. After 30 min, the cells were centrifuged at 600 
rpm for 1 min and supernatant was discharged. The pellets were re-suspended in 
the Tyrode normal solution, which contained in mM: 140 NaCl; 6 KCl; 10 Glucose; 
10 HEPES; 1 MgCl2; 1 CaCl2; pH was adjusted to 7.4 by 1M NaOH. After 20 min, 
the suspension was placed on the glass bottom of experimental chamber equipped 
with perfusion system. The imaging was performed with 40x objective of inverted 
microscope equipped with a laser scanning confocal system (BioRad Microscience 
Ltd., Hemel Hempstead, Hertfordshire, UK). Ca2+ imaging was performed along 
the line placed near the centre of the cell and parallel to its long axis at 500 fps. 
Myocytes were perfused with Tyrode solution at 37oC. Experimental protocol 
included 1 min of myocytes field-stimulation at 1 Hz, and recording of 3-5 Ca2+ 
transients and 16-18 s of Ca2+ activity at rest. The analysis of Ca2+ transients and 
Ca2+ sparks was made in custom-made macro in Fiji.  
2.4.3.1 Ca2+ transient analysis  
Custom-made macro was used to determine the Ca2+ transient parameters, as shown 
(Lyon et al., 2009). It produced the average profile of the fluorescence (Figure 2.7B) 
and determined the starting point, endpoint and maximum for each of the transients, 
then produced the general parameters, such as normalized amplitude (F/F0), 
duration (ms), time to peak (ms), time to F50 (ms),  time to 80% of repolarization 
(ms) and time constant of decay or Tau (ms).  
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To determine synchronicity of Ca2+ releases across the cell we applied the method 
similar to (Louch et al., 2006). Briefly, the steps of the macro code included:  
determination of the half-maximum of the peak Ca2+ fluorescence (F50 value) for 
each of the transient. Then the part of the scan starting from the beginning of the 
transient till the maximum was duplicated for each transient and the threshold was 
applied using F50 value (Figure 2.7C). Then for each pixel of the line it determined 
the time from staring point to reach F50. The resulting profile of time to F50 was 
averaged across all Ca2+ transients. Standard deviation of this profile was used as 
desynchrony-index of Ca2+ release (Louch et al., 2006). 
 
Figure 2.7. Main steps of the Ca2+ transient analysis. A) Linescan of 3 consecutive Ca2+ 
transients. B) Fluorescence profile that used for the analysis of Ca2+ transients parameters. 
C) Time to peak parts from each transient showed in A binarised with threshold F50 value. 
Bottom: the mean of 3 TTF50s obtained from Ca2+ transients showed above. 
2.4.3.2  Ca2+ sparks analysis  
The SparkMaster plugin (Picht et al., 2007) in Fiji with 4.2 determination criteria 
and 25 background was used to analyse Ca2+ sparks. SparkMaster plugin 
automatically calculates several parameters of Ca2+ sparks such as: amplitude 
(F/F0); Half maximum full width (µm); Half maximum full duration (ms); time to 
peak (ms); and Tau (ms). The linescan image was cut horizontally to exclude the 
parts with waves and better Ca2+ spark determination.  According to literature data 
(Cheng et al., 1993) sparks are local Ca2+ releases, so we excluded a very long 
(>150 ms duration) and wide events (>4 µm full width). 
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Two additional important parameters were estimated according to the (Kolstad et 
al., 2018): Ca2+ spark mass, a parameter that is proportional to the amount of Ca2+ 
released through an average Ca2+ spark and total Ca2+ spark mediated Ca2+ leak. 
The mass of Ca2+ spark was calculated according to the following formula: 
𝑀𝑎𝑠𝑠 =  𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 ×  𝐹𝑢𝑙𝑙 𝑊𝑖𝑑𝑡ℎ 𝐻𝑎𝑙𝑓 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 ×
 𝐹𝑢𝑙𝑙 𝐷𝑢𝑟𝑎𝑡𝑖𝑜𝑛 𝐻𝑎𝑙𝑓 𝑀𝑎𝑥𝑖𝑚𝑢𝑚  (𝑛 (
𝐹
𝐹0
) ∙ 𝑚 ∙ 𝑠)     (5) 
Spark-mediated Ca2+ leak was counted by the following formula: 
𝐶𝑎2+ 𝑙𝑒𝑎𝑘 = 𝑀𝑎𝑠𝑠 × 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦  (𝑝 (
𝐹
𝐹0
))      (6) 
2.4.4 Cell shortening measurements with Ionoptix system 
These experiments were performed by Dr. Ivan Diakonov. Cardiomyocyte 
contractions were measured by the Ionoptix system in which the IonWizard 6.0 
software was able to follow the movement of the cell edges, imaging was performed 
with IonOptix Myocam camera (Ionoptix Corp. Milton, MA). Myocytes in 
suspension were placed on the glass bottom of the chamber that connected to 
perfusion system and field stimulator. During experiments cells were perfused with 
KH buffer at 37 oC and field stimulated at 0.5 Hz. Single myocytes were selected 
for the experiments that have a rod shape and followed the stimulation pulses. The 
contractions were measured at the baseline and after application of the 
pharmacological agents, when the steady-state contraction was established. 
For each condition 10-15 contractions were analysed. The software measured the 
amplitude of contraction as deflection of cell length during contraction as compared 
to baseline. Time parameters of contraction were also investigated, such as time to 
peak and 90 % repolarization time. 
2.5 Molecular study 
2.5.1 Western blot 
The protein expression was studied by western blot analysis. The proteins were 
extracted from the snap-frozen cell pellets (~4-5 millions of cells). The cells were 
lysed with 50 µl of RIPA buffer (Sigma) contained protease inhibitor and 1mM 
dithiothreitol (DTT). Then concentrations of proteins were determined by Bio-Rad 
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DCTM Protein Assay Kit (Bio-Rad) according to the manufacturer’s instructions. 20 
mg of proteins were mixed with 4 x loading buffer, heated at 70 °C for 15 minutes, 
centrifuged and then loaded in 8-10 % polyacrylamide gels. The run was performed 
at 120 V for 2-3 h depending on the protein size. When the run was finished the 
proteins were transferred in PVDF membrane during 1 h t 70 V (most of the proteins 
or overnight at 30 V (Cav1.2) using Bio-Rad wet transfer system. The transfer was 
checked by Punseau S (Sigma Aldirich # P7170) staining. Then the membranes 
were washed with Tris buffer saline (TBS) contained 0.1% of Tween and blocked 
for 1 h with 5 % non-fat milk. Then the membranes were incubated with the 
corresponding primary antibodies and left in a rochet at 4 °C overnight. The 
following antibodies were used: Cav1.2 (Alomone), Cav3 (BD), pCaMKII 
(ThermoScientific), pPKA substrate (Cell Signalling) and GAPDH (Invitrogen).  
On the next day, the membranes were washed 3 times by TBS-T. Then the 
membranes were incubated at room temperature with the corresponding secondary 
antibodies for 1 h goat anti-rabbit (1:100; Thermo Fisher Scientific #31460) and 
goat anti-mouse -HRP (1:1000; Thermo Fisher Scientific #31430). Secondary 
antibodies were washed out 3 times with TBS-T. Then the membranes were 
incubated with the ImmobilonTM Western Chemiluminescent HRP Substrate 
(Merck Millipore) and the chemiluminescence was detected on a ChemidocTM MP 
System (Bio-Rad). Analysis of bands density was performed in Image Studio Lite 
ver. 5.2.1 (LiCOR Biosciences). 
2.6  Statistical analysis 
All graphs in this work were produced and statistical analysis was performed using 
GraphPad Prism 6. Normality was tested using the Kolmogorov–Smirnov test. For 
double comparisons the unpaired Student t-test or nonparametric Mann–Whitney 
test was used according to the result of normality test. Statistical differences of more 
than two groups were assessed with the analysis of variance (ANOVA) with 
Bonferroni correction or Kruskal–Wallis test with Dunn’s post-hoc, depending on 
the normality of the samples. All data are expressed as mean± standard error of the 
mean (S.E.M.). A value of P<0.05 was considered statistically significant.  
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3 Structural organisation of RV myocytes and 
comparison with LV 
3.1 Introduction 
First, we started with the evaluation of cellular membrane organisation and Ca2+ 
handling in healthy RV myocytes. We used LV myocytes as a control because the 
membrane organisation and Ca2+ handling of LV myocytes are well studied 
(Gorelik et al., 2006; Louch et al., 2004, Lyon et al., 2009). 
Differences between ventricles are described in the general introduction; here we 
summarise the most important ones. Alterations between the RV and LV start from 
their different embryological origin (Zaffran et al., 2004). Then a huge difference 
between systemic and pulmonary circulation and chambers shape lead to a 
complete different working conditions in LV and RV myocytes (Greyson, 2008). 
Contraction of RV produces large volume changes whereas LV work produces 
pressure generation (Pouleur et al., 1980).  
On the cellular level interventricular differences are species dependent. In rodents, 
longer AP duration in LV myocytes produces larger Ca2+ transients than in RV 
myocytes. In large mammalians RV myocytes have only deeper notches than LV 
(Molina et al., 2016). Differences in SERCA2a expression and regulation between 
ventricles in rats produced longer Ca2+ transients in RV myocytes as compared to 
LV ones (Sathish et al., 2006). Cell contraction is significantly dependent on the 
amount of Ca2+ released, so LV myocytes have stronger and larger contractions as 
compared to RV myocytes (Sabourin et al., 2018). 
Abovementioned differences in cell behaviour could arise from the distinct 
organisation of Ca2+ release microdomains in RV and LV myocytes. ECC in 
ventricular myocytes relies on the membrane organisation. Sarcolemma membrane 
in ventricular myocytes folds in a very organized TAT network to maintain a fast 
propagation of excitation for the simultaneous contraction of the cells (Bers & 
Despa, 2013). TAT concentrates several important proteins for ECC such as LTCC, 
NCX, βAR and many others (Bers and Despa, 2013). However, there are many 
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types of myocytes that lacks of organized TAT network, probably due to a distinct 
working condition (Richards et al., 2011).  
In LV myocytes TAT membrane is the primary place of LTCCs localization 
(Bhargava et al., 2013; Scriven et al., 2000). This subgroup of LTCCs is coupled 
with RyR2 in dyads, where the CICR occurs. When the TAT network is sparse, for 
example, in atrial cell or in failing cells, LTCC distribution become more equalized 
across different membrane structures and that leads to a characteristic Ca2+ cycling 
properties and makes these cells to be more prone to arrhythmia (Glukhov et al., 
2015; Sanchez-Alonso et al., 2016). 
Thus, the sarcolemma membrane serves as the organisational scaffold for the ECC 
in myocytes. We hypothesized that RV and LV myocytes have a profound 
differences in membrane organisation which promoted alternative Ca2+ handling 
functioning and myocytes contraction.  
The main objectives of this chapter were: 
1. To study the cell dimensions, surface topography and TAT system 
organisation in healthy rat RV and LV myocytes.  
2. To determine the distribution and colocalization of LTCC, RyRs and Cav3 
in RV and to compare it with those in LV myocytes  
3. To investigate contraction properties of the RV and LV myocytes.  
4. To assess the chamber - specific differences in Ca2+ transients and 
spontaneous Ca2+ activity in RV and LV myocytes. 
5. To figure out the spatial localization of LTCCs in RV myocytes and 
characterize their functional behaviour. 
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3.2 Methods 
3.2.1 Surface topography characterisation 
Surface topography of live cardiomyocytes was visualized by SICM that used a 
nano-pipette (ID ~80-100 nm) for non-contact scanning of the topography (Novak 
et al., 2009). The experiments were performed on freshly isolated myocytes as 
described in section 2.3.3. 
3.2.2 Confocal microscopy of live cardiomyocytes 
The TAT network of single myocytes was stained by 10 mM Di-8ANEPPS and 
visualized by confocal microscopy as describes previously (Section 2.3.1). The 
images of TAT structure were analysed in Fiji (Schindelin et al., 2012) by custom-
made macro, as described in section 2.3.1.1.  
3.2.3 Confocal study of Cav3 and Cav1.2 protein colocalization 
Visualization of signal Cav1.2 with Cav3 arrangement and colocalization was 
performed at faculty of imaging unit Imperial College London. Cells were plated 
on a glass 13 mm coverslips and fixed with 4 % PFA. After fixation myocytes were 
permeabilized (0.2 % Triton X-100, 10 % bovine calf serum in PBS) for 1 h after 
the PBS washing steps. Then the RV and LV myocytes were incubated with mouse 
monoclonal anti-Cav3 (dilution 1:200, BD instruments) and rabbit polyclonal anti-
Cav1.2 (dilution 1:200, Alomone labs, ACC-013). After overnight incubation with 
primary antibodies, secondary Alexa Fluor 488 anti-rabbit (dilution 1:1000) and 
Alexa Fluor-546 anti-mouse (dilution 1:1000) antibodies were applied. 
Visualization of protein arrangement was performed with Zeiss LSM-780 inverted 
confocal laser scanning microscope. 
3.2.4 STED study of Cav1.2 and RyR2 localization 
Stimulation emission depletion experiments were performed at the Unit of 
Advanced Optical Microscopy of Humanitas Research Hospital, Milan, Italy with 
assistance of Dr. Tilo Schorn. For these experiments cardiac myocytes were fixed 
with methanol at -20oC. Cells were incubated over night with the following primary 
antibodies and dilutions: rabbit anti-Cav1.2 1:200 (Alomone labs, ACC-013), 
mouse anti-RyR2 1:500 (Thermo Fisher Scientific, C3-33). After washing, 
myocytes were incubated for 1 h with the following secondary antibodies and 
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dilutions: anti-rabbit Abberior STAR-580 1:1000 and anti-rabbit Abberior STAR-
635 1:1000. Samples were imaged using a Leica a Leica SP8 STED3X confocal 
microscope system using a 100x oil objective and a pixel size of 40 nm. Images 
were analysed in Fiji using Jacob colocalization plugin. 
3.2.5 In vivo epicardial mapping 
Epicardial multiple-lead recordings were performed by Dr. Stefano Rossi as 
describes elsewhere (Savi et al., 2016). Briefly, the measurements were performed 
in anesthetized rats placing an 11×11 electrode array. The array was positioned on 
the surface of the LV and then moved to the RV. Unipolar electrograms were 
recorded during normal sinus rhythm or during ventricular pacing via specific 
protocols at three selected electrodes of the array, using near-threshold, 1-ms 
cathodal current pulses. Standard procedures (Carnevali et al., 2013; Rossi et al., 
2008) were applied to measure conduction velocity (CV), excitability, 
refractoriness, and mean parameters of ECG. 
3.2.6 Ionoptix measurements of cell contraction 
Measurements of cell shortening of ventricular myocytes were performed by Dr. 
Ivan Diakonov. Detailed description is presented in section 2.4.4. Briefly, cells 
were placed at the glass bottom of a custom-made perfusion chamber and left for 5 
min to settle down. Perfusion was performed with KH buffer saturated with 
oxygen/CO2 mixture (95%/5%) at 37
oC temperature controlled. Only cells which 
were following the pace but which did not exhibit spontaneous contractions were 
selected. The contractions were measured at steady-state.  
3.2.7 In vivo epicardial mapping 
Epicardial multiple-lead recordings were performed by Dr. Stefano Rossi as 
describes elsewhere (Savi et al., 2016). Briefly, the measurements were performed 
in ane anesthetized rats placing an 11×11 electrode array. The array was positioned 
on the surface of the LV and then moved to the RV. Unipolar electrograms were 
recorded during normal sinus rhythm or during ventricular pacing via specific 
protocols at three selected electrodes of the array, using near-threshold, 1-ms 
cathodal current pulses. Standard procedures (Carnevali et al., 2013; Rossi et al., 
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2008) were applied to measure conduction velocity (CV), excitability, 
refractoriness, and mean parameters of ECG. 
3.2.8 Optical mapping of Ca2+ transients 
Optical mapping of Ca2+ transients was performed on live cardiac myocytes stained 
with the Ca2+-sensitive fluorescent dye Fluo-4AM. Detailed description can be 
found in section 2.4.2. Myocytes studied placed on the glass bottom chamber of 
inverted microscope equipped with CMOS camera ULTIMA-L (SciMedia, USA 
Ltd, CA; 500 fps, 1.5–2 μm/pixel). Myocytes were constantly perfused with HBSS 
and 2 stimulation protocols were applied: 1) to measure Ca2+ transients properties: 
5 min of 1 Hz followed by 5 s of recording; 2) Analysing the spontaneous Ca2+ 
waves 1 min of 4 Hz stimulation followed by stimulation cessation and 16 s 
recording. 
Ca2+ transient properties were analysed in a custom- made code in Fiji, that was 
applied before for a line scan Ca2+ transient analysis (Lyon et al., 2009). 
Spontaneous Ca2+ events were divided into propagated waves (occupied the entire 
cell surface) and non-propagated waves (occurred only at certain place of cell). Ca2+ 
wave frequency was counted as the number of each Ca2+ event per observation time. 
3.2.9 Confocal measurements of Ca2+ transients and Ca2+ sparks 
Ca2+ sparks and Ca2+ transients were analysed from line-scan images acquired by 
the confocal microscope as described before in (Lyon et al., 2009). Briefly, 
myocytes were loaded with Fluo4-AM via 30 min incubation in 10 mol/L solution 
of Fluo4-AM. After washing cells were placed in the glass bottom of a specific 
chamber of inverted microscope equipped with a laser scanning confocal system 
(BioRad Microscience Ltd., Hemel Hempstead, Hertfordshire, UK). 
Experiment protocol included 1 min of 1 Hz field stimulation followed by recording 
of few (3-5) Ca2+ transients and 16-18 s of rest spontaneous Ca2+ activity.  
Ca2+ sparks were analysed with a SparkMaster plugin (Picht et al., 2007). Ca2+ 
transients were analysed in terms of synchronicity of activation as described (Louch 
et al., 2006).  
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3.2.10 Super resolution patch clamp technique with pipette clipping modification 
This methodology is described in detail in section 2.4.1. It included the generation 
of surface topography image by SICM using pipette with ~ 80-100 nm diameter tip, 
controlled widening of the tip diameter out of the cell surface (Novak et al., 2013) 
to increase the probability of channel occurrence and approaching the desired 
topological position (T-tubule or crest). Then the pipette was lowered down until it 
reached the membrane and a high resistance seal was established. Recordings were 
performed in cell attached mode of patch-clamp technique as described (Sanchez-
Alonso et al., 2016).  
In experiments with BayK8644, the 10 mmol/L of drug was added to pipette 
internal solution. To exclude the rapid LTCC internalization that was observed 
when cells were bathed in BayK8644.  
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3.3 Results 
3.3.1 Myocytes characterization 
To characterize the differences between RV and LV myocytes we first compared 
their shape. The measurements of cell dimensions were performed in images 
obtained with phase contrast. The examples of RV and LV myocytes are shown in 
Figure 3.1.  
 
Figure 3.1. Representative images of RV and LV myocytes. Bars are 10 µm.  
Analysis of cell dimensions of RV and LV myocytes have shown, that both 
ventricles have myocytes with a similar length (Figure 3.2A), but RV myocytes are 
significantly thinner than LV myocytes (Figure 3.2B).  
 
 
Figure 3.2. Characterization of RV and LV myocytes. A) Cell length and B) cell width 
(n=40-58 cells, N=3-5 rats, *P<0.05, by unpaired Student t test).  
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3.3.2  Surface topography 
Previously LV myocyte surface topography was characterized by SICM imaging 
(Gorelik et al., 2006). As has been shown in previous work, LV myocytes have a 
regularly organized surface with repetitive Z-grooves and doomed crests structures 
and clear T-tubule openings present in Z-grooves. Surface topography of RV 
myocytes was found to be pretty much the same as of LV myocytes, with regular 
structures and Z-grooves (Figure 3.3A). To analyse the surface regularity, we 
calculated Z-groove ratio as a ratio of the total length of observed Z-grooves to the 
extrapolated Z-groove length (See 2.3.3.1; (Gorelik et al., 2006)). The average Z-
groove ratio is not different between LV and RV myocytes (Figure 3.3B). The 
density of T-tubule openings that are present on a 10x10 scan was counted 
manually. RV and LV showed the same mean density of T-tubule opening at the 
surface (Figure 3.3B). 
 
 
Figure 3.3. Characterization of surface topography of control myocytes. A) 10x10 µm 
surface scans of the LV (right) and RV (left) topography. Z-grooves, crest and T-tubule 
openings are marked by the arrows. B) Bar graph, representing the average Z-groove ratio 
of the LV and RV myocytes. C) Bar graph representing the average number of T-tubule 
openings per 100 µm2 area. (n=24-33 cells, N=5-6 rats) 
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3.3.3 Transverse-axial tubular system 
To assess the internal membrane organisation, myocytes were stained with 10 mM 
Di-8ANEPPS. The examples of confocal images obtained from RV and LV 
myocytes are shown in Figure 3.4. Internal structure of LV myocytes was well 
characterized before (Ibrahim et al., 2013). RV myocytes have a well-developed 
TATS, comparable with TATS of the LV myocytes.  
 
Figure 3.4. Representative images of the TATS  of control LV (top) and RV (bottom) 
myocytes, visualized by Di-8ANEPPS staining and corresponding power peaks of T-
tubular regularity. 
Statistical analysis of the TAT density and power of transverse oriented tubules (T-
tubules) regularity is presented in Figure 3.5. TAT network has similar density in 
RV and LV myocytes and slightly (not significantly) lower T-tubule regularity in 
RV as compared to LV myocytes. 
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Figure 3.5. Average TAT density and regularity in control RV and LV myocytes. A) 
Average TAT system density, B) Average T-tubule regularity (n=50-70 cells, N=5-7 rats).  
To have a more complete view on the possible differences between RV and LV 
TAT structure, the new methodology was applied (Wagner et al., 2014). According 
to this protocol, TAT network image converted into skeletonized picture, the 
examples of fragments of TAT network before and after skeletonization are shown 
in Figure 3.6. The length of skeletonized TATS per area was determined, Figure 
3.6C. RV myocytes showed a significantly longer length of TATS per area 
compared to LV myocytes, probably due to the extensive branching. Another 
parameter that was estimated from the TATS skeletons is the density of triple 
junctions as a number of triple junctions of three individual, continuously connected 
tubule components. This parameter was used to characterize the branching 
complexity of the TATS membrane network (Wagner et al., 2012). RV myocytes 
showed significantly higher number of triple junctions per area compared to LV 
myocytes.  
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Figure 3.6. Analysis of TAT network skeleton organisation in RV and LV myocytes. 
A) Representative fragments of the confocal images of LV (left) and RV (right) 
cardiomyocytes. B) TAT network of LV and RV myocytes displayed in A after the 
skeletonization. C) Average TAT network length in LV and RV myocytes. D) Average 
density of triple junctions in TAT network. (n=66-70 cells, N=6-7 rats, *p<0.05, by Mann-
Whitney test). 
Moreover, the TATS skeleton was analysed in terms of tubules directional 
orientation. This analysis provided information regarding the relative number of 
tubules arranged in transversal and axil directions. The histograms of the LV and 
RV myocytes TATS distribution across different directions are shown in Figure 
3.7. Both RV and LV myocytes have a two peak distribution with a higher peak of 
T-tubules and smaller peak of A-tubules. On the right panel in Figure 3.7 histogram 
subtraction is indicated that LV myocytes have a higher frequency of T-tubules and 
lower frequency of A-tubules as compared to RV myocytes. Statistical analysis of 
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the average T-tubule length aligned in transversal and axial directions (Figure 3.8) 
proved the observations from Figure 3.7.  
 
Figure 3.7. Representative histograms of directional distribution of TAT network 
from LV (left) and RV (middle) myocytes. On the right: histogram subtraction (LV – 
RV), showing the differences between them. 
 
Figure 3.8. Statistical analysis of the TAT distribution in different directions. Left: 
Mean total length of axial tubules in LV and RV myocytes. Right: average length of 
transverse elements of TAT system in control LV and RV myocytes. (n=56-70 cells, N=6-
8 rats, *p<0.05, by unpaired Student t test). 
3.3.4 L-type Ca2+ channels and ryanodine receptors immunostaining 
TAT network in ventricular myocytes brings LTCC in close proximity to RyRs to 
ensure simultaneous activation of all the Ca2+ release channels (Bers, 2008). We 
hypothesize that differences in TAT network organisation found between LV and 
RV myocytes produce alterations in L-type Ca2+ channels distribution and their 
colocalization to ryanodine receptors. In order to study protein arrangement and 
colocalization we applied STED microscopy. Representative images of control LV 
and RV myocytes stained by Cav1.2 (green) and RyR2 (red) are presented in Figure 
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3.9. Myocytes from both ventricles showed a well-organized arrangement of Cav1.2 
and RyR2, that has in a regular pattern with a ~2µm distance. 
 
Figure 3.9. Representative STED images of LV and RV myocytes stained with Cav1.2 
and RyR2 antibodies. Scale bar 10µm. 
In order to determine the relative levels of the proteins, we analysed the protein 
signal density as a percentage of cell area occupied by the immunofluorescence 
signal. LV myocytes have a 21% higher Cav1.2 density as compared to RV 
myocytes (P<0.05, Figure 3.10). The signal density of RyR2 is similar between LV 
and RV myocytes (Figure 3.10). 
 
Figure 3.10. Average density of A) Cav1.2 signals and B) RyR2 signals from control 
LV and RV myocytes. (n=28-29 cells, N=5 rats, by Mann-Whitney test) 
The relative colocalization between Cav1.2 and RyR2 was analysed via 
determination of Pearson and Manders coefficients (Figure 3.11, (Manders et al., 
1993)). LV and RV myocytes showed similar mean Pearson correlation 
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coefficients. Also the Manders coefficients for the Cav1.2 colocalization with RyR2 
were close in control LV and RV myocytes. At the same time, the Manders 
coefficient for the colocalization of RyR2 with Cav1.2 showed a 3 times higher 
value in LV myocytes versus RV myocytes (p<0.01, Figure 3.11). 
 
Figure 3.11. Colocalization analysis of Cav1.2 and RyR2 in control LV and RV 
myocytes. (n=28-29 cells, N=4-5 rats, **p<0.01, by Mann-Whitney test).  
 
3.3.5 Colocalization of Cav1.2 with Cav3 
Previous studies of LTCC localization in ventricular myocytes showed a great 
colocalization of this channels with Cav3, the main protein of caveolae (Scriven et 
al., 2005). Moreover cells with the absent or sparse TAT network, such as atrial 
myocytes, our recent results indicated a great importance of caveolae for LTCC 
localization and function (Glukhov et al., 2015). We hypothesize that for RV 
myocytes which have less organized TAT network, caveolae play a more important 
role. We studied an immunofluorescence images of RV and LV myocytes stained 
against Cav1.2 and Cav3 antibodies. Representative pictures are shown in Figure 
3.12.  
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Figure 3.12. Representative confocal images of RV and LV myocytes showing Cav1.2 
(green), Cav3 (red) and merged images (yellow). Bar -10 µm. 
The analysis of Cav3 signal density showed that RV and LV myocytes have similar 
amount of Cav3 (Figure 3.13A). The colocalization analysis of Cav1.2 and Cav3 
revealed no differences in Pearsons coefficient between RV and LV myocytes. 
Manders coefficients for both Cav1.2 and Cav3 were higher in RV myocytes than 
in LV myocytes (p<0.01, Figure 3.13C and 3.13D).  
 
Figure 3.13. Statistical analysis of Cav3 density and colocalization with Cav1.2.A) 
Signal density of Cav3 antibody. B) Pearson correlation coefficient of Cav1.2 with Cav3 in 
control LV and RV myocytes. C) Manders colocalization coefficient for Cav1.2. D) 
Manders colocalization coefficient for Cav3. (n=20-21 cells; N=4 rats; **p<0.01 by 
unpaired Student t test).  
 
3.3.6 Functional studies of tissue refractoriness, cells contraction and Ca2+ 
transients 
As described in section 1.3.1, differences in contraction and Ca2+ handling between 
control RV and LV myocytes have been observed previously in several species. 
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These alterations are very species-dependent but there are some common changes 
(Kondo et al., 2006; Sathish et al., 2006).  
Firstly we measured the durations of AP in vivo using an 11by 11 multielectrode 
grid placed on the RV and LV. Effective refractory period is mainly determined by 
APD as the period of membrane depolarization where the sodium currents cannot 
be activated. QT interval is also connected to the APD and it represents an algebraic 
sum of all APD (Vaughan Williams, 1982). Both of these parameters were 
significantly longer in LV compared to the RV (Figure 3.14A and B).The same 
trend was observed for the activation time and T-wave duration, in LV these 
parameters were significantly longer than in the RV (Figure 3.14C and D). 
 
Figure 3.14. Analysis of the electrocardiogram in control tissue. A) The effective 
refractory period. B) QT interval (an index of ventricular action potential duration), C) QR 
interval as an indicator of activation time, D) T-wave duration (an indicator of the 
ventricular repolarization time). (N= 7 rats, * P < 0.05, ** P <0.01, *** P <0.001, by 
unpaired t test). 
Then we characterized the contractions in the rat RV and LV myocytes. The 
examples of LV and RV contraction traces measured by IonOptix microscope 
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technique are presented in Figure 3.15A. The amplitude of contraction was similar 
in RV and LV myocytes (Figure 3.15B). Duration of a RV contraction is longer that 
in LV myocytes that is seen from a 13 % higher time to peak (p<0.05, Figure 3.15C) 
and a 21% longer decay time (p<0.01, Figure 3.15D) of contractions in RV 
myocytes as compared to the LV myocytes. 
 
Figure 3.15. Characterisation of RV and LV myocytes shortening. A) Examples of 
contraction recordings obtained from LV and RV contractions. B) maximal cell shortenings 
during contractions. C) Time to contraction peak measured in control LV and RV 
myocytes. D) Duration of 90% of relaxation time observed control LV and RV myocytes. 
(n=14-19 cells, N=4 rats, *p<0.05, **p<0.01, by unpaired Student t test). 
 
Ca2+ transients properties in RV and LV myocytes were analysed from optical 
mapping (OM) traces of myocytes stained with Fluo-4AM. Representative 
examples of OM Ca2+ transients are shown in Figure 3.16A. The measurements of 
Ca2+ transient amplitude using non-ratiometric dye - Fluo4-AM has a potential risk 
of false changes due to the alterations in background cell fluorescence, quality of 
staining, however, there are several reports including this analysis(Louch et al., 
2006; Sabourin et al., 2018; Xie et al., 2012). We provide here and in the next 
chapters the analysis of the amplitude of the Ca2+ transients, but without including 
them into conclusions. RV myocytes have lower amplitude of Ca2+ transient than 
LV myocytes (p<0.01, Figure 3.16B). The durations of both time to peak (Figure 
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3.16C) and 90% of decay time (Figure 3.16D) were similar in control RV and LV 
myocytes.  
 
Figure 3.16. Differences in Ca2+ transients properties between RV and LV myocytes. 
A) Example of Ca2+ transient measured in control LV and RV myocytes. B) Mean Ca2+ 
transient amplitude in control LV and RV myocytes. C) Average time to peak in control 
LV and RV myocytes. D) Average decay time measured in control LV and RV myocytes. 
(n=14-19, N=4, *p<0.05, **p<0.01, by unpaired Student t test). 
 
3.3.7 Spontaneous Ca2+ activity in control RV and LV myocytes. 
To estimate the value of a spontaneous Ca2+ activity in control RV and LV myocytes 
we applied two methods OM of Ca2+waves and confocal linescan Ca2+ sparks 
measurements. The first protocol included 1 min of 4 Hz field stimulation of 
myocytes loaded with Fluo-4AM and then optical recording of Ca2+ changes 
(Glukhov et al., 2015). An example of optical traces obtained from one myocytes 
is shown in Figure 3.17A. Statistical analysis of non-propagated Ca2+ waves 
revealed no differences between control LV and RV myocytes. The frequency of 
propagated Ca2+ waves were 3 times higher than the frequency of non-propagated 
waves in control LV myocytes Figure 3.17B. RV myocytes have similar 
frequencies of propagated and non-propagated waves (NS, Figure 3.17B). The 
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frequency of propagated waves was slightly higher in LV than in RV myocytes 
(NS, Figure 3.17B). 
 
 
Figure 3.17. LV myocytes have a higher frequency of spontaneous Ca2+ waves. A) 
Representative traces showing changes in [Ca2+] from 4 consistent points (1–4) selected in 
a single cardiomyocyte. Cells were electrically paced at 4 Hz for 1 minute to enhance 
sarcoplasmic reticulum Ca2+ loading. Propagating and non-propagating Ca2+ waves were 
recorded during a 16-s rest period after cessation of pacing. On the left, optical traces. B) 
Bar graphs showing the frequency of propagated and non-propagated waves in single LV 
and RV myocytes. (N=4-5 rats, *p<0.01, by Kruskal- Wallis test with Dunn’s post-hoc). 
For understanding of spontaneous Ca2+ activity in control RV and LV myocytes we 
analysed Ca2+ sparks using the established protocol of line-scans analysis (Lyon et 
al., 2009). The protocol included 1 min of the field stimulation to establish the high 
SR loading and then 16-18 s of spontaneous Ca2+ activity recording. The 
representative Ca2+ sparks images are shown in Figure 3.18A. Characterization of 
the Ca2+ sparks properties in control RV and LV myocytes are shown in the Table 
8 and Figure 3.18. We calculated two values of Ca2+ sparks: mass (amplitude X 
FWHM X FDHM) and spark- mediated Ca2+ leak (mass X frequency)  as described 
in (Section 2.4.3.2; (Kolstad et al., 2018)). RV myocytes slightly but not 
significantly lower frequency of Ca2+ sparks as compared with a sparks in LV 
myocytes. The shape of Ca2+ sparks was also different in RV vs. LV myocytes with 
a lower amplitude and width, producing ~ 20 % reduction in Ca2+ spark mass in RV 
myocytes (p<0.001, Figure 3.18C). Lower Ca2+ spark mass and a slight variation in  
frequency of Ca2+ sparks in RV versus LV myocytes produced ~ 40% lower spark- 
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mediated Ca2+ leak in control RV myocytes then in LV myocytes (p<0.05, Figure 
3.18D). 
 
Figure 3.18. RV myocytes have lower frequency of Ca2+ sparks. A) Representative Ca2+ 
sparks images recorded in control LV and RV myocytes. B) Statistical analysis of Ca2+ 
sparks frequency, C) Ca2+ sparks mass, D) Ca2+ spark mediated Ca2+ lead. (n=35-42 cells, 
N=5-6 rats, by Mann- Whitney test).  
Table 8. Ca2+ spark properties observed in control LV and RV myocytes. 
 LV RV 
Frequency, Nspark/µm/100s 1.33±0.14 1.19±0.18 
Amplitude, F/F0 0.35±0.01 0.29±0.01** 
HMFW, µm 2.65±0.05 2.35±0.06** 
HMFD, ms 25.1±0.6 24.3±1.2 
Time to peak, ms 12.6±0.6 11.7±0.5 
Tau, ms 26.3±1.4 26.5±2.0 
Ca2+ spark mass, n(F/F0)*m*s 24.3±1.1 18.8±1.5* 
Ca2+ spark induced Ca2+ leak, p(F/F0)  30.5±4.9 21.8±3.5* 
Values are means ± SE; n = 35-42 cells, N= 4-5 hears, *P < 0.001 vs. the Control 
LV. HMFW- Half maximum full width, HMFD- Half maximum full duration. 
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3.3.8 Analysis of synchronicity in control RV and LV myocytes. 
Observed differences in Ca2+ sparks and waves activity in control LV and RV could 
generally indicate distinct properties of RyR2 that are responsible for the 
intracellular Ca2+ releases. Moreover, our findings of the reduced TAT organisation 
in RV vs. LV myocytes drive us to check the synchronization of the Ca2+ release 
through the cell. The work of Louch et al. proposed the analysis of synchronization 
of activation though the cell via measurements of variability of the half rise time 
(TTF50) (Louch et al., 2006). Figure 3.19A shows the representative examples of 
Ca2+ transients recorded in control LV and RV myocytes. The histograms of TTF50 
distribution in control LV (grey) and RV (green) (Figure 3.19B) clearly indicates 
that RV myocytes have lover pike with more broad distribution of TTF50 as 
compared to LV myocytes. To quantify these differences we used ‘desynchrony 
index’ which defined as a standard deviation of TTF50. RV myocytes showed a 
significantly higher “desynchrony index’ than LV myocytes (p<0.05, Figure 
3.19C). 
 
Figure 3.19. Analysis of the shape of Ca2+ transients. A) Example line scans of Ca2+ 
transients recorded in control LV and RV myocytes. B) Frequency distribution of time to 
50 % of Ca2+ transient amplitude (TTF50) analysed in control LV (grey) and RV (green) 
myocytes (n=30-40 cells, N-3 rats). C) Analysis of a standard deviation of these values, 
defined as the desynchrony index (Louch et al., 2006) (n=30-40 cells, N-3 rats, *p<0.05, 
by unpaired Student t test).  
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Moreover, the TTF50 values have been used to define the early and delayed RyRs 
(Biesmans et al., 2011; Heinzel et al., 2002). Following this methodology, we used 
the cumulative histograms of TTF50 (Figure 3.20A) to determine the point where 
50% of the sites of the line scan have F>F50. Statistical analysis of this time to 50 
% values in LV and RV myocytes (Figure 3.20B) showed slightly less value in LV 
then in the RV. When the values from both RV and LV we put together, we got the 
mean of around 9.9±0.4 ms and for simplicity, we used 10 ms as a reference value 
to divide RyR2 into early (TTF50<10 ms) and delayed (TTF50 >10 ms). 
 
Figure 3.20. Cumulative distribution of TF50 in control LV and RV myocytes. A) 
Cumulative histograms of TF50 distribution in control RV and LV myocytes (n= 30-40 
cells). B) Statistical analysis of 50% of TF50 histogram from every from LV and RV 
myocytes and both of them. 
Identification of early and delayed Ca2+ release points could be useful for checking 
the spatial distribution of RyR2 in myocytes and their colocalization with the 
tubular membrane. Work of Heinzel et al. provides evidence that early Ca2+ release 
sites are arise from RyRs located within a higher TAT density regions and late Ca2+ 
release sites are originated from RyRs located far from tubular membrane (Heinzel 
et al., 2002). Biesmans et al. used this approach to study the properties of Ca2+ 
sparks related to the early or delayed Ca2+ release sites (Biesmans et al., 2011). We 
applied this methodology to study the differences of Ca2+ sparks in relation to their 
origin. The example of Ca2+ transient, corresponding TTF50 trace and Ca2+ sparks 
are presented in Figure 3.21A. Interestingly, in LV myocytes, so called early and 
delayed Ca2+ sparks showed similar properties. On the contrary, in RV myocytes, 
Ca2+ sparks occurred more frequently in the early sites than in delayed sited 
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(p<0.05, Figure 3.21B). Moreover, Biesmans and co-workers showed that early and 
delayed Ca2+ sparks have different duration (Biesmans et al., 2011). We observed 
here similar differences between sparks in RV myocytes (p<0.05, Figure 3.21C). In 
RV myocytes, lower frequency and duration of the delayed Ca2+ sparks leads to a 
less spark induced Ca2+ release in delayed regions than in early sites (p<0.05Figure 
3.21D). Interestingly, delayed Ca2+ sparks in RV myocytes produce significantly 
less Ca2+ release than delayed Ca2+ sparks in LV myocytes (p<0.01, Figure 3.21D). 
 
Figure 3.21. Characterization of two subpopulations of Ca2+ sparks in LV and RV 
myocytes. A) Illustration of Ca2+ transient analysis. Ca2+ sparks were assigned to early and 
delayed areas of Ca2+ transients using the TTF50 values. The TTF50 profile is shown on 
the left. Bar – 20 µm. B) Average frequency of Ca2+ sparks, C) Half maximum of duration, 
D) Ca2+ spark mediated Ca2+ leak analysed in control LV and RV myocytes. (n=36-46 cells, 
N=4-5 rats, *p<0.05, **p<0.01, by Kruskal- Wallis test with Dunn’s post hoc). 
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3.3.9 Spatial localization and properties of L-type Ca2+ channels in control RV 
myocytes 
It was shown before by several methods, that LTCC are not equally distributed 
across sarcolemma membrane in LV myocytes, with much higher chance of 
obtaining LTCC current at T-tubule than at the surface membrane (Bhargava et al., 
2013). In contrast, in atrial myocytes, equal distribution of LTCC between T-tubule 
and sarcolemma membrane have been shown recently (Glukhov et al., 2015). We 
found in literature no data regarding LTCC spatial distribution in RV. We 
hypothesized that alterations of ECC observed between LV and RV could involve 
different distribution of LTCC and altered regulation of the channels. 
To characterize LTCC localization and properties in RV myocytes we applied super 
resolution scanning patch-clamp technique to two different compartments of the 
myocyte membrane TT and crest. Typical LTCC single channel activity was 
observed at T-tubule (Figure 3.22Error! Reference source not found.) and crests 
(Figure 3.23Error! Reference source not found.) of RV myocytes. Single LTCC 
behaviour was close to that observed before in LV myocytes (Bhargava et al., 
2013). 
 
 
Figure 3.22. Single LTCC activity recorded at T-tubule of RV myocytes. On the left, 
example of cardiomyocyte 10x10 μm surface scan shoving the pipette approaching the T-
tubule for the giga-seal formation. On the right, representative LTCC current traces 
recorded at T-tubule applying variable voltages. 
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Figure 3.23. Single LTCC activity recorded at crest of control RV. On the left, typical 
example of 10x10 μm surface scan of RV myocyte with a pipette placed at crest position. 
On the right, representative current traces recorded at crest of RV myocyte holding variable 
potentials. 
Localization and properties of LTCC at T-tubule and crest was characterized using 
the comparison with the corresponding LTCC in LV myocytes. The main 
characteristics of LTCC were analysed applying -6.7 mV (Figure 3.24).  
 
Figure 3.24. Single LTCC recordings performed in T-tubule and crest of LV and RV 
myocytes applying -6.7 mV. 
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LTCC localization in RV was characterized with two parameters: occurrence and 
density (Figure 3.25A-3.25B). Single channel LTCC recordings in LV myocytes 
showed almost 3 times higher chance to obtain LTCC at T-tubule compared to the 
crest (Figure 3.25A), as it was shown before (Bhargava et al., 2013). Surprisingly, 
in RV myocytes the occurrence of LTCC at T-tubule and crest membrane domains 
was almost equal (21.1% of 95 successful patches in T-tubules vs. 21.8% of 78 
successful patches, Figure 3.25A).  
The occurrence of the LTCC doesn’t take in consideration the number of LTCC 
obtained in the patch. To include also the number of channels in the patch, the ingle 
channel density analysis was performed. LTCC single channel density was 
calculated as total number of the channels to the total patched area (Figure 3.25B). 
The density of LTCC in LV myocytes was almost 4 times higher at T-tubule as 
compared to crest region. RV myocytes showed almost similar density of LTCC at 
T-tubule (2.7 channel/µm2) and crest (2.1 channel/µm2).  
Also to check LTCC clustering in control RV and LV percentage of multiple 
channels was calculated (Figure 3.25C). In both LV and RV myocytes the chance 
of multichannel LTCC recording was higher at crest that at T-tubule (not 
significant). 
 
 
Figure 3.25. LTCCs spatial localization in RV and LV myocytes. A. LTCC current 
occurrence at T-tubule and crest of LV and RV myocytes. n/m- number of patches with 
LTCC/ total number of successful patches. B) Single channel LTCC density at T-tubule 
and crest in LV and RV myocytes. C) Percentage of multi-channel LTCC recordings from 
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the total number of patches with a LTCC current. n1/n = number of patches with more than 
one LTCC/ total number of patches showing LTCC activity. 
Functional properties of LTCC recorded at T-tubule and crest in LV myocytes have 
similar Po Figure 3.26A) and amplitude Figure 3.26B). In RV myocytes the LTCC 
recorded at T-tubule have lower open probability (Po) compared to the crest of RV 
and T-tubule of LV myocytes: RV: 0.029±0.004 at T-tubule vs. 0.049±0.009 at 
crest, p<0.05; and vs. 0.043±0.006 at T-tubule in LV myocytes, p<0.05, Figure 
3.26A). The amplitude of the LTCC at -6.9 mV measured at crest of RV myocytes 
was significantly lower than amplitude of LTCC at crest of LV myocytes 
(amplitude: RV crest: 0.56±0.04 vs. LV crest: 0.69±0.01 pA, p<0.05, Figure 
3.26B).  
 
Figure 3.26. Properties of LTCC in control RV and LV myocytes. A) Open probability 
of single LTCC recorded at T-tubule and crest in LV and RV myocytes holding -6.7mV. 
(N=6-17 channels, from 31-95 cells, *P<0.05, by unpaired Student t test). B) Amplitude of 
single LTCC recorded at T-tubule and crest of LV and RV myocytes with potential set -
6.7 mV. (N=6-17 channels, from 31-95 cells, *P<0.05, by Mann-Whitney test). 
 
3.3.9.1 Total membrane LTCC density study with LTCC agonist BayK8644. 
To characterize total membrane density of LTCC in control RV and LV myocytes 
an LTCC agonist BayK8644 (BayK) was applied. This drug increases the mean 
time of channel opening with a slight modification of the channel conduction 
(Brown et al., 1984; Hess et al., 1984). Representative traces of LTCC recorded at 
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-6.7mV in T-tubule and crest of LV and RV myocytes are shown in Figure 3.27. It 
is clear, that LTCC after BayK application opens at high conductance state with a 
longer open time as compared to recordings in normal external buffer (Figure 3.27).  
 
Figure 3.27. Traces of single LTCC activity recorded at-6.7mV in T-tubule or crest of 
LV and RV myocytes in presence of BayK. 
Membrane density of LTCC in RV and LV myocytes in absence and presence of 
BayK is shown in Figure 3.28. The density of LTCC at T-tubule and crest of LV 
myocytes was similar with and without the BayK. On the contrary, LTCC 
membrane density was ~40% higher at T-tubule and crest of RV myocytes in 
presence of BayK. It could be a sign of existence of some LTCC in RV myocytes 
that are inactive or having very low Po under the normal conditions, to detect them.  
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Figure 3.28. Single LTCC density measured in LV and RV myocytes in absence and 
presence of BayK. (n/m = number of patches with channels/total number of successful 
patches). 
Analysis of functional properties of LTCC in the presence of BayK showed some 
differences between the channels in RV and LV myocytes. Application of BayK 
increased the open probability of LTCC located at T-tubule and crest of both RV 
and LV myocytes by an order (Figure 3.26A vs. Figure 3.29A). Interestingly, the 
Po of LTCC located at T-tubule of RV was less than Po of LTCC located at T-
tubule of in presence of BayK (LV T-tubule: 0.43±0.07 vs. RV T-tubule: 0.29±0.01, 
p<0.05, Figure 3.29A).  
Another analysed parameter of LTCC single channel activity was channel 
amplitude (Figure 3.29B). As was mentioned before, BayK induces long openings 
of LTCCs up to the highest conductance state around 1 pA (at -6.7 mV). LTCCs 
located at T-tubule and crest of LV myocytes and crest of RV myocytes are forced 
to open at highest level (Figure 3.29B). However, LTCCs located at T-tubule of RV 
myocytes in presence of BayK had smaller amplitude, than those of LTCCs located 
at crest areas of RV or at T-tubule of LV myocytes (RV T-tubule: 0.67±0.08 pA vs. 
RV crest: 1.12±0.09, p<0.01; vs.LV T-tubule: 1.05±0.03 pA, p<0.001; Figure 
3.29B). We hypothesize that actually two subpopulations of LTCCs could be 
present in T-tubule of RV myocytes, one with amplitude ~ 1pA and another – with 
amplitude ~ 0.4pA. Finding the reason for observed differences requires additional 
experiments. 
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Figure 3.29. Properties of LTCC observed in control LV and RV in presence of BayK. 
A) Open probability of LTCC recorded at-6.7mV in presence of BayK8644. (N=3-8 
channels, 20-53 cells, *p<0.05, by unpaired t test). B) LTCCs mean amplitude at -6.7 mV 
in presence of BayK. (N=3-8 channels, 20-53 cells, **p<0.01, ***p<0.001 by Kruskal-
Wallis test with Dunn’s post-hoc).  
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3.4 Discussion and conclusions 
In this chapter we characterized the structural organisation and Ca2+ handling in RV 
myocytes and compared these properties to those of LV myocytes. Both ventricles 
have a pronounced differences starting from by embryological origin and working 
condition. The physiology and hemodynamic functions of RV in the normal state 
differ considerably from those of LV (Dell’Italia et al., 1995). Our results and 
previous papers from other laboratories showed the huge differences between 
organisation and function of RV and LV myocytes. Generally, we observed altered 
contraction and Ca2+ transients in RV and LV myocytes (Figure 3.14 and 3.15). 
Contractions were longer in RV then in the LV myocytes, but the Ca2+ transients 
were much higher in LV then in RV myocytes. As was mentioned before, we could 
not fully rely on our measurements of Ca2+ transient amplitude. Also in literature 
there are contradicting data about the differences between RV and LV Ca2+ transient 
amplitude (Table 4). For example, Sabourin et al. showed that in rat LV myocytes 
Ca2+ transient amplitude is higher than in the RV (Sabourin et al., 2018), but in the 
different study the amplitude of Ca2+ transients has been shown to be similar in 
control RV and LV myocytes with the longer contractions found in RV myocytes 
(Sathish et al., 2006). It is unclear whether this differences are attributable for the 
problems with Fluo4-AM Ca2+ transient measurements or intrinsic differences 
between RV and LV myocytes. Higher Ca2+ transients in LV myocytes could be 
produced via longer APD, observed in these cells by many groups (Di Diego et al., 
1996; Ramakers et al., 2005).  
To understand if the differences observed were related to internal myocytes 
structure we studied their TAT network and surface topography. Analysis of the 
shape of cardiac myocytes showed that LV myocytes were significantly wider that 
RV ones (Figure 3.2). Our recent findings in atrial myocytes, which possess a 
variable TAT network organisation from almost absent to highly regular tubules, 
showed the correlation of the TAT density and myocyte width (Glukhov et al., 
2015). But RV myocytes showed similar density of TAT network to the LV one 
(Figure 3.5). Moreover, the index of surface regularity (Z-groove ratio) was similar 
in myocytes from both ventricles (Figure 3.3). Detailed investigation of TAT 
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skeleton revealed a significant difference between myocytes. RV myocytes have 
higher skeleton length per area than LV myocytes. Moreover, the complexity of 
TAT network, a parameter indicating the amount of branching was also higher in 
RV myocytes than in LV (Figure 3.6). Directional investigation TAT alignment 
showed that RV myocytes have less frequency of T- tubules appearance with a 
higher amount of A- tubules. Exact roles of T- tubules and A- tubules in ECC are 
not defined. A- tubules are abundant in atrial cells, where they are very long and 
wider then T- tubules (Hund and Mohlerp, 2016). Moreover in atrial myocytes the 
active highly phosphorylated clusters of RyRs are found to locate close to A- 
tubules so they are believed to serve as a place of initial Ca2+ transient onset 
(Brandenburg et al., 2016). In ventricular myocytes the role of A- tubules are not 
so clear. The width of A- tubules was found to be similar to that of T- tubules 
(Wagner et al., 2012). Moreover electron microscopy studies showed formation of 
dyadic junctions between axial tubules and junctional SR as it is happen in T- 
tubules (Asghari et al., 2009).  
The TAT network is a very flexible system in cardiac myocytes, it can easily react 
to changes in stress or loading condition (Jones et al., 2018). Rearrangement of 
TATS during pathology is usually accompanied by an increase of A- tubules 
formation (Schobesberger et al., 2017; Wagner et al., 2012)). This was suggested 
as a first compensatory mechanism which attributed to help with the impaired 
contractility. The density and regularity of TAT network in RV myocytes were 
close to those in unloaded LV myocytes, from the model heterologous heart 
implantation in systemic circulation (Wright et al., 2018). So differences in TAT 
structure between RV and LV could be linked with ventricle-specific loading 
conditions, such as, for example, six times lower afterload, lower pressure in 
systemic circulation (Dell’Italia et al., 1995). 
Altered TAT network has pronounced effects on the Ca2+ cycling in RV versus LV 
myocytes. Firstly we studied the general Ca2+ activity in the heart. Both of our 
experimental setups revealed similar frequency of Ca2+ waves (Figure 3.16) and 
Ca2+ sparks (Figure 3.17) in RV myocytes when compared to LV. However, the 
analysis of Ca2+ sparks mass and spark-induced Ca2+ lead was higher in LV 
myocytes. (Figure 3.17C and 3.17D). The reason for higher mass of Ca2+ sparks 
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could be the higher SR Ca2+ loading in LV myocytes, as indicated higher amplitude 
and HMFW of Ca2+ sparks (Table 2). However, our preliminary results and 
literature data shows that it is not the case, caffeine-evoked Ca2+ releases showed 
similar amplitude in RV and LV myocytes (Sabourin et al., 2018; Sathish et al., 
2006). RyRs phosphorylation has a great impact on the sparks activity under the 
rest condition, in the work of Sathish et al. the phosphorylation level of RyR2 was 
significantly higher in LV myocytes than in RV ones (Sathish et al., 2006). 
Phosphorylated RyRs could be opened for a longer time, increasing amount of Ca2+ 
released through Ca2+ spark. 
Another consequence of disorganized TAT network in RV myocytes is an alteration 
of LTCC- RyR coupling. The analysis of LTCC and RyRs density in RV and LV 
myocytes showed that density of LTCC was lower in RV myocytes (Figure 3.10). 
Moreover the colocalization analysis of Cav1.2 with RyRs in RV and LV myocytes 
showed less Manders coefficient for RyRs with Cav1.2 in RV myocytes compared 
to LV myocytes. That could be an indicator of fewer couplons in RV versus LV 
myocytes. Recent studies showed that sparks originate from RyRs coupled and 
uncoupled from LTCC have different activity and regulation (Biesmans et al., 2011; 
Dries et al., 2013). These higher amount of uncoupled RyRs could lead to a more 
disorganize Ca2+ transients activation. We studied the synchronisation of Ca2+ 
transient activation via variability in time to half-maximal fluorescence (TTF50) 
across the cell. Analysis of line-scans of Ca2+ transients showed a wider and right-
shifted distribution of TTF50 values in RV versus LV myocytes and significantly 
larger desynchrony index in RV myocytes compared to LV ones (Figure 3.18). 
Similar situation was observed in failing LV myocytes by Louch and co-workers 
(Louch et al., 2006). Desynchronization of Ca2+ transient was addressed to 
reduction of TAT organisation which is leading to formation of inhomogeneous 
impulse propagation and “orphaned” RyR2 formation (Frisk et al., 2014; Song et 
al., 2006). Resent work has also linked inhomogeneous Ca2+ transients with a Ca2+ 
spark kinetics (Kolstad et al., 2018). Sparks with a longer rise time were more 
frequent in places with higher TTF50.  
To address the question about the spatial inhomogeneous Ca2+ spark formation we 
used an approach established in previous works (Biesmans et al., 2011; Heinzel et 
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al., 2002). The approach is based on the analysis of TTF50 distribution across the 
cell surface. The regions with smaller TTF50 have higher T-tubule density whereas 
when TTF50 in larger this was accompanied with lower TAT density (Heinzel et 
al., 2002). Recently Dries and colleagues directly visualized two subpopulations of 
RyR2 - ones located close to T-tubule and another one - far from it (Dries et al., 
2013). Dries et al. analysed the myocytes from large animals (pigs) that possess low 
TAT density. We addressed the same methodology to study rat cells. Firstly, 50% 
TTF50 cumulative distribution showed a mean value 10 ms, that we used as a 
criteria to assign the Ca2+ release site as early (close to T-tubule) or late (further 
from it). The sparks were assigned to early or delayed according to their location 
with the TTF50 of Ca2+ transient. Frequency and shape of early and late Ca2+ sparks 
were similar in LV myocytes (Figure 3.20). In RV myocytes we observed 
significant alterations in properties of Ca2+ sparks located in early and delayed sites 
(Figure 3.20). The frequency and half maximum duration of early sparks were 
higher as the corresponding parameters of delayed sparks. Similar differences only 
in frequency and duration of Ca2+ sparks have been previously observed (Biesmans 
et al., 2011). Higher frequency of Ca2+ sparks in early places was addressed to 
communications of RyR2 with LTCC. Ca2+ that reaches RyR2 in diastole is higher 
close to T-tubule, than far away from it. Interestingly, the experiments of Biesmans 
et al. showed that blocking of LTCC didn’t change the sparks activity in early 
release areas, but application of LTCC agonist increased the Ca2+ sparks rate at 
early areas. This was suggested that sparks were indeed ‘spontaneous’ and did not 
require sarcolemmal Ca2+ influx. Moreover RyR2 close to T-tubule could be 
exposed with an elevated local [Ca2+], that could promote the activation of CaM 
and CaMKII, that enhance the RyR2 openings (Dries et al., 2013; Saucerman and 
Bers, 2008; Song et al., 2005). In LV we did not see any differences between early 
and delayed sparks that could be attributed to a higher membrane organisation in 
LV myocytes and larger amount of T-tubule. 
We next characterized the spatial localization and function of LTCC in RV 
myocytes. Interestingly, the distribution of LTCC between T-tubule and crest was 
almost equal (Figure 3.24). This distribution of LTCC was strictly different from 
the distribution in LV myocytes, where we and other observed much higher 
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occurrence and density of LTCC in T-tubule than in the crest (Bryant et al., 2015; 
Sanchez-Alonso et al., 2016). Moreover, atrial myocytes have also almost equal 
chance to get LTCC current in T-tubule and crest (Glukhov et al., 2015). Firstly, 
we hypothesize, that as in atria myocytes, RV myocytes have higher density of 
caveolae, membrane domain where LTCC predominantly anchored (Scriven et al., 
2000) then LV myocytes. But it was not a case, as the immunostaining showed 
similar density of Cav3 in both RV and LV (Figure 3.13) and our preliminary results 
from electron microscopy showed similar levels of caveolae in RV and LV 
myocytes (data not shown). But the colocalization between Cav1.2 and Cav3 in RV 
myocytes was higher than in LV myocytes. Thus with the same amount of caveolae, 
the amount of LTCC linked with it was higher in RV myocytes than in LV 
myocytes. However, further functional experiments needed to understand the 
consequences of these findings, such as, for example, incubation of the cells with 
MβCD, that is capable to remove the cholesterol out of membrane and flatten the 
caveolae.  
As indicated before, RV myocytes in terms of their TAT network structure were 
close with unloaded LV myocytes. Unloaded LV myocytes were showed a similar 
occurrence of LTCC in T-tubule and crest (Wright et al., 2018). Moreover, a large 
part of LTCC were silent or possess a very low Po under the normal conditions in 
unloaded LV myocytes, but were active in presence of LTCC agonist BayK. 
Application of BayK on RV myocytes revealed a ~40% higher density of LTCC 
located at both T-tubule and crest, whereas it doesn’t affect the density of LTCC in 
LV myocytes. The exact reasons for this silent subpopulation of LTCC in RV are 
not clear, but we can hypothesize that RV need to adapt to variable loading 
conditions during the rest or exercise and for this it should have some resources to 
easy increase the contractility. A similar picture was observed by (Sathish et al., 
2006) with SERCA2a level. RV myocytes in his work have a significantly slower 
Ca2+ uptake than LV myocytes because a large portion of SERCA2a in RV was 
inhibited via association with phospholamban (PLB).  
Not only spatial localization of LTCC was different between RV and LV myocytes, 
the properties of the channels were also altered in RV and LV myocytes. The 
analysis LTCC located in T-tubule of RV myocytes showed less Po than LTCC 
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located in crest of RV and T-tubule of LV myocytes (Figure 3.25). This could 
indicate a lower Ca2+ influx thorough LTCC in T-tubule, that could be responsible 
for the less triggering of sparks in RV vs. LV myocytes. 
The amplitude of LTCC was measured at maximum activation step to -6.7 mV. 
When recorded in normal solutions, LTCC in crest of RV myocytes have slightly 
lower average amplitude that LTCC at crest of LV myocytes (Figure 3.25). 
Interestingly, in the presence of BayK, the mean amplitude of LTCC in T-tubule of 
RV was significantly lower than LTCC in any other locations (Figure 3.28). This 
could be due to the existence of 2 pools of LTCC – one with normal amplitude ~ 
1pA and another one – with amplitude ~ 0.45 pA. This smaller LTCC behaved like 
normal ones, they have voltage dependence like LTCC, and in the presence of BayK 
they opened in “mode 2” with long lasting open states and high open probability 
(Hess et al., 1984). Firstly, we checked the reports and find out the low frequent 
occurrence of this type of LTCC in T-tubule of rat LV myocytes after 4 days in 
culture and in human LV myocytes from patients with dilated cardiomyopathy. A 
peculiar group of LTCC that possess low amplitude has been described in cerebellar 
granule cells; these channels were built of Cav1.2 subunits and they have been proposed 
to play a specific role in gene regulation (Koschak et al., 2007). Our hypothesis was 
related to a specific membrane compartment and most of the membrane 
compartments are organized by cholesterol- rich lipid rafts. The understanding of the 
nature and the role of this “peculiar” LTCC in myocyte physiology will require additional 
investigations.  
3.4.1 Conclusion 
In summary, differences in working load and contractions between the RV and the 
LV are probably responsible for the lower TATS regularity in RV myocytes with a 
higher proportion of A-tubules, and that in turn leads to a more atrial-like uniform 
distribution of LTCC on the membrane. In RV myocytes, LTCCs are less co-
localised with RyR2 than in LV myocytes, which is due to the lower TATS 
organisation, and that could be responsible for a more desynchronised Ca2+ transient 
activation in RV myocytes and higher differences between early and delayed Ca2+ 
sparks. On the other side, a higher co-localisation of LTCC with Cav3 and T-tubular 
subpopulation of LTCC in RV have a low Po that could indicated a different 
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microdomain organization and regulation of LTCC in  RV versus LV myocytes. 
Thus, we observed a significantly altered Ca2+ signalling microdomain organisation 
in RV and LV myocytes, so we could expect a different remodelling of these 
structures in disease.   
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4 Structural changes in calcium microdomains in RV and LV 
cardiomyocytes in pulmonary hypertension.  
4.1 Introduction 
We observed the differences in microdomain organisation between healthy RV and 
LV myocytes. However, the most important question is how ECC in RV myocytes 
will be changed in pathological conditions. In this chapter, we characterized the 
modification of RV and LV structure and function in pulmonary hypertension (PH). 
PH is a complex disorder which could have a variety of aetiologies as it was 
described in chapter 1. Generally, PH is induced by the proliferation of pulmonary 
vasculature and narrowing of the pulmonary vessels, which results in a profound 
increase in the RV load. The survival of patients with PH is largely dependent upon 
the ability of RV to adapt to the pressure overload (Thenappan et al., 2018). In 
patients with PH, increased resistance of pulmonary vessels leads to profound 
reorganisation of the RV. Crescent-shaped normal RV undergoes significant 
remodelling into a spherical chamber, with thicker walls and a four-times higher 
chamber pressure (Bogaard et al., 2009; Voelkel et al., 2006). During disease 
progression, an excessive electrical remodelling and arrhythmogenicity were also 
observed in the RV, including the prolongation of QT interval and T-wave, an 
appearance of T-wave alternants (Folino et al., 2003; Hlaing et al., 2005). 
Moreover, the pressure overload in the RV could affect the function of the LV as 
well. There is an evidence indicating LV atrophy in PH patients with an impaired 
stroke volume and systolic pressure (Han et al., 2018; Hardziyenka et al., 2011). 
Despite these alterations found in PH hearts, so far there is no specific treatment 
targeted to the RV. Treatments applied for LV hypertrophy have been also proposed 
for the RV (Handoko et al., 2010), but their suitability is still under debate 
(Thenappan et al., 2018). It is clear that a better understanding of the mechanisms 
of RV and LV remodelling in PH is needed. 
In this work, we analysed the changes that occur in both RV and LV in a MCT-
induced rat model of PH. This is a commonly used model (Benoist et al., 2011; 
Sabourin et al., 2018; Wojciak-Stothard et al., 2014) because it is easy to produce 
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and it mimics several important aspects of PH in rats, such as APD prolongation 
and the occurrence of T-wave and Ca2+ transient alternants (Benoist et al., 2012). 
Despite a high interest to this disease, there are some discrepancies about the 
progression of the disease. For example, Ca2+ characterized by confocal imaging in 
isolated ventricular myocytes, were found to be smaller and slower in PH rats 
compared to control (Benoist et al., 2012; Xie et al., 2012). In contrast, others 
studies revealed an increase in the magnitude of Ca2+ transients as well as their 
shortening in PH vs. control (Sabourin et al., 2018). Different protocols and 
durations of MCT exposure between groups make a direct comparison between 
those studies more complicated. The reduction of TAT network density was 
observed in some works (Fowler et al., 2018; Sabourin et al., 2018; Xie et al., 2012). 
This was accompanied by an increase of spontaneous Ca2+ activity in PH RV 
myocytes. Moreover, there are some studies that showed changes in mRNA and 
protein expression levels of LTCC in PH RV myocytes (Benoist et al., 2011; Xie et 
al., 2012). At the same time, a whole-cell LTCC current density was reported to be 
preserved in PH RV myocytes (Benoist et al., 2012; Rocchetti et al., 2014). 
Investigation of alteration of Ca2+ signalling microdomain organisation of RV in 
PH could provide more insights in disease progression. Our resent findings from 
failing LV myocytes and failing atria myocytes indicate the importance of 
microdomain-specific changes in the whole heart physiology (Glukhov et al., 2015; 
Sanchez-Alonso et al., 2016). In ventricular myocytes Ca2+ signalling 
microdomains are maintained by an elaborate organisation of TAT, surface 
sarcolemma and their adjustments to junctional sarcoplasmic reticulum (Fearnley 
et al., 2011). Reduction of TAT in HF has been associated with desynchronization 
of Ca2+ transients, a pronounced increase in Ca2+ spark rate, redistribution of 
LTCCs and their hyperphosphorylation (Louch et al., 2006; Lyon et al., 2009; 
Sanchez-Alonso et al., 2016). We hypothesized that that PH leads to 
arrhythmogenicity that could be studied at many levels, and that RV and LV 
myocytes undergo a significant remodelling in Ca2+ signalling microdomains that 
will affect the rate and synchronicity of Ca2+ release and produce hyperactivation 
of LTCCs. All together these alterations could promote arrhythmogenicity in the 
PH heart.  
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The main objectives of this chapter were: 
1. To analyse electrical and arrhythmogenic activity of the RV and the LV of 
PH rats.  
2. To study the structural changes in the LV and RV shape, surface topography 
and TAT membrane organisation after PH.  
3. To characterize the alterations in Cav1.2, RyRs and Cav3 protein 
arrangement and colocalization in PH.  
4. To assess the PH-induced modifications of myocytes in cell-shortening, 
Ca2+ transients and spontaneous Ca2+ activity in RV and LV myocytes. 
5. To examine how the spatial localization of LTCCs in PH RV myocytes 
affects their functional behaviour. 
6. To determine the modulations of the expression of Cav1.2, PKA and 
CaMKII in PH rats. 
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4.2 Methods 
4.2.1 Monocrotaline model of pulmonary hypertension 
Adult male Sprague Dawley rats (weight <250g, n=12, Charles River, Margate, 
UK) underwent monocrotaline (MCT; 60 mg/kg, Sigma) injection in order to 
induce pulmonary hypertension as described previously (Abdul-Salam et al., 2019; 
Wojciak-Stothard et al., 2014). Age and weight matched rats were used as control 
(n=12). Experiments were performed at 10-12th days after injection. 
Catheterization through the jugular vein was made to measure a right ventricle 
systolic pressure (RVSP). The weight of RV to LV+septum wet tissue was 
measured to assess the right ventricle hypertrophy.  
4.2.2 In vivo epicardial mapping 
Epicardial multiple-lead recordings were performed by Dr. Stefano Rossi as 
describes elsewhere (Savi et al., 2016). Briefly, rats were anesthetized, artificially 
ventilated and subjected to middle thoracotomy. Temperature was maintained 
constant at 37°C. One hundred twenty-one unipolar electrograms (EGs) were 
simultaneously recorded from the epicardial surface via an 11×11 electrode array 
with 0.5 mm interelectrode distance (Figure 4.1A). The array was positioned on the 
surface of the LV and then moved to the RV in both control and treated animals. 
Unipolar electrograms were recorded during normal sinus rhythm or during 
ventricular pacing via specific protocols at three selected electrodes of the array, 
using near-threshold, 1-ms cathodal current pulses. Standard procedures (Carnevali 
et al., 2013; Rossi et al., 2008) were applied to measure conduction velocity (CV), 
excitability, refractoriness, and mean parameters of ECG. 
Conduction velocity. Activation times were estimated using the instant of the 
minimum time derivative of unipolar EGs during QRS complex, and were 
referenced to stimulus onset during a pacing beat. The activation sequence 
(isochrone map) was determined from the activation times of paced beats. Two CV 
were computed: longitudinally (CV-l) and transversally (CV-t) to fibre orientation. 
Anisotropic ratio was determined as CV-l/CV-t. These measures were evaluated 
after stimulation in 3 different areas in the RV and LV from control and MCT 
animals. 
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Refractoriness. Eight baseline stimuli (S1), 1ms duration and twice diastolic 
threshold strength each, were delivered at each of the 3 selected electrodes of the 
array at a frequency slightly higher than sinus rhythm. This programmed 
stimulation protocol was performed in 7 control and 7 MCT animals. The S1 pacing 
sequence was followed by an extra-stimulus S2 (four times higher than S1 strength) 
at the same site whose delay from previous S1 was first progressively decremented 
by 10 ms steps until capture was lost and then progressively incremented by 2 ms 
steps till capture was resumed. We defined an effective refractory period as the 
longest S1–S2 time interval at which impulse initiation failed (Rossi et al., 2008). 
 
Figure 4.1 Multi-electrode 11x11 grid for the epicardial mapping. A) Schematic 
illustration of the electrode arrangement and size, B) bottom view of the grid, C) 
Multielectrode grid placed on the RV, D) Multielectrode grid placed on the LV. 
4.2.3 Surface topography 
Surface topography of freshly isolated cardiomyocytes was acquired by SICM as 
described in section 2.3.3. Myocytes were scanned at the day of isolation by a sharp 
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(100 nm diameter) nano-pipette using a hopping mode of SICM (Novak et al., 
2009). 
4.2.4 Confocal microscopy of TAT network 
The internal TAT network of freshly isolated ventricular myocytes was stained by 
Di-8ANEPPS and visualized by confocal microscope, as described before (Ibrahim 
et al., 2013; Lyon et al., 2009). The TAT structure was analysed in Fiji in terms of 
signal density, regularity of the t-tubules, the skeleton length, number of triple 
junctions per area and directional distribution of t-tubules as described in section 
2.3.1. 
4.2.5 Confocal visualization of Cav1.2 and Cav3 protein arrangement  
Immunofluorescence study of Cav1.2 and Cav3 arrangement and colocalization was 
performed in faculty of Imaging Unit, Imperial College London, as described in 
section 2.3.2.2. Briefly, cells were fixed with 4 % PFA and were permeabilised with 
0.2 % Triton X-100. Then the cells were incubated with 10 % bovine calf serum. 
Then cardiac myocytes were incubated with mouse mono-clonal anti-Cav3 
(dilution 1:500, BD biosciences, 610421) and rabbit polyclonal anti-Cav1.2 
(dilution 1:200, Alomone labs, ACC-013). After overnight incubation with primary 
antibodies, secondary Alexa Fluor 488 anti-rabbit (dilution 1:1000) and Alexa 
Fluor-546 anti-mouse (dilution 1:1000) antibodies were applied. Visualization of 
protein arrangement was performed with Zeiss LSM-780 inverted confocal laser 
scanning microscope using a 64x 1.4 NA oil objective and a pixel size of 80 nm.  
4.2.6 STED study of Cav1.2 and RyR2 localization 
Stimulation emission depletion experiments were performed at the Unit of 
Advanced Optical Microscopy of Humanitas Research Hospital, Milan, Italy with 
the assistance of Dr. Tilo Schorn. Cardiac myocytes were fixed with methanol at -
20oC for 5 min. Cells were incubated overnight with the following primary 
antibodies and dilutions: rabbit anti- Cav1.2 (1:200, Alomone labs, ACC-013), 
mouse anti-RyR2 (1:200, Thermo Fisher Scientific, C3-33). After washing step, 
cardiac myocytes were incubated for 1 h with the following secondary antibodies 
and dilutions: anti-rabbit Abberior STAR 580 (1:1000) and anti-rabbit Abberior 
STAR 635 (1:1000). Samples were imaged using a Leica SP8 STED3X confocal 
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microscope system with a 100x oil objective and a pixel size of 40 nm. Images were 
analysed in Fiji using Jacob colocalization plug-in.  
4.2.7 Optical mapping of Ca2+ transients 
Optical mapping of Ca2+ waves and transients was performed on freshly isolated 
cardiac myocytes stained with Fluo-4AM Ca2+-sensitive dye. A detailed description 
of the method can be found in section 2.4.2. Myocytes were placed on the glass 
bottom chamber of inverted microscope equipped with a CMOS camera ULTIMA-
L (SciMedia, USA Ltd, CA; 500 fps, 1.5–2 μm/pixel). Chamber was constantly 
perfused with HBSS solution at constant temperature of 37oC. Two stimulation 
protocols were applied: 1) 5 min of 1 Hz followed by 5 s of recording to measure 
Ca2+ transients’ properties, and 2) 1 min of 4 Hz stimulation followed by 
stimulation cessation and recording of spontaneous Ca2+ waves. 
Ca2+ transient properties were analysed by using a custom- made code in Fiji. It was 
applied before for a line scan Ca2+ transient analysis (Lyon et al., 2009). 
Spontaneous Ca2+ events were divided into propagated waves (occupied all the cell 
length) and non-propagated waves (occurred only at certain place of cell).  
4.2.7.1 βAR stimulation of Ca2+ transients 
The effect of βAR stimulation on Ca2+ transients was measured by the comparison 
of Ca2+ transient amplitude measured at 1 Hz stimulation in free HBSS with that 
measured in HBSS containing 100 nM of isoprenaline (ISO) (Wright et al., 2014). 
When the perfusion buffer was changed to HBSS + ISO, cell left for 3 min and then 
3 consecutive 5 s recordings were performed at 3, 4, and 5th min after ISO 
application. The effect of ISO on the Ca2+ transient amplitude was measured at the 
same cell before and after the application of ISO.  
4.2.8 Ionoptix measurements of cell contraction 
Measurements of cell shortening of ventricular myocytes were performed by Dr. 
Ivan Diakonov. Detailed description can be found in section 2.4.4. Myocytes were 
attached to the glass bottom of a custom-made perfusion chamber and superfused 
with a KH buffer bubbled with oxygen/CO2 mixture (95%/5%) at a constant 
temperature of 37oC. Only cells with a rod-shape that followed the pacing and 
haven’t exhibit spontaneous contractions were selected. Baseline contractions were 
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measured at least for 10 min to establish a steady-state. After measurements of 
baseline contractions, perfusion was switched to a KH buffer containing 100nm of 
ISO for the stimulation of the βARs. Only steady-state contractions were used in 
analysis. 
4.2.9 Confocal measurements of Ca2+ transients and Ca2+ Sparks 
Ca2+ transients and Ca2+ sparks were recorded in a line-scan mode of a confocal 
microscope as described in section 2.4.3. Briefly, cells were loaded with Fluo4-AM 
for 30 min and placed on a glass bottom of a stimulation chamber equipped with a 
perfusion system. Myocytes were paced at 1 Hz for 1 min and then the fluorescence 
was recorded with 500 lines/s and 0.2-0.4 µm resolution. Analysis of Ca2+ sparks 
and shape of Ca2+ transient was performed in a custom-made macro in Fiji as 
described in 2.4.3.1. 
4.2.10 Super resolution patch clamp technique with pipette clipping modification 
Single LTCC recordings were performed using super resolution scanning patch 
clam technique in cell attached mode, as described in section 2.4.1 (Bhargava et al., 
2013). 
In experiments with LTCC, a channel agonist BayK8644 in concentration 5 µM 
was added to internal pipette solution. 
4.2.11 Western Blot  
Western blot analysis was performed on protein extracts from tissue lysates as 
described in section 2.5.1. Briefly, the proteins were extracted from cell pellets 
using RIPA buffer, protease inhibitor, and DTT (around 500 µL for each samples). 
The protein concentration was quantified with BioRad DSK+ kit using a BSA 
standard curve. Custom-made Tris-Glycine gels 6%- 10% were used for the blots. 
Running protocol included 20 min of pre-run at 70V and 1-2 h of run at 120 V, 
depending on the protein size. After the run, the proteins were transferred on the 
PVDF membrane using a wet transfer system. Membranes were stained with the 
Ponceau S solution (Sigma Aldirich # P7170) to check the quality of a transfer. 
After this, the membranes were washed with PBS + 0.1% Tween. Then they were 
blocked with 5% skim milk and incubated with the primary antibodies overnight at 
4oC (Table 2). On the next day, the membranes were washed with PBS-T and 
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incubated with the corresponding secondary antibodies in 5% milk for 1 hour at 
room temperature. At the end, the membranes were washed and covered with ECL 
detection solution (BioRad). The development was performed using the ChemiDoc 
XRS+ Imaging System (BioRad). 
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4.3 Results 
4.3.1  Physiological data of MCT rats 
The characterization of the monocrotaline model of pulmonary hypertension in rats 
was performed by Dr. Vahitha B. Abdul-Salam. The results are presented in Figure 
4.2. A profound increase of the mean pulmonary pressure was found in rats after 
10-12 days of MCT treatment (P<0.01, Figure 4.2A). The heart weight to body 
weight ratio was not changed after the MCT treatment (Figure 4.2C), but the lungs 
had an increased weight, which can be seen from the Figure 4.2B. Elastic van 
Gieson staining of peripheral arteries showed a significant increase in the 
proportion of muscularised vessels in MCT-treated rats (p<0.01, Figure 4.2E and 
4.2F). Fulton index, as a ratio of the RV weight to LV plus septum weight was used 
to characterize RV hypertrophy. It was markedly increased in MCT-treated rats 
versus control ones (P<0.01, Figure 4.2D). Thus, the observed phenotype was close 
to hypertrophic state of RV described for MCT model.  
 
Figure 4.2 Physiological data of MCT rat model of pulmonary hypertension. A) Mean 
pulmonary arterial pressure measured in control and MCT treated rats. B) Graph 
representing the weight of the length from control and MCT treated animals. C) Graph 
representing the ratio of heart weight to lungs weight in control and MCT treated animals. 
D) Proportion of RV weight to LV+septum weight in control and MCT treated animals. E) 
Elastic van Gieson (EVG) representative staining of peripheral arteries in control and MCT 
treated animals. F) Graph summary of the percentage of muscularised vessels in control 
and MCT treated rats. D) (N =7-12 rats, * P <0.05, **P<0.01, by Mann-Whitney test). 
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4.3.2 PH produce changes in electrical properties of the RV and LV. 
The electrophysiological properties of the RV and the LV from control and PH rats 
were studied by Dr. Stefano Rossi via epicardial multi lead recordings. The basic 
cardiac electrophysiological properties were assessed, such as CV and 
refractoriness according to (Savi et al., 2016).  
The velocity of impulse propagation along (CV-1) and across the fibre directions 
(CV-t) were evaluated from isochrone maps (Figure 4.3A). Representative 
examples are shown in Figure 4.2A. PH led to a significantly slower CV-1 in LV 
tissue, but not in the RV (p<0.05, Figure 4.3B). We found no changes in CV-t 
between the RV and the LV from control and PH rats (Figure 4.3C). Interestingly, 
when conduction anisotropy was calculated by the CV-1/CV-t ratio (Figure 4.3D), 
it showed a significant reduction in PH RV (1.83±0.08) than in control RV 
(2.22±0.09, p<0.01). 
 
Figure 4.3 The electrophysiological properties of the RV and LV in control and PH 
rats. A) Representative isochrone maps of RV and LV from control and PH rats. B) 
Conduction velocity (CV-l) computed longitudinally to fibre orientation, C) CV-t, 
computed transversely to fibre orientation, D) anisotropy of CV (CV-l/CV-t), E) the 
effective refractory period. (N=7 rats, * P < 0.05, ** P <0.01, by one-way ANOVA test 
with Bonferroni correction). 
The refractoriness of the cardiac tissue was assessed by the effective refractory 
period (ERP). The ERP was significantly shorter in control RV than in control LV 
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(p<0.01, Figure 4.3E). PH led to different prolongations of ERP in the RV (by 20%, 
p<0.01) and the LV (by 15%, p<0.05). Thus, ERP in RV and LV in PH rats became 
not statistically different. 
For the analysis of arrhytmogenic activity we analysed the data from S1-S2 
stimulation protocol for the appearance of extra systolic beats. There was a 
tendency to increase the appearance of extrasystole in PH RV where 5 on 7 rats  
showed at least one extrasystole whereas is was seen only in 3 on 7 animals in 
control RV. We did not observe in the appearance of extrasystole in control and PH 
LV.  
The ECG parameters were evaluated to study the heart rate and propensities of the 
arrhythmias (Figure 4.4). The R-R interval represents a time between the activation 
of the ventricles at heart rate and is produced by a single sinoatrial node. Thus, there 
we did not expect to have the differences between RV and LV in terms of R-R 
interval (Figure 4.4B). Moreover there were no changes in R-R interval between 
control and PH rats (Figure 4.4B). Similar R-R interval in all conditions allowed us 
to use the QT interval as an index of cardiac action potential without frequency 
correction (Figure 4.4A). Both control and PH rats showed longer QT intervals in 
the LV than in the RV (p<0.001). PH produced a 20% prolongation of QT interval 
in the LV (p< 0.001) and 18% prolongation in the RV (p<0.05). Statistical analysis 
of QR duration (activation time) and T-wave duration (repolarization phase) 
showed their longer durations in the LV as compared to the RV in both control and 
PH rats (p<0.05, Figure 4.4C-4.4D). PH did not produce alterations of activation 
time and T-wave duration in both RV and LV.  
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Figure 4.4. Analysis of the electrocardiogram parameters. A) QT interval (an 
index of ventricular action potential duration), B) RR interval (inversely related to 
the heart rate), C) QR interval as an indicator of activation time, D) T-wave duration 
(an indicator of the ventricular repolarization time). (N= 7 rats, * P < 0.05, ** 
P<0.01, *** P <0.001, by one-way ANOVA test with Bonferroni correction). 
4.3.3 Alteration of the cardiomyocytes shape 
To understand the influence of PH on the myocytes shape, we applied a phase 
contrast light microscopy to freshly isolated myocytes. RV myocytes in PH rats 
have significantly different shape with a shorter length (P<0.001, Figure 4.5A) and 
wider width (P<0.01, Figure 4.5B), that suggested a pronounced hypertrophic 
process. The length to width ratio of RV myocytes was pronouncedly decreased 
(P<0.01, Figure 4.5C). LV myocytes in PH rats became thinner (LV PH: 24.3+0.9 
vs. LV CON: 31.7±1.1, p<0.01), that led to a higher LWR in PH LV myocytes (p< 
0.05).  
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Figure 4.5. Myocytes shape characterization. Graph summary shown differences in the 
A) length, B) width and C) length to width ratio between RV and LV from control and PH 
rats. (n=40-58, N=3-5 rats, *P<0.05, **P<0.01, ***P<0.001 by one-way ANOVA test with 
Bonferroni correction).  
4.3.4 Pulmonary hypertension promoted flattering of RV surface topography 
We used the SICM microscopy to visualize the surface topography of live 
cardiomyocytes isolated from control and PH rats. Representative examples of 
surface scans are shown in Figure 4.6A. LV myocytes showed a similar regular 
striated topography in PH rats and in control ones. The surface regularity analysis 
of RV myocytes showed a significant reduction of z-groove ratio in PH myocytes 
compared to control ones. Z-groove ratio of PH RV myocytes was 0.59±0.03 A.U. 
vs. 0.68±0.02 A.U. in control RV (p<0.05). Density of T-tubule openings was 
analysed from LV and RV myocytes surface scans. This analysis showed similar 
mean T-tubule densities in RV and LV myocytes from control and PH rats. 
 
Figure 4.6. Study of myocytes surface topography. A) Scans of 10x10 surface regions 
of LV (up) and RV (bottom) from control (left) and PH (right) rats obtained by SICM. B) 
Average Z-groove ratio of LV and RV myocytes from control and PH rats. C) Average 
number of openings counted on 100 µm2 surface counted on RV and LV myocytes from 
control and PH rats. (n=23-34, N=4-6, p<0.05, by Kruskal- Wallis test with Dunn’s post-
hoc). 
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4.3.5 Reorganisation of TAT network in PH myocytes. 
Several studies reported a reduction of TAT network of RV myocytes in severe PH 
(Sabourin et al., 2018; Xie et al., 2012). The initial changes of TAT network at early 
stages of PH are less characterized. Representative images of the TAT structure of 
RV and LV myocytes from control and PH rats are shown in Figure 4.7. Myocytes 
from both ventricles undergo TAT remodelling process that can be seen from the 
dominant frequency graphs (Figure 4.8). The density of TAT network of RV 
myocytes was reduced in PH by 26 % (p<0.05 for RV, Figure 4.8C). The regularity 
of T-tubules was reduced significantly in PH RV myocytes compared to control 
ones (by 27 %, p<0.05, Figure 4.8D). In contrast, the density and regularity of T-
tubules in LV myocytes did not change significantly (p=0.2). 
 
Figure 4.7. Representative images of LV (top) and RV (bottom) myocytes from 
control (left) and PH (right) rats. 
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Figure 4.8. Analysis of TAT network changes in PH myocytes. A) Power peaks of the 
T-tubular regularity of LV myocytes from control and PH rats. B) Power peaks of the T-
tubular regularity of RV myocytes from control and PH rats. C) Average TAT density of 
LV and RV myocytes from control and PH rats. D) Mean power of T-tubular regularity of 
LV and RV myocytes from control and PH rats. (N=5-8 rats, *p<0.05, by one-way 
ANOVA with Bonferroni correction). 
To understand detail changes of TAT organisation, we applied protocol from 
(Wagner et al., 2014). Representative fragments of TAT structure of LV and RV 
myocytes from control and PH rats and corresponding skeletonized pictures are 
shown in Figure 4.9. Analysis of TAT skeleton length per area showed that in PH 
rats RV myocytes have a 6% increase of the skeleton length as compared to control 
ones (p<0.05, Figure 4.9C). The complexity of the TAT network was assessed by 
a number of triple junctions per area (Wagner et al., 2012). In PH rats, both RV and 
LV myocytes have an increased number of triple junctions compared to control 
ones (by 20%, p<0.05 and 25%, p< 0.001, accordingly, Figure 4.9F). 
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Figure 4.9. Representative fragments of TAT images of control and PH rats. A. 
Fragments of LV myocytes from control (top) and PH (bottom) rats. B) Skeletonized 
images that presented in A. C) Bar graph showing average skeleton length per area 
measured in RV and LV myocytes from control and PH rats. D) Fragments of TAT images 
of RV myocytes from control (top) and PH (bottom) rats. E) Skeletonized images that 
presented in D. F) The average density of triple junctions of TAT network measured in RV 
and LV myocytes from control and PH rats. (n=20-70 cells, N=3-7 rats, *p<0.05, **p<0.01, 
***p<0.001, by one-way ANOVA with Bonferroni post hoc). 
The directional distribution of TAT network was obtained via directionality 
histograms created in Fiji, as described in (Wagner et al., 2014). Representative 
histograms of TAT network directional distribution in RV myocytes from control 
and PH rats and subtraction histogram are shown in Figure 4.10. Subtraction 
histogram highlighted that in PH RV myocytes the average frequency of A-tubules 
become higher, than in control RV myocytes. At the same time the frequency of the 
T-tubules was lower in PH RV myocytes compared to control ones. Statistical 
analyses of the average length of tubules aligned transversally and axially to the 
cell main axis are presented in Figure 4.10B and 4.10D. In PH RV myocytes have 
a higher length of axial tubules whereas the length of transverse tubules was 
reduced (p<0.05, Figure 4.10).  
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Figure 4.10. Directionality analysis of TAT network changes in PH rats. A) 
Representative histograms of directional distribution of TAT network of RV form control 
(green) and PH (red) rats. B) Average length of axial tubule in LV and RV myocytes from 
control and PH rats. C) Histogram subtraction PH RV – control RV), highlighting the 
differences between control and PH RV myocytes. D) The average length per area of 
transverse tubules in TAT network of LV and RV myocytes from control and PH rats. 
(n=20-73 cells, N 4-6 rats; *P < 0.001 by unpaired Student t test.) 
 
4.3.6 PH lead to increase in colocalization of Cav1.2 with RyR2 in RV myocytes 
Disturbance and reorganisation of TAT network observed in PH myocytes could 
produce changes in the membrane-anchored proteins. To understand the impact of 
PH on the ECC we studied the LTCC α subunit Cav1.2 density and its colocalization 
with RyR2 by super-resolution STED microscopy. The representative images of 
RV and LV myocytes stained against Cav1.2 and RyR2 antibodies are shown in 
Figure 4.11A. On the right side of the Figure 4.11 the presented the magnified 
10x10 µm areas of the corresponding whole cell images are shown.  
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Figure 4.11. Representative images of LV and RV myocytes stained with Cav1.2 
(green) and RyR2 (red) antibodies. A) Whole cell images showing merged signals. Bar 
equals to 20 µm. B) Magnified 10 x 10 µm portions of the images marked by a white 
box in A. Bar equals to 2 µm 
We characterized the density of the signals from both Cav1.2 and RyR2. In PH rats, 
RV myocytes had a 20% lower Cav1.2 density compared to control RV myocytes 
(p<0.05, Figure 4.12A). There were no changes in RyR2 density in both RV and 
LV myocytes after PH (Figure 4.12B).  
Then, we aimed to determine the structural alterations of Ca2+ interplay between 
LTCC and RyR2 and studied the colocalization changes in RV and LV myocytes 
after PH. Pearson correlation coefficient was 30% higher in PH RV myocytes than 
in control ones (p<0.05, Figure 4.13A). Manders coefficient in PH RV become 
higher than in control RV myocytes for Cav1.2 colocalization with RyR2 (p<0.01, 
Figure 4.13B) but not for the RyR2 colocalization with Cav1.2 (Figure 4.13C). 
There were not significant changes in colocalization of Cav1.2 with RyR2 in PH 
LV myocytes versus control LV (Figure 4.13). 
172 
 
 
Figure 4.12. Analysis of changes in signal densities after PH. A) Average Cav1.2 signal 
density in LV and RV myocytes from control and PH rats. B) Average RyR2 signal density 
measured in LV and RV myocytes from control and PH rats. (n=10-20 cells, N=3-5 rats, 
by one-way ANOVA test with Bonferroni correction). 
 
Figure 4.13. Increased colocalization between Cav1.2 and RyR2 in RV PH cells. A) 
Analysis of Pearson correlation coefficient between Cav1.2 and RyR2 in RV and LV 
myocytes. B) Manders colocalization coefficient of Cav1.2 colocalization with RyR2. C) 
Manders colocalization coefficient of RyR2 colocalization with Cav1.2. (n=10-25 cells, 
N=3-4 rats, **p<0.01, by one-way ANOVA test with Bonferroni correction). 
4.3.7 PH lead to reduction of Cav3 density and colocalization with Cav1.2  
LTCC main pore subunit Cav1.2 is mostly anchored to caveolae in cardiac myocytes 
which regulates its functioning (Balijepalli et al., 2006; Scriven et al., 2005). We 
hypothesized that the reduction of Cav1.2 is caused via down-reduction of caveolae 
structures in PH RV myocytes. The representative images of LV and RV myocytes 
labelled with Cav1.2 and Cav3 antibodies are shown in Figure 4.14. 
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Analysis of Cav3 signal density showed a 25 % reduction of this parameter in PH 
RV myocytes compared to control RV (p<0.05, Figure 4.15A). LV myocytes from 
control rats has a similar Cav3 density as control LV myocytes. 
Colocalization of Cav1.2 with Cav3 was performed in IMARIS (Oxford 
instruments). The Pearson coefficients were lower in PH LV and RV myocytes as 
compared to the corresponding control myocytes (p<0.05, Figure 4.15D). To have 
a second verification of the data, we determined the Manders coefficients and 
percentage of protein volume colocalization. Both parameters were lower for 
Cav1.2 colocalized with Cav3 in PH RV myocytes versus control ones (p<0.05, 
Figure 4.15B and 4.15E). Similar reduction was observed in Manders coefficient 
and % of colocalized Cav3 with Cav1.2 in PH RV myocytes as compared to control 
RV cells (p<0.05, Figure 4.15C and 4.15F). In LV myocytes there were no changes 
in both Manders coefficients of Cav1.2 and Cav3 colocalization. 
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Figure 4.14. Representative images of RV and LV myocytes from control and PH rats 
stained with Cav1.2 (green) Cav3 (red) and merged images. 
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Figure 4.15. Reduction of Cav3 density and colocalization diminishing of Cav3 with 
Cav1.2. A) Average density of Cav3 signal measured in LV and RV myocytes from control 
and PH rats. B) Graphs showing the % of Cav1.2 colocalized with Cav3 in LV and RV 
myocytes from control and PH rats. C) Graphs showing the % of Cav3 colocalized with 
Cav1.2 in LV and RV myocytes from control and PH rats. D) Statistics of the Pearson 
coefficient of Cav1.2 colocalization with Cav3. E). Manders coefficient analysis for the 
Cav1.2 colocalized with cav3. F) Manders coefficient of the Cav3 colocalization with 
Cav1.2. (n=20-30 cells, N=3-4 rats, p<0.05, by one-way ANOVA test with Bonferroni 
correction).  
 
4.3.8 PH induced prolongation of myocytes contraction and Ca2+ transients. 
Characterization of functional changes in myocytes from PH rats was started with 
cell contraction and Ca2+ transients. Literature data about the Ca2+ transient changes 
are controversial (Benoist et al., 2012; Sabourin et al., 2018; Xie et al., 2012). Most 
of the studies were concentrated on changes in RV myocytes at severe stages of 
PH. We focused on the alterations in both RV and LV myocytes in early stage of 
PH. Contraction experiments for PH myocytes were performed with the same 
settings as for control cells (section 3.3.6). PH led to a ~40% increase of the cell 
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shortening amplitude in RV myocytes (p<0.05, Figure 4.16A) but not in LV 
myocytes. Prolongation of relaxation time was observed in PH RV myocytes 
compared to control ones (p<0.01, Figure 4.16C). LV myocytes had similar 
contraction properties in control and PH rats. 
 
Figure 4.16. Changes in cell shortening in PH rats. A) Maximal cell shortening changes 
in LV and RV myocytes in PH rats. B) Time to peak of contraction, studied in control and 
PH myocytes from RV and LV. C) Time to 90% of relaxation measured in LV and RV 
myocytes from control and PH rats. (n=11-19 cells, N=4 rats, *p<0.05, **p<0.01 by one-
way ANOVA test). 
Alterations of Ca2+ transient properties were studied by optical mapping of single 
myocytes. The examples of Fluo-4AM optical traces recorded in LV and RV 
myocytes from control and PH rats are presented in Figure 4.17A. As it was 
mentioned in section 3.3.6, we cannot fully rely on the measurements of the Ca2+ 
transient amplitude produced using Fluo4AM, so we will not use the amplitude 
measurements for any conclusions (Figure 4.17B). However, other parameters of 
Ca2+ transients could be estimated from these experiments. RV myocytes in PH rats 
had a larger duration of time to peak (p<0.01, Figure 4.17C) and a longer decay 
time (p<0.001, Figure 4.17D) than in control RV myocytes. PH also changed LV 
Ca2+ transients. In PH LV myocytes duration of decay time was significantly longer 
than in control LV (p<0.05, Figure 4.17D). 
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Figure 4.17. Prolongation of Ca2+ transients in PH RV myocytes. A) Representative 
examples of Ca2+ transient traces measured in LV and RV myocytes paced at 1 Hz. B) 
Average Ca2+ transient amplitude alterations in LV and RV myocytes from control and PH 
rats. C) Time to peak of Ca2+ transient measured in control and PH rats. D) Duration of 
Ca2+ transient decay (90%) observed in LV and RV myocytes from control and PH rats. 
(n=10-30 cells, N=3-4 rats, *p<0.05, ***p<0.01, ***p<0.001, by one-way ANOVA test). 
4.3.9 The effect of βAR stimulation on cell contractions. 
The observed alterations of cardiomyocyte contraction and Ca2+ transient properties 
could be partially induced by βAR stimulation. There are some reports indicating a 
high level of catecholamines in PAH patients that would lead to a persistant βAR 
stimulation (Sato et al., 2015). We thus hypothesized that myocytes from PH rats 
are less sensitive to βAR stimulation. To answer to this question, we analysed the 
effect of the nonselective βAR agonist (ISO) on contraction and Ca2+ transients of 
RV and LV myocytes. In these experiments we measured the amplitude of 
contraction and Ca2+ transient before and after ISO application on the same cell that 
excludes the potential problems with the dye loading.  
The traces of cells contraction before and after application of ISO are shown in 
Figure 4.18A. Statistical analysis of the ISO effect on sarcomere shortening 
indicated that PH RV myocytes had almost a 2 times lower response to βAR than 
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control RV myocytes (p<0.05, Figure 4.18B). At the same time, application of ISO 
produced a ~50% reduction of Ca2+ transient amplitude in PH RV myocytes as 
compared to control RV myocytes. We did not find any differences for ISO 
stimulation of control and PH LV myocytes. 
 
Figure 4.18. Alterations of maximal βAR stimulation in PH LV and RV myocytes. A) 
Representative changes in RV and LV myocyte contractions after application of ISO. (KH- 
Krebs-Henseleit buffer). B) The effect of ISO stimulation on the contraction amplitude in 
LV and RV myocytes from control and PH rats. (n=11-18 cells, N=4 rats, *p<0.05, one-
way ANOVA with Bonferroni correction). C) Changes induced by ISO application in the 
amplitude of Ca2+ transients measured in RV and LV myocytes from control and PH rats. 
(n=27-35 cells, N=4 rats, **p<0.01, by one-way ANOVA with Bonferroni correction).  
4.3.10 Increase in spontaneous Ca2+ activity in PH myocytes 
Several pathologies were associated with the Ca2+ handling dysregulation, and an 
increased spontaneous Ca2+ activity was observed in PH RV myocytes (Sabourin 
et al., 2018; Xie et al., 2012). We hypothesized that observed alterations in 
myocytes structure in PH will change the spontaneous Ca2+ activity in PH 
myocytes. We applied two methods for investigation of a spontaneous Ca2+ activity: 
OM for Ca2+ waves and line scan microscopy for Ca2+ sparks.  
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For the first type of experiments, myocytes loaded with Fluo-4AM were electrically 
paced at 4 Hz for 1 min, and then spontaneous Ca2+ waves were recorded during 
16-s rest period. Figure 4.19 presented the optical image of a myocyte loaded with 
Fluo-4AM and optical traces of Ca2+ waves showing non-propagated and 
propagated Ca2+ waves. Statistical analysis of the frequency of non-propagated Ca2+ 
waves showed a two times higher value in PH RV myocytes as compared to control 
ones (p<0.01, Figure 4.19C). The frequencies of propagated Ca2+ waves in RV and 
LV myocytes were preserved in PH. (Figure 4.19D).  
 
Figure 4.19. Increased spontaneous Ca2+ wave activity in PH myocytes. A) Optical 
imagine of cardiac myocyte loaded with Fluo-4AM. B) Representative traces of 
spontaneous Ca2+ activity measured in isolated ventricular myocytes during 16-s rest period 
after 1 min of 4Hz pacing. Optical traces of Fluo-4AM florescence changes recorded from 
3 different points (1–3) selected in the cardiomyocyte. C) Bar graph showing statistical 
analysis of frequency of non-propagated waves in control and PH myocytes. D) Bar graph 
indicating statistical analysis of propagated Ca2+ waves frequency in control and PH 
myocytes. (N=4-7 rats, *p<0.05, ***p<0.001 by Kruskal- Wallis test with Dunn’s post 
hoc).  
The second method used a line-scan mode of confocal microscope to visualize 
spontaneous Ca2+ sparks (Lyon et al., 2009). Representative line-scans of Fluo4-
AM fluorescence are presented in Figure 4.20A. Basic properties of Ca2+ sparks are 
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presented in Table 9 and Figure 4.20. The frequency of Ca2+ sparks was two times 
higher in PH RV myocytes as compared to control ones (p<0.01, Figure 4.20B). 
PH did not change the frequency of Ca2+ sparks in LV myocytes (Figure 4.20B). 
PH led to alteration of the Ca2+ spark shape in RV myocytes, they had a higher 
amplitude (p<0.05) and a longer duration (p<0.05) than control RV myocytes. This 
variations produced a significantly higher mass of the spark in PH RV myocytes 
than in control RV myocytes (p<0.001). Consequently, spark-mediated Ca2+ leak 
was 2.5 times higher in PH RV myocytes than in control RV myocytes (p<0.01, 
Figure 4.20D). The mass of Ca2+ sparks and spark-mediated Ca2+ leak were similar 
between control and PH LV myocytes (Figure 4.20C and 4.20D). 
 
Figure 4.20. The modulation of Ca2+ sparks parameters induced by PH. A) 
Representative line scans of Fluo4- AM fluorescence recorded in LV and RV myocytes 
from control and PH rats. B) Analysis of Ca2+ sparks frequency, B) Ca2+ spark mass and 
C) Ca2+ leak in control and PH myocytes. (n= 26-49 cells, N=3-5 hearts/group., by one-
way ANOVA test with Bonferroni correction). 
  
181 
 
Table 9. Ca2+ sparks properties in RV and LV myocytes from control and PH rats. 
 LV RV 
CON PH CON PH 
Frequency, 
Nspark/µm/100s 
1.3±0.1 1.4±0.3 1.18±0.18 2.0±0.2* 
Amplitude, F/F0 0.35±0.01 0.34±0.01 0.29±0.01 0.36±0.01* 
HMFW, µm 2.65±0.05 2.67±0.07 2.35±0.06 2.51±0.03 
HMFD, ms 25.1±0.6 26.9±1.1 24.3±1.2 28.6±0.6* 
Time to peak, ms 12.6±0.6 12.6±0.9 11.7±0.5 14.3±0.5* 
Tau, ms 26.3±1.4 27.3±1.7 26.5±2.0 32.4±1.0* 
Ca2+ spark mass, 
n(F/F0)*m*s 
24.3±1.1 24.2±1.1* 18.8±1.5 26.7±0.9* 
Ca2+ spark induced Ca2+ 
leak, p(F/F0)  
30.5±4.9 24.9±5.5 21.8±3.5 55.8±7.0* 
Values are mean±SEM, n = 26-49, N=3-5 hearts/group. Spark mass was calculated as 
amplitude*width*duration, and spark leak was calculated as mass*frequency. *p<0.05, 
**p<0.001 vs. the corresponding CON group, by one-way ANOVA test. 
4.3.11 RV myocytes from PH rats exhibit less synchronous Ca2+ transients 
The observed different Ca2+ handling properties of PH myocytes and the 
disorganisation of TATS can lead to the uncoupling of RyR2 from TAT network, 
producing “orphaned” RyRs (Song et al., 2006). This could result in a different 
pattern of Ca2+ release in PH myocytes as compared to control ones. We compared 
the shape of Ca2+ release using TTF50 profiles. The representative images of Ca2+ 
transients are presented in Figure 4.21A. The histograms of TTF50 distribution in 
LV (Figure 4.21B) and RV myocytes are shown in (Figure 4.21B and 4.21C). PH 
had no effect on the TTF50 histogram of LV myocytes (Figure 4.21B), whereas in 
PH RV myocytes TTF50 had a right-shifted distribution of values as compared to 
control RV myocytes (Figure 4.21C). We applied the methodology of (Louch et al., 
2006) to estimate the de-synchronization of the Ca2+ transient. The average 
‘desynchrony index’ values are presented in (Figure 4.21D). PH RV myocytes have 
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a ~19% higher ‘desynchrony index’ than control RV myocytes (p<0.05, Figure 
4.21D).  
  
Figure 4.21 Analysis of Ca2+ transient activation in LV and RV myocytes. A) 
Representative examples of Ca2+ transient line scans recorded in LV and RV myocytes 
from control and PH rats. B) Histogram of TF50 distribution in control and PH LV 
myocytes. C) Histograms of TTF50 distribution in control and PH RV myocytes. D) 
Analysis of desynchrony index in RV and LV myocytes from control and PH rats (n=24-
51 cells, N=3-5 rats, *p<0.05 by one-way ANOVA with Bonferroni post hoc). 
As discussed before in section 3.3.8, we applied the method of Biesmans et al. to 
divide the observed Ca2+ sparks in accordance with their TTF50 position. Using 
this approach, we looked at the modifications of early and delayed sparks 
separately. As we did not observe the differences in a general Ca2+ sparks properties 
in LV myocytes, we did not found the alterations of both early and delayed sparks 
in LV myocytes (Figure 4.22 B-4.22D). In the RV, PH lead to significant alterations 
in the properties of delayed Ca2+ sparks (Figure 4.22). Delayed Ca2+ sparks from 
PH myocytes had a larger amplitude than control RV myocytes (p<0.05, Figure 
4.22F) and became significantly wider (p<0.01, Figure 4.22G).  
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Figure 4.22. Analysis of early and delayed Ca2+ sparks in control and PH myocytes. 
A) Typical example of a line scan image during and after 1 Hz stimulation. On the left the 
TTF50 profile is presented. Sparks were assigned to early and delayed release areas 
corresponding to their position on the scan line. Statistical analysis of Ca2+ sparks 
parameters in LV myocytes from control and PH rats: frequency, B) Ca2+ spark amplitude, 
C) Half maximum of duration. (n=20-37, N=3-4). D) Analysis of Ca2+ sparks frequency, 
E) amplitude and F) half maximum of duration in control and PH RV myocytes. (n=35-47 
cells, N=4-5 rats, *p<0.05, **p<0.01, *p<0.001, by one-way ANOVA test with Bonferroni 
correction).  
4.3.12 L-type Ca2+ channels redistribution in PH RV myocytes 
Spatial localization of L-type Ca2+ channels was assessed by the super resolution 
scanning patch-clamp technique. Representative traces of LTCC single channel 
activity recorded in normal external solution at -6.7 mV are shown in Figure 4.23. 
Single LTCC activity was also recorded in the presence of a channel agonist BayK. 
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Traces of LTCC activity recorded in the presence of BayK in T-tubules and crests 
of RV myocytes from control and PH rat are shown in Figure 4.24. 
 
Figure 4.23. Traces of single LTCC activity recorded at -6.7 mV in T-tubule and crests 
of RV myocytes from control and PH rats. 
 
 
Figure 4.24 Single LTCC recordings acquired at T-tubule or crest regions of RV 
myocytes from control and PH rats in presence of LTCC agonist BayK8644. 
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Analysis of spatial localization of LTCCs after PH in RV myocytes was performed 
in normal external solution and with BayK in the bath (Figure 4.25). Density of 
LTCC was reduced in PH RV myocytes by ~2.1 times in T-tubule and ~2.3 times 
at the crest. The density of LTCC in T-tubule in the presence of BayK was reduced 
by 28% in PH RV myocytes versus control RV myocytes. LTCC density was 40 % 
higher at the crest of PH RV myocytes as compared to control ones. Application of 
the LTCC agonist showed that the observed reduction of LTCC density during the 
physiological recordings could be attributed to the redistribution and silencing of 
the channels. 
  
Figure 4.25. Density of LTCC measured in control and PH RV myocytes in absence 
and presence of BayK8644. n/m- number of patches with LTCC / total number of 
successful patches. 
LTCC open probability and amplitude were studied (Figure 4.26A and 4.26B). In 
normal external solution, LTCCs had an 80% higher Po in T-tubules of PH 
myocytes than in T-tubules of control myocytes (p<0.05, Figure 4.26A). The same 
higher Po of LTCCs located in T-tubules of PH rats than in T-tubules of control RV 
myocytes was observed when channels were recorded in the presence of BayK 
(P<0.05, Figure 4.26A). 
Single channel activity can be analysed in terms of current-voltage relationship 
(Figure 4.27 and Figure 4.28) or using amplitude at single voltage, in this case at -
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6.7 mV (Figure 4.26B). In both cases, when LTCCs were recorded in normal 
external solution, no alterations of LTCC amplitude or conductance in PH RV 
myocytes were observed. As it was shown in control RV myocytes, the presence of 
BayK LTCCs had a lower amplitude in T-tubules that in the crest. PH lead to an 
increase in LTCC amplitude in T-tubule compared to the corresponding LTCCs in 
control RV myocytes (p<0.05, Figure 4.26B). Conductance of LTCCs was also 
higher at T-tubules of PH rats versus T-tubules of control rats (p<0.05, Figure 4.28). 
On the contrary, LTCC conductance and amplitude measured at -6.7 mV for the 
channels recorded at crests of PH RV myocytes were significantly lower as the 
conductance and amplitude at -6.7 mV measured at the crests of control RV 
myocytes (p<0.01, Figure 4.28, p<0.01, Figure 4.26B). 
 
Figure 4.26. Alteration of LTCC properties in PH RV myocytes. A) Open probability 
of single LTCC measured at-6.7mV in absence and presence of BayK8644. (Number of 
successful patches used in physiological control: T-tubule-20, crest 17, PH T-tubule-7, 
crest-8; BayK: Control T-tubule-7, crest-6, PH: T-tubule-3, crest 5 channels, *p<0.05, by 
Kruskal- Wallis test with Dunn’s post-hoc). B) Average single LTCC amplitude measured 
at -6.7 mV in myocytes with and without BayK (*P<0.05, ***P<0.001 by Kruskal- Wallis 
test with Dunn’s correction). 
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Figure 4.27. Current-voltage LTCC dependence measured at T-tubule (top) and crest 
(bottom) of control and PH RV myocytes in absence (left) and presence (right) of 
BayK. Normal solution: control: T-tubule-20, crest 17, PH T-tubule-7, crest-8; BayK: 
Control T-tubule-7, crest-6, PH: T-tubule-3, crest 5 channels, *p<0.05, ***p<0.001 vs. 
control LTCC amplitude at corresponding voltage, by unpaired t-test. 
 
Figure 4.28. Conductance of single LTCC measured at T-tubule and crest of RV 
myocytes from control and PH rats in absence and presence of BayK. (Physiological: 
control: T-tubule-20, crest 17, PH T-tubule-7, crest-8; BayK: Control T-tubule-7, crest-6, 
PH: T-tubule-3, crest 5 channels, *p<0.05, by one-way ANOVA test with Bonferroni 
correction).  
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4.3.13 Average expression of Cav1.2, Cav3 and levels of kinase activity in RV and 
LV myocytes  
Finally, we performed the western blot analysis of Cav1.2 and Cav3 expression and 
the level of phosphorylation of CaMKII and PKA in control and PH RV and LV 
myocytes (Figure 4.29 and 4.30). PH had no effect on the expression of Cav1.2, in 
both RV and LV myocytes. As LTCC and RyR2 are both the targets of PKA and 
CaMKII phosphorylation, we checked the activity of these kinases in control and 
PH myocytes. To investigate the level of the PKA activity, we applied the antibody 
specific to pPKA-substrate, as it was performed in (Seul Han et al., 2018). PH RV 
myocytes had a slight (by 10%, not significant) increase of the PKA substrate 
density than control RV myocytes (Figure 4.29B). pCaMKII phosphorylated at 
Thr286 was used to assess CaMKII activity. RV myocytes from PH rats showed 
about 20% higher level of pCaMKII than the control ones (not significant, Figure 
4.29B). PH did not change the expression of both pPKA and pCaMKII in LV 
myocytes (Figure 4.30). 
As discussed before, Cav3 is important for maintenance of LTCCs and their 
function, as it brings together LTCC with many signalling proteins and regulatory 
units, such as PKA (Balijepalli et al., 2006). Expression of Cav3 in PH RV 
myocytes was ~ 35% smaller than in control RV myocytes (not significant, Figure 
4.29B). 
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Figure 4.29. Western blot analysis of the protein expression in control and PH RV 
myocytes. A) Blots showing the relative levels of Cav1.2, pCaMKII, pPKA substrate, Cav3 
and GAPDH in control and MI RV myocytes. B) Average density of Cav1.2, pCaMKII, 
pPKA substrates, and cav3 normalized to GAPDH. (Control (C) n=4, PH n=4 rats). 
 
 
Figure 4.30. Western blot analysis of protein expression in the LV myocytes from 
control and PH rats. A) Representative blots of Cav1.2, pCaMKII, pPKA substrate, Cav3 
and GAPDH performed on samples from control and PH LV myocytes. B analysis of mean 
protein density from the blots showed in A. (Control (C) n=4, PH n=4 rats).  
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4.4 Discussion  
This chapter was devoted to investigate the PH-induced alterations in RV and LV 
function on different levels. To make a better description of PH in rats we studied 
it effects on molecular, cellular and whole organ levels.  
First, we analysed the phenotype of PH induced in rat by MCT. Despite a wide 
usage of this model, the protocols of MCT applications differ from one publication 
to another. Benoist et al. proposed that MCT injection of 30 mg/kg will lead to RV 
hypertrophy, whereas 60 mg/kg would produce RV failure (RVF) (Benoist et al., 
2012). The common protocols include a 60 mg/kg injection and animals were 
sacrificed around 20-25 days after the injection when the pronounced RVF was 
established (Benoist et al., 2011; Rocchetti et al., 2014; Xie et al., 2012). 
Monitoring the changes of RV dynamics and shape at several time points after 60 
mg/kg of MCT injection showed that the pronounced hypertrophy of RV is usually 
developed after 2 weeks (Abdul-Salam et al., 2019; Sabourin et al., 2018). We 
followed the protocol of (Abdul-Salam et al., 2018) and treated the rats with MCT 
for 10-12 days. The physiological measurements that are shown in Figure 4.2, 
indicated a significant increase of PAP, muscularisation of the vessels in the lungs 
and RV / LV+ septum ratio in MCT treated rats. These results indicate an 
appearance of PH with a RV hypertrophy, similar to that described by (Abdul-
Salam et al., 2019; Sabourin et al., 2018). 
Progression of PH in humans is accompanied by the formation of the 
arrhythmogenic activity at the last stages of the disease (Handoko et al., 2010). In 
rats with RVF, arrhythmogenicity was also observed by Benoist et al. (Benoist et 
al., 2011). Here, we investigated the formation of pro-arrhythmogenic substrates at 
the early stage of PH in rats via analysis of impulse propagation and tissue 
refractoriness. The velocity of impulse propagation along a fibre orientation was 
lower in PH LV than in control LV tissue and there were no changes observed in 
the CV of the RV. However, the formation of pro-arrhythmogenic substrates 
depends on the anisotropy of CV in the tissue. In healthy ventricular tissue, the 
anisotropic ratio is around 1:2 and the increase of the anisotropic ratio was linked 
to the generation of unidirectional conduction block and sink to source mismatch 
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(Van Rijen et al., 2004; Volders et al., 1999). Here, we found a decrease in CV 
anisotropy in the PH RV (Figure 4.3) that cannot be considered as pro-arrhythmic 
(Linnenbank et al., 2014). 
We also observed prolongation of ERP in the RV and LV from PH rats, which could 
be related to the prolongation of QT interval (reflects APD in ECG, Figure 4.4), 
and to the increase of Ca2+ transient duration observed in RV and LV myocytes 
(Figure 4.17). Prolonged ERP could either increase or decrease arrhythmogenesis 
(Linnenbank et al., 2014). Increasing the ERP can precipitate torsades de pointes, 
a type of ventricular tachycardia caused by EADs or DADs (Cleland and Krikler, 
1992; Volders et al., 1999). On the other side, a longer ERP could interrupt 
tachycardia caused by re-entry mechanisms by prolonging the length of the re-
entrant circuits (Wiener and Rosenblueth, 1946). Thus, both of the observed 
alterations in CV anisotropy and ERP prolongation solely cannot produce a pro-
arrhythmogenic substrate. We did not see a significant increase in occurrence of 
extrasystole in the PH RV as compared to the control RV, so we could assume this 
stage of the disease is not severe enough for the development of pro-
arrhythmogenic substrates.  
We observed pronounced changes in the shape of both RV and LV myocytes in PH 
rats, while RV myocytes became more hypertrophic and the LV myocytes became 
atrophied (Figure 4.5). As it is an early stage of the disease, we observed a 
significant change of the RV mass, but not the LV mass (Figure 4.2). The changes 
in the RV mass could be due to the adaptation to the work in conditions of increased 
PAP (Figure 4.2). On the other side, if the RV is dilated, the interventricular septum 
shifts toward the left, altering LV geometry and increasing pericardial constriction 
(Foschi et al., 2017). In our case, the hypertrophied RV could already shift the 
septum towards the left that induce the changes of cell shape and Ca2+ handling, 
however it is not enough for a significant changes in the ventricular mass. This trend 
could be responsible for the significant atrophy of the LV observed at severe PH 
(30 days after MCT injection; (Han et al., 2018)).  
Changes in myocytes shape lead to the damage of the membrane structures. In our 
studies we found that a surface topography was altered only in RV myocytes but 
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not in LV (Figure 4.6). Sarcolemma membrane flattering was studied by our group 
on LV myocytes during the progression of HF (Lyon et al., 2009; Schobesberger et 
al., 2017). It was shown that reorganisation of surface sarcolemma is correlated 
with an impaired contractility of cells and a high rate of spontaneous Ca2+ activity 
(Heinzel et al., 2008; Lyon et al., 2009). Both impaired contractility and altered 
Ca2+ handling were observed in RV myocytes, but not in LV cells after PH (Figure 
4.16-4.19).  
The internal TAT network is more flexible than the surface sarcolemma. It changes 
to adapt to the alteration in the load and stress (Heinzel et al., 2008). We showed 
that in PH, RV myocytes have a reduced density and regularity of T-tubules (Figure 
4.8). Significant reduction of both TAT density and regularity was found at later 
stages of PH hypertension by (Fowler et al., 2018; Rocchetti et al., 2014; Xie et al., 
2012). Sabourin et al. also observed the reduction of TAT regularity in the RV after 
14 days of PH as well as in LV myocytes after 21 of PH (Sabourin et al., 2018). 
Moreover, the TAT skeleton analysis showed a higher complexity of the network 
in both RV and LV myocytes (Figure 4.9), probably due to an increase of A-tubules 
formation and a reduction of T-tubules (Figure 4.10). As discussed before (section 
3.4) and in the work by (Schobesberger et al., 2017), A-tubules are appeared during 
the hypertrophic state of disease. They were proposed to be a compensatory 
mechanism that serves to maintain the ECC under the stress when initial T-tubules 
organisation is destroyed (Jones et al., 2018). In ventricular myocytes, new tubules 
formation in axial direction could be driven by actin filaments formation, which 
was observed in HF (Lichter et al., 2014). Higher proliferation of actin filaments 
was also found in RV myocytes of PH hypertensive rats (Stones et al., 2013). 
Reduction of surface regularity and reorganisation of TAT network in PH RV 
myocytes were accompanied by a pronounced increase of cell shortening (Figure 
4.16) and Ca2+ sparks amplitude (  
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Table 9). As discussed in the introduction, there are some discrepancies in the 
literature about the effect of PH on myocytes cell shortenings and Ca2+ transient 
that could be related to different protocols of MCT treatment. We hypothesize that 
high neurohormonal activity observed in PH, could be responsible for a higher basal 
βAR stimulation in PH RV myocytes. Application of non-selective βAR agonist, 
ISO, showed a less potent effect on cell contraction and Ca2+ transients of PH RV 
myocytes then on control RV cells (Figure 4.18). LV myocytes from control and 
PH rats had similar cell shortenings, and potentiation under the βAR stimulation 
(Figure 4.16-4.18). 
Membrane reorganisation and surface flattering in PH RV and LV myocytes could 
promote a higher rate of spontaneous Ca2+ activity. We used two separate 
methodologies to investigate the spontaneous Ca2+ events in RV and LV myocytes: 
optical mapping and line modification of confocal microscopy. Both approaches 
showed a pronounced increase in the frequency of Ca2+ waves and Ca2+ sparks in 
RV myocytes after PH, but not in LV myocytes (Figure 4.19 and 4.20). A higher 
sparks rate was observed at 14 days of PH (Sabourin et al., 2018), and at 30 days 
of MCT treatment (Benoist et al., 2014; Xie et al., 2012). The shape of Ca2+ sparks 
was also modified in PH. Ca2+ sparks in RV had a higher amplitude and a longer 
duration than in control RV myocytes (Table 4.1) producing a larger mass of Ca2+ 
spark and spark-mediated Ca2+ leak. In the work of Sabourin et al. Ca2+ sparks in 
PH RV myocytes have a similar amplitude, but a wider and a longer duration than 
in control RV myocytes (Sabourin et al., 2018). However, Benoist et al. reported a 
pronounced increase of both Ca2+ spark mass and spark mediated leak in 
hypertrophic stage of RV (Benoist et al., 2012). Increased spontaneous Ca2+ 
releases through RyR2 could be induced via phosphorylation of the receptors by 
CaMKII and PKA (Bers and Perez-Reyes, 1999). The levels of pCaMKII and 
pPKA substrate were slightly but not significantly higher in PH RV myocytes as 
compared to control ones (Figure 4.29). Phosphorylation of RyR2 at Ser 2808 and 
Ser 2814 was not changed in RV and LV myocytes after PH (Sabourin et al., 2018). 
Ca2+ sparks rate could be altered by variation of the SR Ca2+ loading. However our 
preliminary study and others showed the unchanged SR Ca2+ loading in RV 
myocytes after 14 and 30 days of PH (Benoist et al., 2014; Sabourin et al., 2018). 
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Thus, we hypothesize that an increased [Ca2+] in cytosol due to the prolonged Ca2+ 
transient or increase influx through LTCC could be responsible for triggering of 
RyR2 openings.  
Disorganisation of TAT network in HF was associated with a slower and more 
desynchronous activation of Ca2+ transients (Louch et al., 2006). We analysed the 
shape of Ca2+ transients by TTF50, distribution and variability. RV myocytes from 
PH rats showed a right-shifted distribution of TTF50 with a significantly higher 
desynchrony index as compared with control RV myocytes (Figure 4.21). LV 
myocytes possessed a similar TTF50 distribution and desynchrony index. Fowler 
et al. reported the magnification of desynchrony in RV Ca2+ transients but at the 
late stages of PH (Fowler et al., 2018). First, we hypothesized that the 
reorganisation of TAT network removed LTCCs from the coupling with RyR2 that 
will became “orphaned” as it happened in HF (Song et al., 2006). However, it is not 
the case, the analysis LTCC and RyR2 arrangement and colocalization by STED 
microscopy showed no reduction of RyR2 colocalization with Cav1.2 (Figure 4.13). 
A recent study proposed that desynchronization of Ca2+ transients is one of the 
consequences of reorganisation of RyR2 clusters in HF (Kolstad et al., 2018). 
Smaller RyR2 clusters were shown to produce an invisible non-spark Ca2+ leak, and 
large clusters were responsible for the irregular and slow Ca2+ sparks that could be 
attributed to the delayed regions of Ca2+ transients. The analysis of the Ca2+ sparks 
properties in early and delayed sites of Ca2+ transient showed that Ca2+ sparks that 
originated in delayed regions was significantly longer and higher in PH RV 
myocytes as compared to control (Figure 4.22F and 4.22G). This could be a 
consequence of reorganisation of RyRs clusters in RV following PH.  
Investigation of LTCC expression and density in PH showed that expression of the 
pore-forming protein, Cav1.2, was preserved in both RV and LV myocytes (Figure 
4.29 and 4.30). At later stages of PH, a significant reduction of Cav1.2 expression 
was observed in RV myocytes by (Benoist et al., 2011; Xie et al., 2012), although 
during the hypertrophic stage of the disease it was still unchanged (Benoist et al., 
2012; Rocchetti et al., 2014). Immunocytochemical study and functional patch 
clamp investigation showed a potential silencing of LTCC in PH RV myocytes 
(Figure 4.13). Analysis of LTCC density in T-tubules and crests in the presence of 
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BayK showed a pool of non-active LTCC in both membrane domains (Figure 4.25). 
LTCC in both T-tubules and crests are mainly anchored in caveolae (Cavalli et al., 
2007; Shibata et al., 2006). We analysed the expression and the density of Cav3 
immunofluorescence in control and PH RV myocytes. Expression level of Cav3 
was slightly reduced in PH (Figure 4.29). The density of Cav3 immunofluorescence 
was analysed inside the cell and thus could be proportional to the T-tubular fraction 
of Cav3. This Cav3 density and its colocalisation with Cav1.2 was significantly 
reduced in PH RV myocytes, as compared to control RV myocytes (Figure 4.15), 
which could indicate the redistribution of Cav3 from T-tubules to the outer 
membrane among with the LTCC.  
The observed reduction of the number of active LTCC in the membrane could be 
compensated by an increased activity of the remaining ones. The open probability 
of T-tubule LTCCs of PH myocytes was significantly higher than in control RV 
myocytes (Figure 4.26). This could be a compensatory mechanism to maintain the 
loading conditions in terms of loss of some LTCCs.  
We did not find any differences in LTCC mean amplitude and conduction under 
the normal conditions, but in the presence of BayK, LTCCs in T-tubules had a 
smaller mean amplitude and conductance as compared to the crest LTCC (Figure 
4.26 and 4.28). PH lead to a significant increase of the LTCC conductance in the 
presence of BayK in T-tubules and reduction of average LTCC conductance in the 
crest, making T-tubules and crest LTCCs not different (Figure 4.28). It is possible 
that down-regulation of Cav3 during PH and the redistribution of LTCC from their 
native location to non-canonical regions produced these functional alterations. This 
question will be addressed in further investigations. 
4.4.1 Conclusion 
In summary, at the early stage of PH, we found that an elevated PAP in PH rats 
causes a significant cell structural remodelling in RV myocytes, which includes cell 
hypertrophy, reduction of TAT network, z-groove flattening and LTCC 
redistribution. This structural reorganization is accompanied by the adaptive 
changes in cell shortening, desynchronization of Ca2+ transients, higher Po of LTCC 
and increased Ca2+ spark rate. The cellular changes could in part be responsible for 
the electrical remodelling observed in vivo, such as prolongation of ERP and 
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reduction of CV anisotropy, however, these changes are not severe enough for an 
increase in arrhythmias in the tissue. In LV myocytes, PH leads to prolongation of 
Ca2+ transients but without changes in the TAT organization. Altogether our 
findings suggest that at this stage of PH significant cellular structural and functional 
remodelling occurs. However the arrhythmogenic activity in RV that reported at 
later stages of the disease in RV is not present. Suggesting that these changes 
observed at the cellular level could be the first stage before the development of 
arrhythmias in the long term.   
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5 Alterations in microdomain organisation of RV in left 
sided HF.  
5.1 Introduction 
Idiopathic pulmonary arterial hypertension is not the most common cause of RV 
dysfunction (Thenappan et al., 2018). The leading case of PH in the world is due to 
left sided HF (La Vecchia et al., 2001; Thenappan et al., 2018). The patients with 
HF who developed signs and/or symptoms of RV failure have a very poor prognosis 
and median survival is usually less than two years (Anavekar et al., 2008; Di Salvo 
et al., 1995; Larose et al., 2007; Oakley, 1988). Moreover, RV hypertrophy and 
failure showed to be an independent risk factor for morbidity and mortality of HF 
patients (Ghio and Tavazzi, 2005). The exact mechanisms how LV failure could 
promote RV pathological changes are not clear. It was proposed that septal 
dyssynergia, pulmonary hypertension, neurohormonal activation or inflammation 
can provoke RV hypertrophy and failure in HF (Haddad et al., 2008; Quaife et al., 
1998). Some studies proposed that pulmonary pressure was elevated due to the 
elevated left-sided filling pressures in failing LV (Jiang et al., 2011; 
Kalogeropoulos et al., 2011; La Vecchia et al., 2001). However, others have not 
reported the appearance signs of RV ischemia/infarct, septal infarct, or pulmonary 
hypertension in HF patients (Quaife et al., 1998; Voelkel et al., 2006).  
The mechanism of RV progression in disease in the settings of LV dysfunction is 
of key importance in understanding the disease. Pathophysiological remodelling of 
cardiac function in HF occurs at multiple levels. As was shown in previous chapter 
we attempt to study alterations of RV myocytes structure and function in HF to 
compare it with progression of LV myocytes. We used a well-studied model of 
myocardial infarction in rats induced by coronary artery ligation (Lyon et al., 2009). 
Recently in our laboratory and other groups was found that 16 weeks after MI LV 
myocytes undergo significant destruction of membrane organisation that lead to 
increased irregular Ca2+ activity, LTCC redistribution and hyperphosphorylation 
(Bryant et al., 2015; Louch et al., 2006; Lyon et al., 2009). Moreover, progressive 
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reorganisation of Ca2+-signalling microdomains was shown to capable to produce 
an arrhythmogenic triggers in the whole heart (Sanchez-Alonso et al., 2016). 
Specifically, we wanted to investigate the local control of LTCC in RV myocytes. 
In LV myocytes from MI rats LTCCs were relocated from their predominant 
localization (in T-tubule) to surface membrane (crest) where LTCCs become 
hyperphosphorylated and arrhythmogenic (Sanchez-Alonso et al., 2016). Different 
regulation of two subpopulations of LTCC was found (Bryant et al., 2015; Sanchez-
Alonso et al., 2016). 
Therefore, we hypothesized that MI induced the rearrangement of the sarcolemma 
membrane in RV myocytes that leads to altered function of single LTCCs and 
higher spontaneous Ca2+ activity in failing RV myocytes.  
The main objectives of this chapter were: 
1. To study alteration of RV myocytes shape, surface topography and internal 
TAT network organisation after MI.  
2. To investigate the effect of MI on the properties of Ca2+ transients, 
spontaneous Ca2+ waves and Ca2+ sparks in RV myocytes.  
3. To assess the spatial localization and functional behaviour of LTCCs in MI 
RV myocytes  
4. To check the expression levels of Cav1.2, Cav3 and phosphorylation activity 
of pCaMKII and pPKA in MI RV myocytes.  
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5.2 Methods 
5.2.1 Rat myocardial infarction HF Model 
The study of HF effect on single RV myocytes was performed in a model of chronic 
MI in adult Sprague-Dawley rats. The model was produced by Dr. Catherine 
Mansfield in Imperial College London. This is an established model frequently 
produced in our laboratory via ligation of the left anterior descending coronary 
artery. Myocytes were isolated 16 weeks after the operation. Our group validated 
this model before (Lyon et al., 2009; Sanchez-Alonso et al., 2016), showing a 
pronounced increase of LV weight, dilatation and elevated levels of brain 
natriuretic peptide in serum (Lyon et al., 2009). 
5.2.2 Myocytes isolation 
Myocytes were isolated from control and failing hearts according to the protocol 
described in section 2.2.1. 
5.2.3 Scanning ion conductance microscopy 
Surface topography of live cardiomyocytes was assessed by SICM as described in 
2.3.3. RV and LV myocytes were plated on petri dishes covered with laminin. The 
recordings were made in hopping mode of microscope with 100 nm I.D. 
borosilicate pipettes. Z-groove ratio was used for the regularity analysis of surface 
membrane (Gorelik et al., 2006). 
5.2.4 Confocal microscopy investigation of TATS in the live cardiomyocytes 
The subcellular TAT system was visualized by confocal imaging of live cells 
stained with Di-8-ANEPPS as described previously (Lyon et al., 2009). Analysis 
of TAT network density, regularity skeletons length and complexity was performed 
as described in method section 2.3.1. 
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5.2.5 Optical mapping of Ca2+ events in isolated myocytes 
Optical mapping of Ca2+ waves and transients was performed as described in 
section 2.4.2. Briefly, freshly isolated cardiac myocytes were stained with Fluo-
4AM and placed in perfusion chamber of inverted microscope equipped with 
CMOS camera ULTIMA-L (SciMedia, USA Ltd, CA; 500 fps, 1.5–2 μm/pixel). 
Chamber was constantly perfused with HBSS temperature was controlled to 37oC. 
Two stimulation protocols were applied: 1) 5 min of 1 Hz followed by 5 s of 
recording to measure Ca2+ transient’s properties. 2) 1 min of 4 Hz stimulation 
followed by stimulation cessation and recording of spontaneous Ca2+ waves  
Ca2+ transient properties were analysed using a macro code in Fiji. Spontaneous 
Ca2+ events were visualized in BraviAna (Brainvision Ana v. 120) and manually 
checked for the propagation of the waves. Frequency of propagated and non-
propagated Ca2+ waves was counted separately. 
5.2.6 Calcium sparks and transients investigation with line mode of confocal 
microscope  
Ca2+ sparks and Ca2+ transients were analysed from confocal line-scans of Fluo4-
AM fluorescence. Detailed protocol is described in section 2.4.3. Briefly, cells were 
field-stimulated at 1 Hz for enhancement of SR Ca2+ loading, then few (3-5) Ca2+ 
transients were recorded together with 8-16 s rest Ca2+ activity. Analysis of Ca2+ 
sparks and Ca2+ transients was performed in custom made macro in Fiji. 
5.2.7 Super-resolution patch clamp technique 
This methodology was described in detail in section 2.4.1. Briefly, the protocol 
included the visualization of a myocyte surface topography by SICM then the tip 
of pipette was precisely widened by clipping (Bhargava et al., 2013). After pipette 
moved to a desired surface region (T-tubule or crest) and lowered down until it 
reached the membrane. A high resistance seal then was established and single 
LTCC recordings were performed in a cell-attached modification of path-clamp 
technique.  
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For experiments when PKA activity needs to be blocked 10µM of PKA antagonist, 
H89, was added in external LTCC buffer prior to experiments. Solution of drug was 
used only at the day of preparation. Myocytes during LTCC recordings were kept 
in H89 solution no longer than 30 min, than a new dish with myocytes were treated 
with a drug. 
5.2.8 Western blot 
Detailed procedure is described in the section 2.5.1. Proteins were extracted from cell 
pellets and the level of proteins was determined with BioRad DSK+ kit using BSA as 
standard protein. The following primary antibodies were used for immunoblotting: 
Cav1.2 (1: 200), pPKA substrate (1: 1000), pCaMKII (1:500); Cav3 (1:1000) and 
GAPDH (1:1000). Secondary antibodies were anti-mouse and anti-rabbit linked with 
HRP in dilution 1:2000. Density of the bands was normalized to GAPDH levels.  
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5.3  Results  
5.3.1 Alterations of the cell shape after MI 
The shape of myocytes was analysed after the MI. RV and LV myocytes became 
markedly hypertrophied in MI rats (Figure 5.1). Failing LV myocytes became 21% 
longer (Figure 5.1A) and 35% wider (Figure 5.1B) with a decreased LWR (Figure 
5.1C) than control ones. Similar changes but with less extend happened with RV 
myocytes in MI rats. They became an 8 % longer (Figure 5.1A) and 28 % wider 
(Figure 5.1B) but the LWR was not altered compared to the myocytes from control 
rats (Figure 5.1C). 
 
Figure 5.1. Characterization of changes in the myocytes shape in MI rats. A) Myocyte 
length, B) myocyte width and C) length to width ratio in RV and LV myocytes from control 
and MI rats (n=60-100 cells, N=6-10 rats; by one-way ANOVA test with Bonferroni 
corrections). 
5.3.2 Surface topography study 
Surface structure of life cardiomyocytes was assessed by SICM. Representative 
10x10 µm scans are presented in Figure 5.2. Analysis of surface topography was 
performed with Z-groove ratio determination (Figure 5.3). Failing LV myocytes 
possessed a pronounced reduction of Z-groove ratio from 0.69±0.02 au in control 
LV myocytes to 0.40±0.02 au in failing ones (p<0.001). RV myocytes undergo 
similar reduction of Z-groove ratio but for a less extend. Z groove ratio reduced 
from 0.68±0.03 au in control RV to 0.49±0.02 au in MI rats 
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Figure 5.2. Representative surface scans of myocytes topography of LV (top) and RV 
(bottom) myocytes from control (left) and MI (right) rats. 
 
 
Figure 5.3. Bar graphs showing the average Z-groove ratio of LV and RV myocytes 
from control and MI rats. (n=40-100 cells, N=4-10 rats, *p<0.05, *** p<0.001, by one-
way ANOVA with Bonferroni correction). 
5.3.3 Changes of TAT network parameters of RV in failing hearts 
The reduction of TAT network density and its reorganisation after MI in rats were 
well studied by our group (Ibrahim et al., 2011; Schobesberger et al., 2017) and 
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others (Louch et al., 2006; Wei et al., 2010). Most of the works agreed that LV 
myocytes undergo gradual reduction of TAT density and regularity, which fist 
accompany with initial increase in the amount of A-tubules, that lost in the end 
stages of HF (Schobesberger et al., 2017). RV myocytes TAT network from control 
and 16 weeks post-MI stage are presented in Figure 5.4. The reorganisation of TAT 
structure in MI can be mentioned from the corresponding power peak plots that 
shown in Figure 5.4 and statistical analysis of TAT density (Figure 5.5). In failing 
rats RV myocytes have a 12 % (p<0.001) reduction of TAT density and a 42% 
(p<0.001) reduction of T-tubule regularity.  
 
Figure 5.4. Representative Di-8ANEPPS images of TAT network in control and MI 
RV myocytes and corresponding power frequency graphs of T-tubule regularity.  
 
Figure 5.5. Statistical analysis of TAT parameters changes in MI. A) TAT network 
density of control and MI RV myocytes. B) Power of T-tubule regularity analysis of control 
and MI RV myocytes. (N=9-10 rats, p<0.001 by unpaired Student t-test).  
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The portions of TAT images were processed accordingly to the protocol of (Wagner 
et al., 2014). Representative portions of TAT network of RV myocytes from control 
and MI rats and corresponding TAT skeleton images are presented in Figure 5.6. 
The analysis of the TAT skeleton length per area indicated that in MI rats RV 
myocytes have a slightly (by 4 %) but significantly (p<0.05) less length of TAT 
skeleton as compared to RV myocytes from control rats. Complexity analysis of 
TAT network by the number of triple junctions per area showed similar values in 
RV myocytes from control and failing rats (Figure 5.6C). 
 
Figure 5.6. RV TAT skeleton changes in MI. A) Representative fragments of the TAT 
network images of RV myocytes from control (top) and MI (bottom) rats and 
corresponding skeletonized TAT structures. B) Average TAT network skeleton length per 
area measured in RV from control and MI rats. C) Average number of triple junctions in 
TAT network found in RV myocytes from control and MI rats. (n=50-60 cells, N=5-6 rats, 
*p<0.05, by Mann-Whitney test). 
Directional distribution of TAT in control and MI RV myocytes was obtained by 
the directionality histograms created by Fiji. Representative examples of directional 
histograms of RV myocyte TAT network are presented in Figure 5.7A. The analysis 
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of average length of A-tubules and T-tubules revealed preserved levels of both A-
tubules and T-tubules in RV myocytes from MI rats (Figure 5.7B). 
 
Figure 5.7. Directionality study of TAT network changes in RV after MI. A) 
Representative histogram of directional distribution of TAT network of control RV 
myocyte. B) Representative histogram of directional distribution of TAT network in RV 
myocyte from MI rat. B) Average length of A-tubules and T-tubules found in RV myocytes 
from control and MI rats. (n=40-50 cells, N=4-5 rats). 
 
5.3.4 Failing RV cells have higher and longer Ca2+ transients. 
During the progression of HF many groups observed alterations of ECC coupling 
that is caused by changes in Ca2+ transients parameters. Our recent study revealed 
that Ca2+ transients became more prolonged with reduced amplitude in failing LV 
myocytes. Here we studied the changes 16 weeks post MI in RV myocytes. The 
OM traces recorded in control and MI RV myocytes are shown in Figure 5.8A. As 
discussed before, we cannot rely on Ca2+ transient amplitude measurements. Thus 
the values of Ca2+ transient amplitude are shown here only for comparison. (Figure 
5.8B). No changes were found in Ca2+ transient time to peak in MI (Figure 5.8C). 
Comparison of a 90 % decay time between control and failing RV myocytes showed 
a significant prolongation of the Ca2+ transient decay in failing RV myocytes 
(p<0.05, Figure 5.8D).  
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Figure 5.8. Failing RV myocytes have higher and longer Ca2+ transients compared to 
control RV myocytes. A) Representative traces of Ca2+ transients measured in control and 
MI RV myocytes. B) Average Ca2+ transient amplitude in control and MI RV myocytes. 
C) Statistical analysis of time to peak of Ca2+ transient in control and MI RV myocytes. D) 
90% of Ca2+ transient decay time observed in control and MI RV myocytes. (n=18-28 cells, 
N=3-4 rats; *p<0.05, **p<0.01, by unpaired Student t test). 
Significant prolongation of Ca2+ transients observed by optical mapping and 
reduction of TATS density and regularity in MI RV myocytes drives us to 
hypothesize that MI RV myocytes should have more desynchronized activation. 
The examples of line-scans of Ca2+ transients recorded in control and MI RV 
myocytes are presented in Figure 5.10. Analysis of TTF50 histograms (Figure 
5.10B) and ‘desynchrony indexes’ (Figure 5.10C) showed that RV myocytes from 
post-MI rats have a right shifted distribution of TTF50 with a slightly higher (p=0.1) 
‘desynchrony index’. 
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Figure 5.9. Analysis of synchronicity in control and MI RV myocytes. A) Examples of 
Ca2+ transient line scans recorded in control and MI RV myocytes. Bar – 20 µm. B) 
Histograms of TF50 distribution in control (black) and MI (red) RV myocytes. C) Average 
‘desynchrony index’ of Ca2+ transient measured in control and MI RV myocytes. (n=24-27 
cells, N=3-4 rats, p=0.1, by unpaired t test). 
 
5.3.5 MI lead to an increase of a spontaneous Ca2+ activity in RV myocytes 
To analyse spontaneous Ca2+ behaviour we applied two methods. Optical mapping 
of Ca2+ waves was applied after 1 min of 4 Hz field stimulation to ensure the equal 
SR loading in all the experiments. The optical Ca2+ traces recorded from control 
and failing RV myocytes are shown in Figure 5.10A. Statistical analysis of the non-
propagated Ca2+ waves frequency showed two times higher frequency in failing RV 
myocytes as compared to control ones (p<0.05, Figure 5.10B). The propagated 
waves had the reduced frequency in MI (p<0.05).  
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Figure 5.10. Increased frequency of spontaneous Ca2+ waves in failing RV myocytes. 
A) Examples of spontaneous Ca2+ waves acquired in control and MI RV myocytes during 
a 16-s rest period after 4Hz stimulation. B) Bar graph showing the analysis of non-
propagated and propagates Ca2+ waves frequency measured in control and MI RV 
myocytes (N= 4-7 rats, *P<0.05, by one-way ANOVA with Bonferroni post hoc). 
The study of Ca2+ sparks using line-scans also indicated an increase in Ca2+ activity 
in MI RV myocytes as compared to control RV myocytes (Table 10). Line-scans 
of Fluo4-AM fluorescence recorded in control and MI RV myocytes are shown in 
Figure 5.11. In MI rats RV myocytes had higher frequency of Ca2+ sparks (p<0.05, 
Figure 5.11B), higher mass (p<0.05, Figure 5.11C) and as a consequence, Ca2+ leak 
induced by the sparks was significantly higher than observed in control RV 
myocytes.  
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Figure 5.11. Alteration on Ca2+ sparks properties in RV from 16 weeks post MI rats. 
A) Representative line scans of Fluo4-AM fluorescence recorded in control and MI RV 
myocytes. Bar – 20 µm. B) Bar graphs showing the average Ca2+ sparks frequency, C) Ca2+ 
sparks mass, D) Ca2+ leak in control and MI RV myocytes. (n=19-21 cells, N=3 rats, 
*p<0.05, ***p<0.001, by Mann-Whitney test). 
Table 10. Ca2+ sparks parameters measured in control and MI RV myocytes. 
 
RV CON RV MI 
Frequency, Nspark/µm/100s 0.9±0.2 2.2±0.4* 
Amplitude, F/F0 0.28±0.02 0.345±0.007** 
HMFW, µm 2.33±0.08 2.61±0.09* 
HMFD, ms 22.3±1.2 27.1±1.1* 
Time to peak, ms 11.7±0.5 13.5±0.7 
Tau, ms 26.5±2.0 27.8±1.7 
Ca2+ spark mass, 
n(F/F0)*m*s 
18.8±1.5 28.4±2.0** 
Ca2+ spark induced Ca2+ 
leak, p(F/F0)  
22.2±4.9 53.4±9.3*** 
Values are means ± S.E.M.; n = 19-21 cells, N= 3 rats, *P < 0.05, **P < 0.01, ***P 
< 0.001 vs. the CON RV. HMFW- Half maximum full width, HMFD- Half 
maximum full duration. 
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5.3.6 Hyperphosphorylation of LTCC in T-tubule of RV in post MI rats. 
Our resent work (Sanchez-Alonso et al., 2016) showed that MI in LV myocytes 
lead to redistribution of LTCC from a predominant localization at T-tubule to a 
crest domain. Moreover this relocalisation of LTCC from T-tubule to surface 
membrane was accompanied by hyperphosphorylation of crest LTCC via CaMKII. 
We hypothesize that changes of intracellular Ca2+ behaviour in RV could be 
promoted by relocalisation of LTCC in RV myocytes.  
The action of MI on spatial localization of LTCC in RV myocytes was analysed by 
super resolution scanning patch-clamp technique. Typical single LTCC recordings 
obtained holding -6.7 mV are presented in Figure 5.12. Higher activity of T-tubule 
LTCC can be mentioned in MI RV myocytes. 
 
Figure 5.12. Traces of single LTCC activity recorded at T-tubule or crest of RV 
myocytes from control and post MI rats. 
Study of LTCC spatial distribution in MI RV myocytes showed a ~30 % reduction 
of LTCC occurrence at T-tubule and a ~43 % reduction at crest as compared to T-
tubule and crest of control RV myocytes (Figure 5.13A). Analysis of LTCC density 
in T-tubule showed a slight (15%) increase of the channel density in post MI RV 
myocytes as compared to control ones (Figure 5.13B). Density of LTCC at T-tubule 
of RV was slightly changed in MI (Figure 5.13B), as the higher chance was to 
obtain multiple LTCC in the patch (Figure 5.13C).  
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Figure 5.13. LTCCs localization analysis in control and post MI RV myocytes. A) 
Single channel LTCC occurrence observed at T-tubule and crest of RV myocytes from 
control and post- MI myocytes. n/m- number of patches with LTCC/ total number of 
successful patches. B) Density of single channel LTCC activity observed at T-tubule and 
crest of control and post MI myocytes. C) Percentage of multi-channel LTCC patches from 
the total number of seals with a LTCC current. n1/n = number of patches with more than 
one LTCC/ total number of patches showing LTCC activity 
Open probability of T-tubule LTCC was significantly increased in MI RV myocytes 
as compared to control RV myocytes (MI: 0.26±0.05 vs. Control T-tubule: 
0.029±0.004, p<0.05, Figure 5.14). LTCC at crest of MI RV myocytes have similar 
open probability as LTCC at crest of control RV myocytes.  
 
  
Figure 5.14. Open probability of LTCC recorded at T-tubule and crest of RV 
myocytes from control and post MI rats. (n=5-15 channels from 41-66 myocytes, 10 
rats; *p<0.05, ***p<0.001, by Mann-Whitey test).  
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Current ̶ voltage dependence of LTCC located at T-tubule (Figure 5.15A) and crest 
(Figure 5.15B) of RV myocytes from control and MI rats was analysed. MI 
produced in RV myocytes a significant increase in conductance of the channel (MI 
T-tubule: 8.8±1.1 pS vs. control T-tubule: 17.8±2.1 pS, p<0.01, Figure 5.15C). 
 
Figure 5.15. Current-voltage (IV) characteristics of LTCC recorded at T-tubule or 
crest of control and MI RV myocytes. A) IV properties of LTCC recorded at T-tubule of 
Control and post MI RV myocytes, B) IV graphs of LTCC recorded at crest of control and 
post MI RV myocytes. (n=5-15 channels from 41-66 myocytes, 10 rats; *p<0.05 to the 
corresponding amplitude of LTCC in control RV myocytes, by Mann-Whitney test). C) 
LTCC conductance analysed at T-tubule and crests of control and post MI RV myocytes 
(n=5-15 channels from 41-66 myocytes, 10 rats; *p<0.05, **p<0.001, by Kruskal - Wallis 
test). 
5.3.6.1 Inhibition of PKA activity in T-tubule of RV myocytes return the properties 
of LTCC to control level  
In our previous work high open probability of LTCC located at the crest of MI LV 
myocytes was explained through the hyperphosphorylation of these channels via 
CaMKII (Sanchez-Alonso et al., 2016). Studies in human cardiomyocytes from HF 
patients recently indicated that in ischemic cardiomyopathy LTCC became highly 
activated at T-tubule of LV myocytes due to an increased PKA phosphorylation 
(Sanchez-Alonso et al., 2018). Here we tested the hypothesis that in MI RV 
myocytes LTCC was hyperphosphorylated by PKA.  
MI RV myocytes was treated with H89 to block PKA activity. Typical traces of 
single LTCC activity at T-tubule of Control, MI and MI treated with H89 are 
presented in Figure 5.16. Analysis of functional LTCC behaviour showed 
significant reduction of open probability of LTCC observed at T-tubule in MI 
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myocytes treated with H89 (MI + H89: 0.039±0.009 vs. MI: 0.26±0.05, p<0.001, 
Figure 5.17A). Open probability of control and MI treated with H89 are not 
significantly different. Conductance of T-tubule LTCC recorded in MI RV 
myocytes treated with H89 was significantly lower compared to conductance of 
LTCC in MI myocytes (MI+ H89 10.6±1.2 pS vs. MI 17.8±2.1 pS, p<0.001, Figure 
5.17B). Current-voltage characteristics of T-tubule LTCC in MI myocytes treated 
with H89 are similar to the characteristics of T-tubule LTCC of control RV 
myocytes (Figure 5.17B).  
 
Figure 5.16. Traces of LTCC recorded at T-tubule of RV myocytes isolated from 
control, MI and MI myocytes treated with H89 to block PKA activity. 
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Figure 5.17. Inhibition of PKA returned the properties of LTCC at T-tubule of MI 
RV myocytes back to control level. A) Open probability of LTCC measured at -6.7 mV 
in T-tubule of control RV, post-MI RV and post-MI RV myocytes in presence of H89, 
PKA antagonist (n of channels control- 17, MI – 12, MI +H89 – 5, ***p<0.001, by Kruskal-
Wallis test). B) Mean LTCC conductance at T-tubule of control, post-MI and post-MI 
treated with H89 RV myocytes. (n of channels control- 8, MI – 8, MI +H89 – 4, 
***p<0.001, by Kruskal-Wallis test). 
5.3.7 Molecular analysis of Cav1.2 expression and level or kinases activity in 
control and MI myocytes 
Western blot analysis was performed to check the relative expression of Cav1.2 and 
Cav3; also we wanted to understand the relative kinase activity in control and MI 
myocytes. Figure 5.18 and Figure 5.19 are presenting the blots of the proteins levels 
in control and MI RV and LV myocytes, respectively. Expression of Cav1.2 was 
similar in control and MI RVM (Figure 5.18B). According to (Bers, 2001), LTCC 
can be phosphorylated via PKA and CaMKII. In LV myocytes we observed high 
CaMKII activity with a reduced PKA phosphorylation (Figure 5.19), similar to 
observed before (Sanchez-Alonso et al., 2016). MI RV myocytes have similar 
levels of pPKA substrates expression and slightly higher pCaMKII level as 
compared to control RV myocytes (Figure 5.18B). As discussed before, Cav3 is 
important for caveolae, which houses LTCC in T-tubule and sarcolemma 
membrane (Balijepalli et al., 2006). Expression of Cav3 in MI RV myocytes was 
~50 % lower than in control RV myocytes (not significant, Figure 5.18B). 
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Figure 5.18. Western blot analysis of protein expression in control and MI RV 
myocytes. A) Representative blots of Cav1.2, pCaMKII, pPKA substrates, Cav3 and 
GAPDH protein levels in control and MI RV myocytes, B) Mean density of Cav1.2, 
pCaMKII, pPKA substrates, and cav3 normalized to GAPDH. (Control (C) n=4, MI n=3 
hearts). 
 
Figure 5.19 Western blot analysis of protein expression in control and MI LV 
myocytes. A) A representative blot showing Cav1.2, pCaMKII, pPKA substrate, Cav3 and 
GAPDH expression in the LV myocytes from control and MI rats. B) Relative average 
density of the pPKA band, pCaMKII and cav3 bands normalized to the GAPDH signal, 
(Control n=4 MI: n=4 rats). (Cav1.2 signal was almost undetectable). 
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5.4 Discussion  
Here we observed alterations in the shape of CMC from both RV and LV myocytes 
in MI rats (Figure 5.1). Myocytes from both RV and LV became significantly 
longer and wider, but RV changed to a lesser extent. The LWR was reduced in LV 
and not altered in RV myocytes after MI (Figure 5.1C). The shape of myocytes 
plays important role in maintaining the passive conductance properties, as was 
shown before (Van Rijen et al., 2004). Moreover the alterations of cells shape in 
HF could be accompanied with changes in surface topography and disturbance of 
TAT structure (Schobesberger et al., 2017). We observed significant flattering of 
surface topography in RV myocytes after MI (Figure 4.2), similar to what was 
observed in failing LV myocytes (Lyon et al., 2009; Sanchez-Alonso et al., 2016). 
That was accompanied by the reduction of TAT density and regularity in RV 
myocytes (Figure 5.5). In HF many researchers observed the disturbance of TAT 
network of LV myocytes (Louch et al., 2004; Lyon et al., 2009; Sanchez-Alonso et 
al., 2016). Analysis of TAT skeleton in control and MI RV myocytes showed 
significant reduction of skeleton length per area with preserved levels of A-tubules 
and T-tubules in MI RV myocytes (Figure 5.6 and 5.7). This could be related to a 
late stages of disease, Schobesberger et al. observed that after the initial grow of 
axial tubules on the 4 and 8 weeks after MI, then A-tubules were lost at the 16 
weeks of MI (Schobesberger et al., 2017). This overall reduction of TAT density in 
the late HF could be related to switch from adaptive to maladaptive remodelling in 
the heart and could be induced via increased wall stress observed in HF (Heinzel et 
al., 2008). Moreover, Stefanon and co-workers observed an increased deposition of 
collagen in extracellular matrix of RV and LV myocytes (Stefanon et al., 2013). 
This collagen deposition could promote tubular dilatation and loss (Crossman et al., 
2017). 
MI promoted also functional alterations of RV myocytes. We observed a 
significantly higher amplitude and longer decay of Ca2+ transients evoked by 1 Hz 
stimulation in MI RV myocytes as compared to control RV myocytes (Figure 5.8). 
There are some contradictions about the change of amplitude of Ca2+ transient in 
failing LV myocytes with some reports indicating smaller amplitude and longer 
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duration (Heinzel et al., 2008; Lyon et al., 2009), whereas other showed larger 
amplitude with a longer repolarization (Louch et al., 2006). In most of those studies 
the prolongation of the Ca2+ transient decay was promoted by down-regulation of 
SERCA2. Moreover, prolongation and desynchronization of Ca2+ transient 
activation was observed in LV myocytes and was addressed to disturbance of TAT 
network and formation of orphaned RyR2 (Heinzel et al., 2008; Louch et al., 2006). 
However this study showed that time to peak of Ca2+ transient, and “desynchrony 
index” were similar in control and MI RV myocytes (Figure 5.7 and 5.8).  
High frequency of spontaneous Ca2+ waves and Ca2+ sparks was found in MI RV 
myocytes (Figure 5.10 and 5.11). LV myocytes from failing rats  had a significantly 
higher frequency of Ca2+ sparks (Lyon et al., 2009). This high activity of RyR2 is 
usually linked with disturbance of surface membrane and TAT network (Mørk et 
al., 2009; Song et al., 2006). 
Moreover, we cannot exclude the increased sensitivity of RyR2 to cytosolic or 
luminal Ca2+ due to increased phosphorylation of RyRs by PKA, or CaMKII, or 
redox modification of RyRs (Terentyev et al., 2008). Whether these effects are 
modulated by a spatial loss of local control mechanisms, remain uncertain. Recent 
studies of RyR2 cluster organisation showed a higher dispersion of RyR2 clusters 
with an increased Ca2+ sparks activity (Jones et al., 2018; Macquaide et al., 2015). 
Ca2+ sparks in MIRV myocytes have higher mass and spark mediated Ca2+ leak was 
significantly higher in MI RV myocytes (Figure 5.11). This higher leak could 
trigger the additional Ca2+ releases and increase the rate of Ca2+ activity.  
TAT network disturbance could have a primary implications in LTCC localisation 
and function. After MI the occurence of LTCC in the patch was slightly less at both 
T-tubule and crest as compared with control RV myocytes (Figure 5.13). The single 
channel density of LTCC at T-tubule was preserved probably due to higher chance 
of multi-channel occurrence (Figure 5.13B and 5.13C). 
LTCC located at T-tubule of MI RV myocytes have higher conductance and higher 
open probability, whereas crest-LTCC in MI RV myocytes were similar to control 
ones (Figure 5.14 and Figure 5.15). In failing LV myocytes local control of LTCC 
was also observed with a higher Po of crest LTCC subpopulation (Bryant et al., 
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2015; Sanchez-Alonso et al., 2016). Moreover, local regulation was also observed 
in atrial MI cells, which have the preserved LTCC occurrence but the T-tubule 
LTCC conductance was reduced(Glukhov et al., 2015). This regulation could be an 
attempt of myocytes to maintain its loading condition under the increased stress 
induced by HF. TAT network disturbance and Cav3 down-regulation in MI RV 
myocytes could promote the loss of LTCC its native localization and 
hyperphosphorylation. 
Our recent findings showed that phosphorylation of LTCC located in different 
microdomains is produced by different kinases. Higher activity of the crest LTCC 
in LV myocytes was found to be induced via CaMKII hyperphosphorylation 
(Sanchez-Alonso et al., 2016). However, our study in failing human myocytes 
showed that LTCC in T-tubule could be locally phosphorylated by PKA (Sanchez-
Alonso et al., 2018). Phosphorylation of L-type Ca2+ channels by PKA increases 
the probability and duration of the open state of the channels (Neumann et al., 
1991). We applied H89 the PKA antagonist on MI myocytes and found significant 
reduction of both open probability and mean conductance back to the control values 
(Figure 5.17). Moreover, the total level of pPKA substrates was similar in control 
and MI RV myocytes, suggesting a possible local activation of the kinase. Increased 
PKA stimulation could be due to intensive cAMP production and cAMP 
compartmentation (Ather et al., 2013; Nikolaev et al., 2010). Loss of local cAMP 
signals was observed in failing LV myocytes (Lyon et al., 2009). PKA could also 
phosphorylate the RyR2 and hyperphosphorylation of RyR2 in HF leads to a ‘leaky’ 
channel phenotype, causing increased Ca2+ sparks and Ca2+ waves activity (Ono et 
al., 2000; Reiken et al., 2003). 
5.4.1 Conclusion 
In conclusion for this chapter, we could mention a different degree of structural and 
functional changes between RV and LV myocytes observed after 16 weeks of MI. 
The MI –induced remodelling of TATS, flattening of z-grooves, and distribution of 
LTCC are less severe in the RV myocytes than in the LV myocytes probably due 
to the more distant location of the RV myocytes from the infarcted area. These 
structural changes in RV myocytes are strong enough to induce a significant 
increase in spontaneous Ca2+ spark rate and an elevated Po of the LTCC in T-
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tubules, perhaps as a result of local PKA phosphorylation. In the LV myocytes, as 
we have discovered previously, functional LTCC redistribute from T-tubular to 
crest location, with activation of crest subpopulation of LTCC by local CaMKII-
mediated phosphorylation (Sanchez-Alonso et al., 2016). Thus, MI induces 
remodelling of different molecular pathways in RV and LV myocytes; however, it 
still remains to be studied whether these differences in pathways RV and LV 
myocytes occur due to different severity of MI-induced changes or due to intrinsic 
properties of RV and LV myocytes. 
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6 General discussion, limitations and future work 
6.1 General discussion 
Current study provides an evidence of structure- function relationship for rat RV 
myocytes. We observed differences in membrane organisation in RV versus LV 
myocytes, which could be responsible for a cascade of functional alterations, for 
example, observed differences in Cav1.2 density. Structure of the cells greatly 
affects the functioning of these cells, and we found pronounced changes in 
functioning of RV and LV myocytes; such as: the rate of Ca2+ activity, 
synchronization of Ca2+ transient activation, spatial Ca2+ sparks distribution and 
LTCC localization and open probability. These results are clearly indicates the 
importance of structural-functional relationship for cardiac myocytes. 
Our work using the model of PH allowed us to conclude that even at the early stages 
both the RV and LV function was already changed. The RV is more suffering in 
the disease as it is directly linked with pulmonary vein, but the alterations of the 
LV cannot be neglected. The summary for Ca2+ handling alterations in RV 
myocytes is presented in Figure 6.1. PH myocytes have different shape and this 
affects both impulse propagation and spontaneous Ca2+ activity. Internal membrane 
reorganisation and reduced surface folding produced slower Ca2+ transients, a 
higher rate of local Ca2+ activity and an altered LTCC membrane localization. 
Colocalization of LTCCs with RyR2s was not reduced in PH. LV myocytes were 
atrophied with an increased complexity of TAT network and exhibited a longer 
Ca2+ releases. The results of this study will provide an insight on the mechanism of 
pathological changes in RV and LV under PH. 
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Figure 6.1. Schematic of PH-induced alterations in RV myocytes. Control RV myocytes 
have a highly organized surface membrane and TAT network that produce an efficient 
coupling between LTCC and RyR2. The Ca2+ efflux through LTCC is highly localized that 
can reach only closely located RyR2. In PH RV surface structure regularity and TAT 
structure deteriorates producing more spread Ca2+ influx from LTCC which could trigger 
more Ca2+ sparks from the RyR2.  
The 5th chapter highlighted the RV -specific changes in microdomain organisation 
under the HF. The major discovery of this part is that a disruption in the membrane 
organisation after the failure of RV lead to hyperactivation of Ca2+ released 
channels in T-tubules, which can promote pathological changes in cellular 
physiology. Importantly, the changes on the cellular level were close to those 
occurred in LV myocytes, such as Z-groove reduction, TAT disturbance and Ca2+ 
transient prolongation. But on the microdomain level the reorganisation of RV 
myocytes was significantly different from the LV myocytes with preserving Ca2+ 
transient activation, reorganisation of LTCC located at T-tubule in clusters with a 
higher open probability and conductance. Long open states of LTCCs are 
particularly pro-arrhythmic in the setting of AP prolongation (Sanchez-Alonso et 
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al., 2016). Thus, our results indicated different mechanisms of microdomain 
regulation in RV and LV myocytes during HF and provide a new dimension in 
understanding of disease pathophysiology. But the understanding of the effect of 
these local alterations on cellular and organ behaviour will require the addition 
study. 
6.2 Study Limitations 
6.2.1 Differences between rat and human studies. 
Animal models are usually good starting point for investigation of disease 
progression understanding of the underlying mechanisms but it has to be mentioned 
that not all of the observed findings can be directly implemented in humans. There 
are some strong differences in the physiology of humans and rodents. These 
alterations were discussed in details in Chapter 1. The human heart is beating at a 
slower rate and produces significantly longer action potentials (Wagner et al., 
2009). On the cellular level, Ca2+ transients were significantly different in rats, 
whereas in large mammalian they showed just a different notch phase (Di Diego et 
al., 1996; Volders et al., 1999). The TAT membrane of human myocytes is far less 
organized than in the rat myocytes producing lower Ca2+ signal compartmentation 
in human cells (Schobesberger et al., 2017; Song et al., 2005). Therefore, the 
observed findings need to be proved directly in the human studies. 
6.2.2 Limitations of cellular studies for the structural analysis of cell morphology 
and TAT structure 
Isolated cardiomyocytes provide a great platform for investigation of cellular and 
sub-cellular physiology such as visualizing the cellular structure and precise 
localization of intracellular molecules. However, this model has several weak 
points such as loss of tissue integrity, including connections between neighbouring 
cardiac cells and the extracellular matrix and potential damage of the cells (Louch 
et al., 2011). Also, isolation has a potential risk of selecting the strongest cells from 
the heterogeneous population. Multicellular preparations, including isolated whole 
hearts and intact tissue samples (isolated trabeculae/ perfused tissue wedges), 
would be useful to avoid the issues associated with cell isolation (Watson et al., 
2019). However, the work with these preparations requires a certain level of tissue 
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transparency or producing thin slices. Our preliminary experiments including 
visualisation of TAT in fixed RV and LV tissue using wheat germ agglutinin were 
not successful.  
6.2.3 Limitations of cellular studies for the functional analysis 
Work with isolated cells allowed to investigate local alterations in microdomain 
organized Ca2+ signalling in ventricular myocytes. However, a direct implication of 
these findings into the functioning of the whole ventricle is complicated. The RV 
and LV are working under a certain pressure and loading conditions, removal of 
this load will drastically alter the behaviour of the ventricles (Müller-Strahl et al., 
2003). In PH patients multiple clinical and experimental studies showed that 
pressure overload in RV lead to impaired LV stroke volume and systolic pressure 
(Markus et al., 2001). However, when the pressure overload was removed in ex vivo 
and in vitro experiments, the LV was shown to develop the normal pressures (Han 
et al., 2018). Thus the ventricular loading conditions should be taken in account 
when the conclusions are drawing. 
6.2.4 Early and delayed Ca2+ sparks analysis. 
We performed the analysis of Ca2+ sparks localization based on assumption that 
TTF50 of Ca2+ transient is correlated with the distance to the nearest membrane. 
We used the methodology of Heinzel et al. to analysed the properties of early and 
delayed Ca2+ sparks (Heinzel et al., 2002). For a certain proof of the relation 
between Ca2+ transient TTF50 measured in this thesis and distance to the tubules a 
double staining protocol is needed, like was done in (Dries et al., 2013). They 
revealed a direct correlation between the two parameters in pig myocytes and 
divided the sparks in coupled, located < 0.5 µm to T-tubule from uncoupled, located 
> 2 µm from the membrane (Dries et al., 2013). Unfortunately, technical 
complications did not allow us to perform similar experimental setup. Thus we 
called sparks early and delayed assuming that separation was performed in 
accordance only with Ca2+ transient.  
6.2.5 H89 is not a specific PKA blocker 
In chapter 5 H89 was used as PKA antagonist to reveal the role of PKA 
phosphorylation in regulation of T-tubule LTCC in RV myocytes. There are many 
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evidences identified that H89 is not a specific PKA blocker, it can block another 8 
protein kinases (Davies et al., 2000; Lochner and Moolman, 2006). Most of these 
kinases do not target LTCC, but at concentration of 10 µM H89 was shown to affect 
the sarcoplasmic reticulum Ca2+-uptake (Lahouratate et al., 1997) , K+ channels 
(Sun Park et al., 2006), and phosphatidylcholine biosynthesis (Wieprecht et al., 
1994). Some of these factors could indirectly affect the LTCC behaviour, so the 
data should be interpreted with care. 
6.3 Prospective 
In order to have the translational data we wish to make the model of RV myocytes 
and implement our findings of LTCC and Ca2+ sparks behaviour in control and PH 
RV myocytes and translate observed results in arrhythmogenesis in the whole heart. 
Similar approach was made previously with the use of a model of single myocytes 
(Grandi et al., 2010; Shannon and Bers, 2004) modified according to the observed 
relocation and hyperphosphorylation of LTCC in failing LV myocytes (Sanchez-
Alonso et al., 2016). They implemented single cell model into three dimensional 
model of left ventricle (Moreno et al., 2011). Using this modelling process it was 
possible to link the changes of TAT network and LTCC localization with EADs 
observed on cellular level and that EADs could produce the formation of re-entrant 
arrhythmias on the whole heart level (Sanchez-Alonso et al., 2016).  
As was said in section 6.1.2, lack of mechanical load in isolated myocytes reduced 
the significance of the obtained results. In chapter 4 we tried to link the alterations 
on the cellular level in RV and LV myocytes with the electrophysiological data 
obtained in vivo. Some of the single cell data could affect the conduction velocity 
in the ventricles, such as, for example, alterations in sell shape and dimensions (see 
paragraph 4.3.2). Unfortunately, other properties of the RV and LV in vivo are load-
dependent and for this reason no clear correlation with single cell data can be 
provided. One of the approached to overcome these differences is to study tissue 
slices that can be cultivates and kept at certain loading conditions, mimicking the 
loading conditions in vivo (Watson et al., 2019).  
Observed TAT network organisation and LTCC spatial localization of RV 
myocytes were close to partially unloaded LV. One of the resent works of Ibrahim 
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et al. showed that unloaded failing hearts have myocytes with partial restored 
structural organisation and Ca2+ handling (Ibrahim et al., 2012). These observations 
drive us to hypothesize that loading conditions have the leading role in membrane 
organisation of myocytes.  
6.4 Clinical implications 
PH and HF could led to pathological increase in RV load and promote the 
maladaptive remodelling of RV leading to RV hypertension and failure (Handoko 
et al., 2010). The progress in treatment allowed reducing the mortality rate in PH 
patients, but there is still no treatments directed to RV (Thenappan et al., 2018). 
The results of RV studies in both PH and MI showed the importance of LTCC in 
disease progression. Ca2+ channel blockers are among the commonly used therapies 
for HF and could be used for some patients with PH (Thenappan et al., 2018). The 
applicability of Ca2+ channel blockers is determined by the vasodilatation test 
(Sitbon et al., 2010). These patients who treated with these drugs have a high five 
years survival rate ~90% (Rich et al., 1992). But these drugs are nonspecific 
blockers, the results of this thesis could give the possibility to treat the LTCC 
located at T-tubule as a target of the therapy. This work could provide the 
theoretical basement of further studies of the RV progression in disease 
development and could help to find the new treatment approaches.  
6.5 Conclusions  
Microdomain organisation of cardiac myocytes plays an important role in maintain 
ECC in health and under pathophysiological changes. More and more studies 
confirmed that in disease the disorganisation alterations of a small microdomain 
organisation such as TAT network disruption (Lyon et al., 2009; Schobesberger et 
al., 2017), dispersion of RyR2 clusters (Kolstad et al., 2018) and LTCC localization 
(Sanchez-Alonso et al., 2016) are responsible for the impaired contractility and 
could provoke arrhythmogenic activity. As compared to LV myocytes the 
organisation of RV myocytes are far less studied and understood. In this thesis we 
demonstrated that RV myocytes have a distinct membrane organisation and altered 
Ca2+ handling as compared to LV myocytes. PH and MI both promote a pronounced 
remodelling of TAT network and LTCC spatial localization, promoting higher 
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spontaneous Ca2+ activity and more desynchronous activation of Ca2+ transients and 
producing the pro-arrhythmogenic substrate in RV. Thus, our multilevel 
investigation showed the complex nature of the RV remodelling in disease. 
Moreover, in both PH and MI models we observed alterations of structure and 
function of both RV and LV myocytes, suggesting the importance of investigation 
all of the chambers in disease. 
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